Section 52

EurekaMag PDF full texts Chapter 51,886


Han, X.; Zhou, D-Bin.; Duan, M-Hui.; Hua, B-Lai.; Wang, X.; Zhang, J-Ping.; Zhao, Y-Qiang.; Shen, T.; Wu, Y-Ji. 2014: C/EBPα in multiple myeloma patients may lead to increased hepcidin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22(5): 1316-1320
Collins, C.; Wang, J.; Miao, H.; Bronstein, J.; Nawer, H.; Xu, T.; Figueroa, M.; Muntean, A.G.; Hess, J.L. 2014: C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America 111(27): 9899-9904
Norrie, I.C.; Ohlsson, E.; Nielsen, O.; Hasemann, M.S.; Porse, B.T. 2014: C/EBPα is dispensable for the ontogeny of PD-1+ CD4+ memory T cells but restricts their expansion in an age-dependent manner. Plos one 9(1): E84728
Welner, R.S.; Bararia, D.; Amabile, G.; Czibere, A.; Benoukraf, T.; Bach, C.; Wansa, K.D.S.A.; Ye, M.; Zhang, H.; Iino, T.; Hetherington, C.J.; Akashi, K.; Tenen, D.G. 2013: C/EBPα is required for development of dendritic cell progenitors. Blood 121(20): 4073-4081
Hasemann, M.S.; Lauridsen, F.K.B.; Waage, J.; Jakobsen, J.S.; Frank, A.-K.; Schuster, M.B.; Rapin, N.; Bagger, F.O.; Hoppe, P.S.; Schroeder, T.; Porse, B.T. 2014: C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors. Plos Genetics 10(1): E1004079
Pulikkan, J.A.; Peramangalam, P.S.; Dengler, V.; Ho, P.A.; Preudhomme, C.; Meshinchi, S.; Christopeit, M.; Nibourel, O.; Müller-Tidow, C.; Bohlander, S.K.; Tenen, D.G.; Behre, G. 2010: C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116(25): 5638-5649
Lee, B.; Qiao, L.; Lu, M.; Yoo, H.S.; Cheung, W.; Mak, R.; Schaack, J.; Feng, G.-S.; Chi, N.-W.; Olefsky, J.M.; Shao, J. 2014: C/EBPα regulates macrophage activation and systemic metabolism. American Journal of Physiology. Endocrinology and Metabolism 306(10): E1144-E1154
Chen, W.; Zhu, G.; Hao, L.; Wu, M.; Ci, H.; Li, Y.-P. 2013: C/EBPα regulates osteoclast lineage commitment. Proceedings of the National Academy of Sciences of the United States of America 110(18): 7294-7299
Dooher, J.E.; Paz-Priel, I.; Houng, S.; Baldwin, A.S.; Friedman, A.D. 2011: C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction. Molecular Cancer Research: Mcr 9(10): 1395-1405
Roe, J.-S.; Vakoc, C.R. 2014: C/EBPα: critical at the origin of leukemic transformation. Journal of Experimental Medicine 211(1): 1-4
Mizutani, T.; Ju, Y.; Imamichi, Y.; Osaki, T.; Yazawa, T.; Kawabe, S.; Ishikane, S.; Matsumura, T.; Kanno, M.; Kamiki, Y.; Kimura, K.; Minamino, N.; Miyamoto, K. 2014: C/EBPβ (CCAAT/enhancer-binding protein β) mediates progesterone production through transcriptional regulation in co-operation with SF-1 (steroidogenic factor-1). Biochemical Journal 460(3): 459-471
Luft, F.C. 2015: C/EBPβ LIP induces a tumor menagerie making it an oncogene. Journal of Molecular Medicine 93(1): 1-3
Zhang, K.; Li, J.; Meng, W.; Xing, H.; Yang, Y. 2010: C/EBPβ and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro. International Journal of Hematology 92(4): 571-578
Hirata, M.; Kugimiya, F.; Fukai, A.; Saito, T.; Yano, F.; Ikeda, T.; Mabuchi, A.; Sapkota, B.R.; Akune, T.; Nishida, N.; Yoshimura, N.; Nakagawa, T.; Tokunaga, K.; Nakamura, K.; Chung, U.-i.; Kawaguchi, H. 2012: C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes. Human Molecular Genetics 21(5): 1111-1123
Henriquez, B.; Hepp, M.; Merino, P.; Sepulveda, H.; van Wijnen, A.J.; Lian, J.B.; Stein, G.S.; Stein, J.L.; Montecino, M. 2011: C/EBPβ binds the P1 promoter of the Runx2 gene and up-regulates Runx2 transcription in osteoblastic cells. Journal of Cellular Physiology 226(11): 3043-3052
Boström, P.; Mann, N.; Wu, J.; Quintero, P.A.; Plovie, E.R.; Panáková, D.; Gupta, R.K.; Xiao, C.; MacRae, C.A.; Rosenzweig, A.; Spiegelman, B.M. 2010: C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143(7): 1072-1083
Anastasov, N.; Bonzheim, I.; Rudelius, M.; Klier, M.; Dau, T.; Angermeier, D.; Duyster, J.; Pittaluga, S.; Fend, F.; Raffeld, M.; Quintanilla-Martinez, L. 2010: C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 95(5): 760-767
Choudhury, M.; Qadri, I.; Rahman, S.M.; Schroeder-Gloeckler, J.; Janssen, R.C.; Friedman, J.E. 2011: C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells. Molecular and Cellular Endocrinology 331(1): 102-108
Satake, S.; Hirai, H.; Hayashi, Y.; Shime, N.; Tamura, A.; Yao, H.; Yoshioka, S.; Miura, Y.; Inaba, T.; Fujita, N.; Ashihara, E.; Imanishi, J.; Sawa, T.; Maekawa, T. 2012: C/EBPβ is involved in the amplification of early granulocyte precursors during candidemia-induced "emergency" granulopoiesis. Journal of Immunology 189(9): 4546-4555
Zou, J.; Li, H.; Chen, X.; Zeng, S.; Ye, J.; Zhou, C.; Liu, M.; Zhang, L.; Yu, N.; Gan, X.; Zhou, H.; Xian, Z.; Chen, S.; Liu, P. 2014: C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB. Molecular and Cellular Endocrinology 390(1-2): 18-25
Cui, T.X.; Lin, G.; LaPensee, C.R.; Calinescu, A.-A.; Rathore, M.; Streeter, C.; Piwien-Pilipuk, G.; Lanning, N.; Jin, H.; Carter-Su, C.; Qin, Z.S.; Schwartz, J. 2011: C/EBPβ mediates growth hormone-regulated expression of multiple target genes. Molecular Endocrinology 25(4): 681-693
Fu, S.-L.; Pang, H.; Xu, J.-Z.; Wu, X.-H. 2014: C/EBPβ mediates osteoclast recruitment by regulating endothelial progenitor cell expression of SDF-1α. Plos one 9(3): E91217
Liu, X.; Liu, K.; Qin, J.; Hao, L.; Li, X.; Liu, Y.; Zhang, X.; Liu, X.; Li, P.; Han, S.; Mao, Z.; Shen, L. 2015: C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma. International Journal of Cancer 136(11): 2524-2534
Bilodeau, M.S.; Arguin, G.; Gendron, F.-P. 2015: C/EBPβ regulates P2X7 receptor expression in response to glucose challenge in intestinal epithelial cells. Biochemistry and Cell Biology 93(1): 38-46
Gonnella, P.; Alamdari, N.; Tizio, S.; Aversa, Z.; Petkova, V.; Hasselgren, P.-O. 2011: C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. Journal of Cellular Biochemistry 112(7): 1737-1748
Atwood, A.A.; Sealy, L.J. 2011: C/EBPβ's role in determining Ras-induced senescence or transformation. Small Gtpases 2(1): 41-46
Buck, M.; Chojkier, M. 2011: C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice. Plos one 6(10): E25497
Alberich-Jordà, M.; Wouters, B.; Balastik, M.; Shapiro-Koss, C.; Zhang, H.; Di Ruscio, A.; DiRuscio, A.; Radomska, H.S.; Ebralidze, A.K.; Amabile, G.; Ye, M.; Zhang, J.; Lowers, I.; Avellino, R.; Melnick, A.; Figueroa, M.E.; Valk, P.J.M.; Delwel, R.; Tenen, D.G. 2012: C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. Journal of Clinical Investigation 122(12): 4490-4504
Huggins, C.J.; Malik, R.; Lee, S.; Salotti, J.; Thomas, S.; Martin, N.; Quiñones, O.A.; Alvord, W.G.; Olanich, M.E.; Keller, J.R.; Johnson, P.F. 2013: C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ. Molecular and Cellular Biology 33(16): 3242-3258
Pawar, S.A.; Shao, L.; Chang, J.; Wang, W.; Pathak, R.; Zhu, X.; Wang, J.; Hendrickson, H.; Boerma, M.; Sterneck, E.; Zhou, D.; Hauer-Jensen, M. 2014: C/EBPδ deficiency sensitizes mice to ionizing radiation-induced hematopoietic and intestinal injury. Plos one 9(4): E94967
Borrelli, S.; Fanoni, D.; Dolfini, D.; Alotto, D.; Ravo, M.; Grober, O.ì M.V.; Weisz, A.; Castagnoli, C.; Berti, E.; Vigano, M.A.; Mantovani, R. 2010: C/EBPδ gene targets in human keratinocytes. Plos one 5(11): E13789
Kyme, P.; Thoennissen, N.H.; Tseng, C.W.; Thoennissen, G.B.; Wolf, A.J.; Shimada, K.; Krug, U.O.; Lee, K.; Müller-Tidow, C.; Berdel, W.E.; Hardy, W.D.; Gombart, A.F.; Koeffler, H.P.; Liu, G.Y. 2012: C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. Journal of Clinical Investigation 122(9): 3316-3329
Cai, R.; Cai, X.; Chen, B.; Xu, W.; Lu, J. 2010: C/EBPε participates in all-trans retinoic acid induction of PI3Kγ in U937 cells via an intronic matrix attachment region sequence. Molecular Biology Reports 37(8): 3795-3800
Grigonis, M.; Knystautas, E.J. 1997: C/Si multilayer mirrors for the 25-30-nm wavelength region. Applied Optics 36(13): 2839-2842
Bain, B.J. 2009: C/beta(0) thalassemia. American Journal of Hematology 84(11): 749
Chen, C.; Liu, Y.; Chen, Y.; Xu, J. 2011: C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors. Cancer Biology and Therapy 12(9): 797-807
Yoshida, H. 2010: C1 (q, r, s). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 57-59
Talman, V.; Tuominen, R.K.; Boije af Gennäs, G.; Gennäs, G.B.A.; Yli-Kauhaluoma, J.; Ekokoski, E. 2011: C1 Domain-targeted isophthalate derivatives induce cell elongation and cell cycle arrest in Hela cells. Plos one 6(5): E20053
D'Auria, E.; Bergamini, M.; Staiano, A.; Banderali, G.; Pendezza, E.; Penagini, F.; Zuccotti, G.Vincenzo.; Peroni, D.Giampietro. 2018: Baby-led weaning: what a systematic review of the literature adds on. Italian Journal of Pediatrics 44(1): 49
Maurya, P.; Singh, K.; Sharma, V. 2009: C1 and C2 nerve sheath tumors: analysis of 32 cases. Neurology India 57(1): 31-35
Hovhannisyan, A.; Pham, T.H.; Bouvier, D.; Qin, L.; Melikyan, G.; Reboud-Ravaux, M.èl.; Bouvier-Durand, M. 2013: C1 and N5 derivatives of cerpegin: synthesis of a new series based on structure-activity relationships to optimize their inhibitory effect on 20S proteasome. Bioorganic and Medicinal Chemistry Letters 23(9): 2696-2703
Proverbio, A.M.; Adorni, R. 2009: C1 and P1 visual responses to words are enhanced by attention to orthographic vs. lexical properties. Neuroscience Letters 463(3): 228-233
Rahme, R.; Koussa, S.; Samaha, E. 2009: C1 arch regeneration, tight cisterna magna, and cervical syringomyelia following foramen magnum surgery. Surgical Neurology 72(1): 83
Zhang, M.; Xia, H.; Li, X.; Wang, X.; Dong, Y.; Zhang, T.; Yu, H. 2010: C1 domain mediates CalDAGIIi localization to the Golgi. Molecular Biology Reports 37(7): 3481-3485
Meems, H.ët.; van den Biggelaar, M.; Rondaij, M.; van der Zwaan, C.; Mertens, K.; Meijer, A.B. 2011: C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIIi. International Journal of Biochemistry and Cell Biology 43(8): 1114-1121
Talman, V.; Provenzani, R.; Boije af Gennäs, G.; Tuominen, R.K.; Yli-Kauhaluoma, J. 2014: C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure-activity relationships and biological activities. Biochemical Society Transactions 42(6): 1543-1549
Das, J.; Rahman, G.M. 2014: C1 domains: structure and ligand-binding properties. Chemical Reviews 114(24): 12108-12131
Yamazaki, M.; Okawa, A.; Mannoji, C.; Kadota, R.; Miyashita, T.; Koda, M. 2009: C1 dome-like laminotomy and posterior C1-C2 polyaxial screw-rod fixation for a patient with cervical myelopathy due to a retro-odontoid pseudotumor. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 16(1): 99-103
Fitzpatrick, J.C.; Clark, P.M.; Capaldi, F.M. 2010: Effect of decellularization protocol on the mechanical behavior of porcine descending aorta. International Journal of Biomaterials 2010(7 Section 2: 2-3
Tamura, N.; Kimura, S.; Farhana, M.; Uchida, T.; Suzuki, K.; Sugihara, K.; Itoh, H.; Ikeda, T.; Kanayama, N. 2014: C1 esterase inhibitor activity in amniotic fluid embolism. Critical Care Medicine 42(6): 1392-1396
Craig, T.J.; Bewtra, A.K.; Bahna, S.L.; Hurewitz, D.; Schneider, L.C.; Levy, R.J.; Moy, J.N.; Offenberger, J.; Jacobson, K.W.; Yang, W.H.; Eidelman, F.; Janss, G.; Packer, F.R.; Rojavin, M.A.; Machnig, T.; Keinecke, H.-O.; Wasserman, R.L. 2011: C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study. Allergy 66(12): 1604-1611
Duehrkop, C.; Banz, Y.; Spirig, R.; Miescher, S.; Nolte, M.W.; Spycher, M.; Smith, R.A.G.; Sacks, S.H.; Rieben, R. 2013: C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage. Plos one 8(8): E72059
Kocsis, I.án.; Gál, J.án. 2014: C1 esterase inhibitor: a biomarker for amniotic fluid embolism?. Critical Care Medicine 42(6): 1548-1549
Hudek, R.; Wanner, G.; Simmen, H-Peter.; Werner, Cément.M.L. 2013: C1 fracture in a patient with a congenital cleft in the posterior arch: report on a failed conservative treatment. BMJ Case Reports
Packer, F.R. 2013: C1 inhibitor concentrate treatment of multiple laryngeal attacks in a 53-year-old woman with hereditary angioedema. ImmunoTherapy 5(8): 855-857
Tapisiz, A.; Ergenekon, E.; Oktem, M.; Koc, E.; Okumus, N.; Zenciroğlu, A.ül.; Atalay, Y. 2010: C1 inhibitor level on neonatal sepsis and its relations with clinical findings. Journal of Paediatrics and Child Health 46(3): 121-124
Mejia, P.; Davis, A.E. 2012: C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria. Shock 38(2): 220-225
Kalfus, I.; Frank, M. 2010: C1 inhibitor therapy and hereditary angioedema. American Journal of Medicine 123(4): E15; Author Reply E17
Arinola, G.; Ezeh, C. 2007: C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with plasmodium falciparum. Iranian Journal of Immunology: Iji 4(1): 44-49
Davis, A.E.; Lu, F.; Mejia, P. 2010: C1 inhibitor, a multi-functional serine protease inhibitor. Thrombosis and Haemostasis 104(5): 886-893
Wouters, D.; Wagenaar-Bos, I.; van Ham, M.; Zeerleder, S. 2008: C1 inhibitor: just a serine protease inhibitor? new and old considerations on therapeutic applications of C1 inhibitor. Expert Opinion on Biological Therapy 8(8): 1225-1240
Varga, L.; Dobó, J.óz. 2014: C1 inhibitor: quantification and purification. Methods in Molecular Biology 1100: 189-205
Seal, C.; Zarro, C.; Gelb, D.; Ludwig, S. 2009: C1 lateral mass anatomy: Proper placement of lateral mass screws. Journal of Spinal Disorders and Techniques 22(7): 516-523
Mummaneni, P.V.; Lu, D.C.; Dhall, S.S.; Mummaneni, V.P.; Chou, D. 2010: C1 lateral mass fixation: a comparison of constructs. Neurosurgery 66(3 Suppl): 153-160
Pan, J.; Li, L.; Qian, L.; Tan, J.; Sun, G.; Li, X. 2010: C1 lateral mass screw insertion with protection of C1-C2 venous sinus: technical note and review of the literature. Spine 35(21): E1133-E1136
Yin, Y-heng.; Yu, X-guang.; Qiao, G-yu.; Guo, S-li.; Zhang, J-ning. 2014: C1 lateral mass screw placement in occipitalization with atlantoaxial dislocation and basilar invagination: a report of 146 cases. Spine 39(24): 2013-2018
Lin, J.M.; Hipp, J.A.; Reitman, C.A. 2013: C1 lateral mass screw placement via the posterior arch: a technique comparison and anatomic analysis. Spine Journal: Official Journal of the North American Spine Society 13(11): 1549-1555
Squires, J.; Molinari, R.W. 2010: C1 lateral mass screw placement with intentional sacrifice of the C2 ganglion: functional outcomes and morbidity in elderly patients. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(8): 1318-1324
Conroy, E.; Laing, A.; Kenneally, R.; Poynton, A.R. 2010: C1 lateral mass screw-induced occipital neuralgia: a report of two cases. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(3): 474-476
Tan, J.; Li, L.; Sun, G.; Qian, L.; Yang, M.; Zeng, C.; Teng, H.; Jia, L. 2009: C1 lateral mass-C2 pedicle screws and crosslink compression fixation for unstable atlas fracture. Spine 34(23): 2505-2509
Sasso, R.C. 2007: C1 lateral screws and C2 pedicle/pars screws. Instructional Course Lectures 56: 311-317
Song, Z.-B.; Xiao, S.-Q.; You, L.; Wang, S.-S.; Tan, H.; Li, K.-Z.; Chen, L.-M. 2013: C1 metabolism and the Calvin cycle function simultaneously and independently during HCHO metabolism and detoxification in Arabidopsis thaliana treated with HCHO solutions. Plant Cell and Environment 36(8): 1490-1506
Witthoff, S.; Mühlroth, A.; Marienhagen, J.; Bott, M. 2013: C1 metabolism in Corynebacterium glutamicum: an endogenous pathway for oxidation of methanol to carbon dioxide. Applied and Environmental Microbiology 79(22): 6974-6983
Zhang, W.; Tang, L.; Sun, H.; Han, S.; Wang, X.; Zhou, S.; Li, K.; Chen, L. 2014: C1 metabolism plays an important role during formaldehyde metabolism and detoxification in petunia under liquid HCHO stress. Plant Physiology and Biochemistry: Ppb 83: 327-336
Sevigny, C.P.; Bassi, J.; Teschemacher, A.G.; Kim, K.S.; Williams, D.A.; Anderson, C.R.; Allen, A.M. 2008: C1 neurons in the rat rostral ventrolateral medulla differentially express vesicular monoamine transporter 2 in soma and axonal compartments. European Journal of Neuroscience 28(8): 1536-1544
Ma, X.-Y.; Yin, Q.-S.; Wu, Z.-H.; Xia, H.; Liu, J.-F.; Xiang, M.; Zhao, W.-D.; Zhong, S.-Z. 2009: C1 pedicle screws versus C1 lateral mass screws: comparisons of pullout strengths and biomechanical stabilities. Spine 34(4): 371-377
Jellema, E.; Jongerius, A.L.; Reek, J.N.H.; de Bruin, B. 2010: C1 polymerisation and related C-C bond forming 'carbene insertion' reactions. Chemical Society Reviews 39(5): 1706-1723
Jin, G-Xin.; Wang, H.; Li, L.; Cui, S-Qian.; Duan, J-Zhu. 2013: C1 posterior arch crossing screw fixation for atlantoaxial joint instability. Spine 38(22): E1397-E1404
Kubota, H.; Sanada, Y.; Yoshioka, H.; Tasaki, T.; Shiroma, J.; Miyauchi, M.; Tanikawa, R.; Matsuki, M.; Ohtsuki, T.; Kato, A. 2015: C1 transverse process-hyoid bone line for preoperative evaluation of the accessible internal carotid artery on carotid endarterectomy: technical note. Acta Neurochirurgica 157(1): 43-48
Papahatjis, D.P.; Nahmias, V.R.; Nikas, S.P.; Andreou, T.; Alapafuja, S.O.; Tsotinis, A.; Guo, J.; Fan, P.; Makriyannis, A. 2007: C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols. Journal of Medicinal Chemistry 50(17): 4048-4060
Beinrohr, László.; Dobó, József.; Závodszky, Péter.; Gál, Péter. 2008: C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends in Molecular Medicine 14(12): 511-521
Dasari, R.; Banuls, L.M.Y.; Masi, M.; Pelly, S.C.; Mathieu, V.ér.; Green, I.R.; van Otterlo, W.A.L.; Evidente, A.; Kiss, R.; Kornienko, A. 2014: C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells. Bioorganic and Medicinal Chemistry Letters 24(3): 923-927
Kareev, I.E.; Kuvychko, I.V.; Shustova, N.B.; Lebedkin, S.F.; Bubnov, V.P.; Anderson, O.P.; Popov, A.A.; Boltalina, O.V.; Strauss, S.H. 2008: C1-(C84-C2(11))(CF3)12: trifluoromethylation yields structural proof of a minor C84 cage and reveals a principle of higher fullerene reactivity. Angewandte Chemie 47(33): 6204-6207
Goel, A. 2008: C1-2 fixation. Journal of neurosurgery. Spine 9(2): 233-5; author reply 235
Gigante, P.R.; Feldstein, N.A.; Anderson, R.C.E. 2011: C1-2 instability from os odontoideum mimicking intramedullary spinal cord tumor. Journal of Neurosurgery. Pediatrics 8(4): 363-366
Kotil, K.; Muslumanoglu, M. 2014: C1-2 posterior arthrodesis technique with a left segmental and right transarticular fixation. A hybrid novel (Kotil) technique. Journal of Craniovertebral Junction and Spine 5(2): 102-105
Frey, M.E.; Dery, F.J.; Cifu, D.X. 2009: C1-2 steroid injection for crowned dens syndrome. Pm and R: the Journal of Injury Function and Rehabilitation 1(4): 379-382
Lee, J.H.; Jahng, T.-A.; Chung, C.K. 2007: C1-2 transarticular screw fixation in high-riding vertebral artery: suggestion of new trajectory. Journal of Spinal Disorders and Techniques 20(7): 499-504
Ni, B.; Guo, X.; Xie, N.; Li, S.; Zhou, F.; Zhang, F.; Liu, Q. 2013: C1-2 transarticular screws combined with C1 laminar hooks fixation: a modified posterior atlantoaxial fixation technique and outcome in 72 patients. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 22(2): 260-267
Konen, O.; Armstrong, D.; Clarke, H.; Padfield, N.; Weksberg, R.; Blaser, S. 2008: C1-2 vertebral anomalies in 22q11.2 microdeletion syndrome. Pediatric Radiology 38(7): 766-771
Hwang, S.W.; Heilman, C.B.; Riesenburger, R.I.; Kryzanski, J. 2008: C1-C2 arthrodesis after transoral odontoidectomy and suboccipital craniectomy for ventral brain stem compression in Chiari i patients. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 17(9): 1211-1217
Ferrante, E. 2008: C1-C2 fluid collection on MRI myelography in patients with spontaneous intracranial hypotension. Cephalalgia: an international journal of headache 28(6): 674; author reply 674-5
Lubelski, D.; Benzel, E.C. 2014: C1-C2 fusion: promoting stability, reducing morbidity. World Neurosurgery 82(6): 1052-1054
Tokuhashi, Y.; Ajiro, Y.; Oshima, M.; Umezawa, N. 2009: C1-C2 intra-articular screw fixation for atlantoaxial subluxation due to rheumatoid arthritis. Orthopedics 32(3): 172
Lavrador, Jé.Pedro.; Oliveira, E.; Gil, N.; Francisco, Aónio.Fernandes.; Livraghi, Sérgio. 2015: C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literature. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 24 Suppl. 4: S465-S471
Vergara, P.; Bal, J.Singh.; Hickman Casey, A.Thomas.; Crockard, H.Alan.; Choi, D. 2012: C1-C2 posterior fixation: are 4 screws better than 2?. Neurosurgery 71(1 Suppl Operative): 86-95
Jacobson, M.E.; Khan, S.N.; An, H.S. 2012: C1-C2 posterior fixation: indications, technique, and results. Orthopedic Clinics of North America 43(1): 11-8 Vii
Harifi, G.; Belkhou, A.; El Bouchti, I.; Ouali Idrissi, M.; Chérif Idrissi, N.; Ousehal, A.; El Hassani, S. 2012: C1-C2 spondylodiscitis in an adult with SAPHO syndrome: an unusual presentation. Rheumatology International 32(2): 445-447
Bourdillon, P.; Perrin, G.; Lucas, F.; Debarge, R.; Barrey, C. 2014: C1-C2 stabilization by Harms arthrodesis: indications, technique, complications and outcomes in a prospective 26-case series. Orthopaedics and Traumatology Surgery and Research: Otsr 100(2): 221-227
Nagaria, J.; Kelleher, M.O.; McEvoy, L.; Edwards, R.; Kamel, M.H.; Bolger, C. 2009: C1-C2 transarticular screw fixation for atlantoaxial instability due to rheumatoid arthritis: a seven-year analysis of outcome. Spine 34(26): 2880-2885
Coyne, T.J.; Fehlings, M.G.; Martin, R.J. 1996: C1-C2 transarticular screw fixation for treatment of C1-C2 instability. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 3(3): 243-246
Muthukumar, N. 2012: C1-C3 lateral mass fusion for type IIa and type IIi Hangman's fracture. Journal of Craniovertebral Junction and Spine 3(2): 62-66
Albert-Weissenberger, C.; Mencl, S.; Schuhmann, M.K.; Salur, I.; Göb, E.; Langhauser, F.; Hopp, S.; Hennig, N.; Meuth, S.G.; Nolte, M.W.; Sirén, A.-L.; Kleinschnitz, C. 2014: C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation. Frontiers in Cellular Neuroscience 8: 269
Whitworth, L.A.; Feler, C.A. 2003: C1-c2 sublaminar insertion of paddle leads for the management of chronic painful conditions of the upper extremity. Neuromodulation: Journal of the International Neuromodulation Society 6(3): 153-157
Dorresteijn, M.J.; Visser, T.; Cox, L.A.E.; Bouw, M.P.; Pillay, J.; Koenderman, A.H.L.; Strengers, P.F.W.; Leenen, L.P.H.; van der Hoeven, J.G.; Koenderman, L.; Pickkers, P. 2010: C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Critical Care Medicine 38(11): 2139-2145
Lin, J.H.; Casillas, A.M.; Sattar, S. 2007: C1-esterase inhibitor autoantibodies in a patient with acute tongue swelling. Allergy and Asthma Proceedings 28(1): 93-96
Wouters, D.; Stephan, F.; Strengers, P.; de Haas, M.; Brouwer, C.; Hagenbeek, A.; van Oers, M.H.J.; Zeerleder, S. 2013: C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia. Blood 121(7): 1242-1244
Pabst, S.; Hamscho, N.; Roller, F.; Stracke, H.; Schranz, D.; Lämmler, C.; Alzen, G.; Krombach, G.A. 2014: C1-esterase inhibitor deficiency in pediatric heart transplant recipients: incidence and findings on ultrasound. Pediatric Radiology 44(3): 258-264
Igonin, A.A.; Protsenko, D.N.; Galstyan, G.M.; Vlasenko, A.V.; Khachatryan, N.N.; Nekhaev, I.V.; Shlyapnikov, S.A.; Lazareva, N.B.; Herscu, P. 2012: C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Critical Care Medicine 40(3): 770-777
Krijnen, P.A.J.; Kupreishvili, K.; de Vries, M.R.; Schepers, A.; Stooker, W.; Vonk, A.B.A.; Eijsman, L.; Van Hinsbergh, V.W.M.; Zeerleder, S.; Wouters, D.; van Ham, M.; Quax, P.H.A.; Niessen, H.W.M. 2012: C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure. Atherosclerosis 220(1): 86-92
Schlapbach, L.J.; Schibler, A.; Jensenius, J.C. 2012: C1-esterase inhibitor treatment in sepsis-can we target the right patients?. Critical care medicine 40(9): 2735-6; author reply 2736-7
Schürmann, D.; Herzog, E.; Raquet, E.; Nolte, M.W.; May, F.; Müller-Cohrs, J.; Björkqvist, J.; Dickneite, G.; Pragst, I. 2014: C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk. Thrombosis and Haemostasis 112(5): 960-971
Sommer, W.; Tudorache, I.; Kühn, C.; Avsar, M.; Salman, J.; Ius, F.; Gras, C.; Weber, P.; Welte, T.; Gottlieb, J.; Haverich, A.; Warnecke, G. 2014: C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation 97(11): 1185-1191
Longhi, L.; Perego, C.; Ortolano, F.; Zanier, E.R.; Bianchi, P.; Stocchetti, N.; McIntosh, T.K.; De Simoni, M.G. 2009: C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Critical Care Medicine 37(2): 659-665
Mészáros, T.; Füst, G.; Farkas, H.; Jakab, L.; Temesszentandrási, G.; Nagy, G.; Kiss, E.; Gergely, P.; Zeher, M.; Griger, Z.; Czirják, L.; Hóbor, R.; Haris, A.; Polner, K.; Varga, L. 2010: C1-inhibitor autoantibodies in SLE. Lupus 19(5): 634-638
Kreuz, W.; Martinez-Saguer, I.; Aygören-Pürsün, E.; Rusicke, E.; Heller, C.; Klingebiel, T. 2009: C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion 49(9): 1987-1995
Lock, R.J.; Gompels, M.M. 2007: C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?. Current Allergy and Asthma Reports 7(4): 264-269
Cugno, M.; Zanichelli, A.; Foieni, F.; Caccia, S.; Cicardi, M. 2009: C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends in Molecular Medicine 15(2): 69-78
Landsem, A.; Nielsen, E.W.; Fure, H.; Christiansen, D.; Ludviksen, J.K.; Lambris, J.D.; Østerud, B.; Mollnes, T.E.; Brekke, O.-L. 2013: C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood. Clinical and Experimental Immunology 173(2): 217-229
Pannell, R.; Kung, W.; Gurewich, V. 2007: C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis. Journal of Thrombosis and Haemostasis: Jth 5(5): 1047-1054
Heydenreich, N.; Nolte, M.W.; Göb, E.; Langhauser, F.; Hofmeister, M.; Kraft, P.; Albert-Weissenberger, C.; Brede, M.; Varallyay, C.; Göbel, K.; Meuth, S.G.; Nieswandt, B.; Dickneite, G.; Stoll, G.; Kleinschnitz, C. 2012: C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms. Stroke 43(9): 2457-2467
Bewtra, A.K.; Levy, R.J.; Jacobson, K.W.; Wasserman, R.L.; Machnig, T.; Craig, T.J. 2012: C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. Allergy and Asthma Proceedings 33(5): 427-431
Ohshima, T.; Kawabata, T.; Takeuchi, Y.; Kakinuma, T.; Iwasaki, T.; Yonezawa, T.; Murakami, H.; Nishiyama, H.; Mashima, K. 2011: C1-symmetric Rh/Phebox-catalyzed asymmetric alkynylation of α-ketoesters. Angewandte Chemie 50(28): 6296-6300
Frings, M.; Atodiresei, I.; Wang, Y.; Runsink, J.; Raabe, G.; Bolm, C. 2010: C1-symmetric aminosulfoximines in copper-catalyzed asymmetric vinylogous Mukaiyama aldol reactions. Chemistry 16(15): 4577-4587
Gual, A.; Castillón, S.; Pàmies, O.; Diéguez, M.; Claver, C. 2011: C1-symmetric carbohydrate diphosphite ligands for asymmetric Pd-allylic alkylation reactions. Study of the key Pd-allyl intermediates. Dalton Transactions 40(12): 2852-2860
Shao, C.; Yu, H.-J.; Wu, N.-Y.; Feng, C.-G.; Lin, G.-Q. 2010: C1-symmetric dicyclopentadienes as new chiral diene ligands for asymmetric rhodium-catalyzed arylation of N-tosylarylimines. Organic Letters 12(17): 3820-3823
Gendrineau, T.; Chuzel, O.; Eijsberg, H.; Genet, J.-P.; Darses, S. 2008: C1-symmetric monosubstituted chiral diene ligands in asymmetric rhodium-catalyzed 1,4-addition reactions. Angewandte Chemie 47(40): 7669-7672
Sedelmeier, J.ör.; Hammerer, T.; Bolm, C. 2008: C1-symmetric oxazolinyl sulfoximines as ligands in copper-catalyzed asymmetric mukaiyama aldol reactions. Organic Letters 10(5): 917-920
Fraile, J.é M.; García, J.é I.; Gissibl, A.; Mayoral, J.é A.; Pires, E.ís.; Reiser, O.; Roldán, M.; Villalba, I. 2007: C1-symmetric versus C2-symmetric ligands in enantioselective copper-bis(oxazoline)-catalyzed cyclopropanation reactions. Chemistry 13(31): 8830-8839
Glasner, H.; Tshuva, E.Y. 2014: C1-symmetrical titanium(IV) complexes of salan ligands with differently substituted aromatic rings: enhanced cytotoxic activity. Inorganic Chemistry 53(6): 3170-3176
Aizawa, T.; Ozawa, H.; Kusakabe, T.; Nakamura, T.; Chanplakorn, P.; Itoi, E. 2010: C1/2 facet cyst revealed by facet joint arthrography. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 15(4): 603-607
Roccaro, A.M.; Sacco, A.; Jimenez, C.; Maiso, P.; Moschetta, M.; Mishima, Y.; Aljawai, Y.; Sahin, I.; Kuhne, M.; Cardarelli, P.; Cohen, L.; San Miguel, J.F.; Garcia-Sanz, R.; Ghobrial, I.M. 2014: C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood 123(26): 4120-4131
Salcher, S.; Hagenbuchner, J.; Geiger, K.; Seiter, M.A.; Rainer, J.; Kofler, R.; Hermann, M.; Kiechl-Kohlendorfer, U.; Ausserlechner, M.J.; Obexer, P. 2014: C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma. Molecular Cancer 13: 224
Asfaw Idosa, B.; Sahdo, B.; Balcha, E.; Kelly, A.; Söderquist, B.; Särndahl, E. 2014: C10X polymorphism in the CARD8 gene is associated with bacteraemia. Immunity Inflammation and Disease 2(1): 13-20
Ghanem, A. 2005: C11-Chirasil-Dex as chiral stationary phase in GC: enantioselective separation of cyclopropane derivatives. Talanta 66(5): 1234-1241
Iacobucci, G. 2018: Babylon app will be properly regulated to ensure safety, government insists. Bmj 362: K3215
Basuroy, K.; Karuppiah, V.; Balaram, P. 2014: C11/C9 helices in crystals of αβ hybrid peptides and switching structures between helix types by variation in the α-residue. Organic Letters 16(17): 4614-4617
Fraisier, V.; Kasri, A.; Miserey-Lenkei, S.ép.; Sibarita, J.-B.; Nair, D.; Mayeux, A.; Bardin, S.; Toyoda, Y.; Poser, I.; Poznyakovskiy, A.; Goud, B.; Hyman, A.A.; Dimitrov, A. 2013: C11ORF24 is a novel type i membrane protein that cycles between the Golgi apparatus and the plasma membrane in Rab6-positive vesicles. Plos one 8(12): E82223
Huang, D.; Sumegi, J.; Dal Cin, P.; Reith, J.D.; Yasuda, T.; Nelson, M.; Muirhead, D.; Bridge, J.A. 2010: C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes Chromosomes and Cancer 49(9): 810-818
Cachia, D.; Wani, K.; Penas-Prado, M.; Olar, A.; McCutcheon, I.E.; Benjamin, R.S.; Armstrong, T.S.; Gilbert, M.R.; Aldape, K.D. 2015: C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathology 32(2): 105-111
Sonti, R.; Dinesh, B.; Basuroy, K.; Raghothama, S.; Shamala, N.; Balaram, P. 2014: C12 helices in long hybrid (αγ)n peptides composed entirely of unconstrained residues with proteinogenic side chains. Organic Letters 16(6): 1656-1659
Li, J.; Ma, L.; Tang, M.; Xu, L. 2013: C12-Ag wire as solid-phase microextraction fiber for determination of benzophenone ultraviolet filters in river water. Journal of Chromatography. a 1298: 1-8
Woods, A.I.; Sanchez-Luceros, A.; Kempfer, A.C.; Powazniak, Y.; Calderazzo Pereyra, J.C.; Blanco, A.N.; Meschengieser, S.S.; Lazzari, M.A. 2012: C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance. Haemophilia: the Official Journal of the World Federation of Hemophilia 18(1): 112-116
Shi, L.; Tummala, N.R.; Striolo, A. 2010: C12E6 and SDS surfactants simulated at the vacuum-water interface. Langmuir: the Acs Journal of Surfaces and Colloids 26(8): 5462-5474
Wan, B.; Wang, X.-R.; Zhou, Y.-B.; Zhang, X.; Huo, K.; Han, Z.-G. 2009: C12ORF39, a novel secreted protein with a typical amidation processing signal. Bioscience Reports 30(1): 1-10
Yuan, J.; Bai, X.; Zhao, M.; Zheng, L. 2010: C12mimBr ionic liquid/SDS vesicle formation and use as template for the synthesis of hollow silica spheres. Langmuir: the Acs Journal of Surfaces and Colloids 26(14): 11726-11731
Piao, L.; Nakagawa, H.; Ueda, K.; Chung, S.; Kashiwaya, K.; Eguchi, H.; Ohigashi, H.; Ishikawa, O.; Daigo, Y.; Matsuda, K.; Nakamura, Y. 2011: C12orf48, termed PARP-1 binding protein, enhances poly(ADP-ribose) polymerase-1 (PARP-1) activity and protects pancreatic cancer cells from DNA damage. Genes Chromosomes and Cancer 50(1): 13-24
Sohrabi, A.; Mirab-Samiee, S.; Rahnamaye-Farzami, M.; Rafizadeh, M.; Akhavan, S.; Hashemi-Bahremani, M.; Modarresl, M.H. 2014: C13orf18 and C1orf166 (MULAN) DNA genes methylation are not associated with cervical cancer and precancerous lesions of human papillomavirus genotypes in Iranian women. Asian Pacific Journal of Cancer Prevention: Apjcp 15(16): 6745-6748
Neville, O.K. 1948: C14 tracer studies in the rearrangements of unsymmetrical alpha-diketones; phenylglyoxal to mandelic acid. Journal of the American Chemical Society 70(10): 3499-3502
Manougian, E.; Pollycove, M.; Linfoot, J.A.; Lawrence, J.H. 1964: C14-Glucose Kinetic Studies in Normal, Diabetic and Acromegalic Subjects. Ucrl-11833. Ucrl Reports . U.S. Atomic Energy Commission 36: 50-72
Kai, K.; Akaike, R.; Iida, K.; Yokoyama, M.; Watanabe, N. 2010: C14-oxylipin glucosides isolated from Lemna paucicostata. Phytochemistry 71(10): 1168-1173
Zhong, S.-L.; Zhang, J.; Hu, Q.; Chen, W.-X.; Ma, T.-F.; Zhao, J.-H. 2014: C1420T polymorphism of cytosolic serine hydroxymethyltransferase and risk of cancer: a meta-analysis. Asian Pacific Journal of Cancer Prevention: Apjcp 15(5): 2257-2262
Chapman, R.M.; Porsteinsson, A.P.; Gardner, M.N.; Mapstone, M.; McCrary, J.W.; Sandoval, T.C.; Guillily, M.D.; DeGrush, E.; Reilly, L.A. 2013: C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease. Journal of Alzheimer's disease: JAD 33(1): 55-68
Postal, M.; Palodeto, B.; Sartorato, E.L.úc.; Oliveira, C.A.éa.d. 2009: C1494T mitochondrial DNA mutation, hearing loss, and aminoglycosides antibiotics. Brazilian Journal of Otorhinolaryngology 75(6): 884-887
Kumagai, G.; Takano, M.; Shindo, K.; Sawada, D.; Saito, N.; Saito, H.; Kakuda, S.; Takagi, K.-i.; Takimoto-Kamimura, M.; Takenouchi, K.; Chen, T.C.; Kittaka, A. 2012: C15-functionalized 16-ene-1α,25-dihydroxyvitamin D3 is a new vitamin D analog with unique biological properties. Anticancer Research 32(1): 311-317
Keeney, S.; Grundy, P.; Collins, P.W.; Bowen, D.J. 2007: C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro. Haemophilia: the Official Journal of the World Federation of Hemophilia 13(4): 405-408
Davies, J.A.; Collins, P.W.; Hathaway, L.S.; Bowen, D.J. 2009: C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels. Acta Haematologica 121(2-3): 98-101
Separovic, D.; Saad, Z.H.; Edwin, E.A.; Bielawski, J.; Pierce, J.S.; Buren, E.V.; Bielawska, A. 2011: C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing. Journal of Lipids 2011: 713867
Chao, C.; Joyce-Shaikh, B.; Grein, J.; Moshrefi, M.; Raoufi, F.; Laface, D.M.; McClanahan, T.K.; Bourne, P.A.; Pierce, R.H.; Gorman, D.M.; Pflanz, S. 2011: C17 prevents inflammatory arthritis and associated joint destruction in mice. Plos one 6(7): E22256
Liu, H.-P.; Xu, Y.; Jin, C.-Y. 2008: C1772T polymorphism of hypoxia-inducible factor-1 alpha gene in Han ethnic population from Northern China. Zhejiang da Xue Xue Bao. Yi Xue Ban 37(3): 267-270
Nakano, N.; Maeyama, K.; Sakata, N.; Itoh, F.; Akatsu, R.; Nakata, M.; Katsu, Y.; Ikeno, S.; Togawa, Y.; Vo Nguyen, T.T.; Watanabe, Y.; Kato, M.; Itoh, S. 2014: C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. Journal of Biological Chemistry 289(18): 12680-12692
Karve, M.; Pandey, D.; Athavale, R. 2014: C18 bonded silica membrane disk modified with Cyanex 302 for Cr(III) and Cr(VI) speciation and flame atomic absorption spectrometric determination. Journal - Association of Official Analytical Chemists 97(1): 211-217
Xu, L.; Feng, J.; Liang, X.; Li, J.; Jiang, S. 2012: C18 functionalized graphene oxide as a novel coating for solid-phase microextraction. Journal of Separation Science 35(12): 1531-1537
D'Orazio, G.; Fanali, S. 2012: C18 silica packed capillary columns with monolithic frits prepared with UV light emitting diode: usefulness in nano-liquid chromatography and capillary electrochromatography. Journal of Chromatography. a 1232: 176-182
Saini, G.; Wiest, L.A.; Herbert, D.; Biggs, K.N.; Dadson, A.; Vail, M.A.; Linford, M.R. 2009: C18, C8, and perfluoro reversed phases on diamond for solid-phase extraction. Journal of Chromatography. a 1216(16): 3587-3593
Yu, C.; Hu, B. 2012: C18-coated stir bar sorptive extraction combined with high performance liquid chromatography-electrospray tandem mass spectrometry for the analysis of sulfonamides in milk and milk powder. Talanta 90: 77-84
Sadikov, T.; Simon, A.J.; Avraham-Lubin, B-Chen.R.; Dratviman-Storobinsky, O.; Cohen, Y.; Goldenberg-Cohen, N. 2012: C1824T mutation in the LMNA gene has no association with senile cataract. Neurobiology of aging 33(7): 1487.e15-9
Thomas, P.A.; Marvey, B.B. 2009: C18:1 Methyl ester metathesis in [bmim][X] type ionic liquids. International Journal of Molecular Sciences 10(11): 5020-5030
Chen, F-Zheng.; Chen, Q-Hong.; Wang, F-Peng. 2010: C19-Diterpenoid alkaloids from Delphinium umbrosum. Journal of Asian Natural Products Research 12(6): 498-504
Bortolin-Cavaillé, M.-L.; Dance, M.; Weber, M.; Cavaillé, J.ér.ôm. 2009: C19MC micro RNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Research 37(10): 3464-3473
Xie, L.; Mouillet, J.-F.; Chu, T.; Parks, W.T.; Sadovsky, E.; Knöfler, M.; Sadovsky, Y. 2014: C19MC micro RNAs regulate the migration of human trophoblasts. Endocrinology 155(12): 4975-4985
Kruer, M.C.; Salih, M.A.; Mooney, C.; Alzahrani, J.; Elmalik, S.A.; Kabiraj, M.M.; Khan, A.O.; Paudel, R.; Houlden, H.; Azzedine, H.; Alkuraya, F. 2014: C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene 537(2): 352-356
Tykodi, S.S.; Fujii, N.; Vigneron, N.; Lu, S.M.; Mito, J.K.; Miranda, M.X.; Chou, J.; Voong, L.N.; Thompson, J.A.; Sandmaier, B.M.; Cresswell, P.; Van den Eynde, B.ît.; Riddell, S.R.; Warren, E.H. 2008: C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(16): 5260-5269
Díaz-Mendoza, M.; Velasco-Arroyo, B.; González-Melendi, P.; Martínez, M.; Díaz, I. 2014: C1A cysteine protease-cystatin interactions in leaf senescence. Journal of Experimental Botany 65(14): 3825-3833
Kawabata, A.; Matsuzuka, T.; Doi, C.; Seiler, G.; Reischman, J.; Pickel, L.; Ayuzawa, R.; Nguyen, T.A.; Tamura, M. 2012: C1B domain peptide of protein kinase Cγ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis. Cancer Biology and Therapy 13(10): 880-889
Wu, Y.-M.; Liu, C.-H.; Huang, M.-J.; Lai, H.-S.; Lee, P.-H.; Hu, R.-H.; Huang, M.-C. 2013: C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Cancer Research 73(17): 5580-5590
Hung, J.-S.; Huang, J.; Lin, Y.-C.; Huang, M.-J.; Lee, P.-H.; Lai, H.-S.; Liang, J.-T.; Huang, M.-C. 2014: C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. Oncotarget 5(8): 2096-2106
He, X.; Zhao, P.; Kang, S.; Ding, Y.; Luan, J.; Liu, Z.; Wu, Y.; Yin, W. 2012: C1GALT1 polymorphisms are associated with Henoch-Schönlein purpura nephritis. Pediatric Nephrology 27(9): 1505-1509
Liu, C.-H.; Hu, R.-H.; Huang, M.-J.; Lai, I.-R.; Chen, C.-H.; Lai, H.-S.; Wu, Y.-M.; Huang, M.-C. 2014: C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity. Plos one 9(8): E94995
Kudo, T.; Sato, T.; Hagiwara, K.; Kozuma, Y.; Yamaguchi, T.; Ikehara, Y.; Hamada, M.; Matsumoto, K.; Ema, M.; Murata, S.; Ohkohchi, N.; Narimatsu, H.; Takahashi, S. 2013: C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood 122(9): 1649-1657
Kozjak-Pavlovic, V.; Prell, F.; Thiede, B.; Götz, M.; Wosiek, D.; Ott, C.; Rudel, T. 2014: C1orf163/RESA1 is a novel mitochondrial intermembrane space protein connected to respiratory chain assembly. Journal of Molecular Biology 426(4): 908-920
Hu, H-Ming.; Chen, Y.; Liu, L.; Zhang, C-Geng.; Wang, W.; Gong, K.; Huang, Z.; Guo, M-Xiong.; Li, W-Xin.; Li, W. 2013: C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(1): 163-173
Agnello, V.; Koffler, D.; Eisenberg, J.W.; Winchester, R.J.; Kunkel, H.G. 1971: C1q Precipitins in the Sera of Patients with Systemic Lupus Erythematosus and other Hypocomplementemic States: Characterization of high and low Molecular Weight types. Journal of Experimental Medicine 134(3): 228-241
Georgakopoulos, T.; Tatford, O.C.; Gurevich, V.; Bertolini, J. 2011: C1q aggregate binding for the determination of anti-complementary activity of immunoglobulin products. Biologicals: Journal of the International Association of Biological Standardization 39(1): 38-42
Wu, F.Q.; Zhao, Q.; Cui, X.D.; Zhang, W. 2011: C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatology International 31(4): 501-505
Bossi, F.; Tripodo, C.; Rizzi, L.; Bulla, R.; Agostinis, C.; Guarnotta, C.; Munaut, C.; Baldassarre, G.; Papa, G.; Zorzet, S.; Ghebrehiwet, B.; Ling, G.S.; Botto, M.; Tedesco, F. 2014: C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proceedings of the National Academy of Sciences of the United States of America 111(11): 4209-4214
Chen, G.; Tyan, D.B. 2013: C1q assay for the detection of complement fixing antibody to HLA antigens. Methods in Molecular Biology 1034: 305-311
Douradinha, B.; McBurney, S.P.; Soares de Melo, K.M.; Smith, A.P.; Krishna, N.K.; Barratt-Boyes, S.M.; Evans, J.D.; Nascimento, E.J.M.; Marques, E.T.A. 2014: C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells. Virus Research 179: 231-234
Lindahl, T.L.; Larsson, A. 1993: C1q binding to platelets induced by monoclonal antibodies and immune complexes-a flow cytometric analysis. Platelets 4(2): 73-77
Santer, D.M.; Hall, B.E.; George, T.C.; Tangsombatvisit, S.; Liu, C.L.; Arkwright, P.D.; Elkon, K.B. 2010: C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. Journal of Immunology 185(8): 4738-4749
Fraser, D.A.; Laust, A.K.; Nelson, E.L.; Tenner, A.J. 2009: C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. Journal of Immunology 183(10): 6175-6185
Baruah, P.; Dumitriu, I.E.; Malik, T.H.; Cook, H.T.; Dyson, J.; Scott, D.; Simpson, E.; Botto, M. 2009: C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 113(15): 3485-3493
Fraser, D.A.; Pisalyaput, K.; Tenner, A.J. 2010: C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. Journal of Neurochemistry 112(3): 733-743
Skoglund, C.; Wetterö, J.; Tengvall, P.; Bengtsson, T.ör. 2010: C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets. Immunobiology 215(12): 987-995
Lobsiger, C.S.; Boillée, S.; Pozniak, C.; Khan, A.M.; McAlonis-Downes, M.; Lewcock, J.W.; Cleveland, D.W. 2013: C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proceedings of the National Academy of Sciences of the United States of America 110(46): E4385-E4392
Lood, C.; Gullstrand, B.; Truedsson, L.; Olin, A.I.; Alm, G.V.; Rönnblom, L.; Sturfelt, G.; Eloranta, M-Leena.; Bengtsson, A.A. 2009: C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis and Rheumatism 60(10): 3081-3090
Son, M.; Santiago-Schwarz, F.; Al-Abed, Y.; Diamond, B. 2012: C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proceedings of the National Academy of Sciences of the United States of America 109(46): E3160-E3167
Rocha, S.; Carvalho, M.J.ão.; Lobato, L.ís.; Santos, J.; Rocha, G.; Vizcaíno, R.ón.; Cabrita, A.ón. 2012: C1q nephropathy and malignancy. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 32(2): 270-272
Wong, C.S.; Fink, C.A.; Baechle, J.; Harris, A.A.; Staples, A.O.; Brandt, J.R. 2009: C1q nephropathy and minimal change nephrotic syndrome. Pediatric Nephrology 24(4): 761-767
Judkins, A.; Townshend, S.; Willis, F. 2010: C1q nephropathy associated with deletion of long arm of chromosome 7. Journal of Paediatrics and Child Health 46(6): 364-365
Niimura, F.; Kamei, A.; Tamame, T.; Yamada, K.; Komaki, F.; Okamoto, S.; Matsuda, S.; Oh, Y.; Endoh, M. 2007: C1q nephropathy in a 2-year-old boy presenting with steroid resistant nephrotic syndrome. Tokai Journal of Experimental and Clinical Medicine 32(3): 95-98
Taggart, L.; Harris, A.; El-Dahr, S.; Iorember, F. 2010: C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatric Nephrology 25(1): 165-168
Zhao, Y.; Fan, H.; Bao, B-yan.; Liu, T.; You, X-Qing.; Li, G-fu. 2014: C1q nephropathy in an old woman with acute renal failure: a case report and literature review. Renal Failure 36(7): 1136-1138
Gunasekara, V.N.; Sebire, N.J.; Tullus, K. 2014: C1q nephropathy in children: clinical characteristics and outcome. Pediatric Nephrology 29(3): 407-413
Wenderfer, S.E.; Swinford, R.D.; Braun, M.C. 2010: C1q nephropathy in the pediatric population: pathology and pathogenesis. Pediatric Nephrology 25(8): 1385-1396
Malleshappa, P.; Ranganath, R.; Chaudhari, A.P.; Ayiangar, A.; Lohitaksha, S. 2011: C1q nephropathy presenting as acute renal failure. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 22(2): 324-326
Bhowmik, D.M.; Jain, S.; Dinda, A.K.; Sharma, A.; Mahajan, S.; Agarwal, S.K. 2011: C1q nephropathy presenting as nephritic-nephrotic syndrome. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 22(3): 561-563
Kanodia, K.V.; Vanikar, A.V.; Shah, P.R.; Kute, V.B.; Feroz, A.; Suthar, K.; Trivedi, H.L. 2012: C1q nephropathy with acute hemolytic uremic syndrome. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 23(3): 556-558
Malleshappa, P. 2013: C1q nephropathy- unity in diversity. Journal of Renal Injury Prevention 2(4): 117-118
Panuncio, A.; Alba, A.; Bacigalupe, C.; Caorsi, H.; Schwedt, E.; Otatti, G.; Saralegui, P.; Mariño, A. 2008: C1q nephropathy. Report of one case. Revista Medica de Chile 136(10): 1307-1310
Teh, B.K.; Yeo, J.G.; Chern, L.M.; Lu, J. 2011: C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Molecular Immunology 48(9-10): 1128-1138
Park, S.-Y.; Choi, J.H.; Ryu, H.S.; Pak, Y.K.; Park, K.S.; Lee, H.K.; Lee, W. 2009: C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. Journal of Biological Chemistry 284(41): 27780-27789
Hou, M.; Liu, J.; Liu, F.; Liu, K.; Yu, B. 2014: C1q tumor necrosis factor-related protein-3 protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis through the phosphoinositide 3-kinase/Akt pathway. International Journal of Molecular Medicine 33(1): 97-104
Singhrao, S.K. 2013: C1q, the classical complement pathway protein binds Hirano bodies in Pick's disease. Microscopy Research and Technique 76(6): 606-611
Färber, K.; Cheung, G.; Mitchell, D.; Wallis, R.; Weihe, E.; Schwaeble, W.; Kettenmann, H. 2009: C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. Journal of Neuroscience Research 87(3): 644-652
Racusen, L.C.; Leffell, M.S. 2013: C1q-binding antibodies in kidney transplantation. New England Journal of Medicine 369(13): 1266-1267
Yabu, J.M.; Higgins, J.P.; Chen, G.; Sequeira, F.; Busque, S.; Tyan, D.B. 2011: C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 91(3): 342-347
Benoit, M.E.; Hernandez, M.X.; Dinh, M.L.; Benavente, F.; Vasquez, O.; Tenner, A.J. 2013: C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. Journal of Biological Chemistry 288(1): 654-665
Mei, J.; Yue, H.-M.; Li, Z.; Chen, B.; Zhong, J.-X.; Dan, C.; Zhou, L.; Gui, J.-F. 2013: C1q-like factor, a target of miR-430, regulates primordial germ cell development in early embryos of Carassius auratus. International Journal of Biological Sciences 10(1): 15-24
Mei, J.; Zhang, Q.-Y.; Li, Z.; Lin, S.; Gui, J.-F. 2008: C1q-like inhibits p53-mediated apoptosis and controls normal hematopoiesis during zebrafish embryogenesis. Developmental Biology 319(2): 273-284
Son, M.; Diamond, B. 2015: C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1). Molecular Medicine 20: 559-568
Glogowska, A.; Kunanuvat, U.; Stetefeld, J.ör.; Patel, T.R.; Thanasupawat, T.; Krcek, J.; Weber, E.; Wong, G.W.; Del Bigio, M.R.; Hoang-Vu, C.; Hombach-Klonisch, S.; Klonisch, T. 2013: C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells. Journal of Pathology 231(4): 466-479
Byerly, M.S.; Petersen, P.S.; Ramamurthy, S.; Seldin, M.M.; Lei, X.; Provost, E.; Wei, Z.; Ronnett, G.V.; Wong, G.W. 2014: C1q/TNF-related protein 4 (CTRP4) is a unique secreted protein with two tandem C1q domains that functions in the hypothalamus to modulate food intake and body weight. Journal of Biological Chemistry 289(7): 4055-4069
Wei, Z.; Peterson, J.M.; Lei, X.; Cebotaru, L.; Wolfgang, M.J.; Baldeviano, G.C.; Wong, G.W. 2012: C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. Journal of Biological Chemistry 287(13): 10301-10315
Schmid, A.; Kopp, A.; Hanses, F.; Karrasch, T.; Schäffler, A. 2014: C1q/TNF-related protein-3 (CTRP-3) attenuates lipopolysaccharide (LPS)-induced systemic inflammation and adipose tissue Erk-1/-2 phosphorylation in mice in vivo. Biochemical and Biophysical Research Communications 452(1): 8-13
Hofmann, C.; Chen, N.; Obermeier, F.; Paul, G.; Büchler, C.; Kopp, A.; Falk, W.; Schäffler, A. 2011: C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflammatory Bowel Diseases 17(12): 2462-2471
Peterson, J.M.; Wei, Z.; Wong, G.W. 2010: C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. Journal of Biological Chemistry 285(51): 39691-39701
Kopp, A.; Bala, M.; Buechler, C.; Falk, W.; Gross, P.; Neumeier, M.; Schölmerich, J.ür.; Schäffler, A. 2010: C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. Endocrinology 151(11): 5267-5278
Wei, Z.; Seldin, M.M.; Natarajan, N.; Djemal, D.C.; Peterson, J.M.; Wong, G.W. 2013: C1q/tumor necrosis factor-related protein 11 (CTRP11), a novel adipose stroma-derived regulator of adipogenesis. Journal of Biological Chemistry 288(15): 10214-10229
Sun, Y.; Yi, W.; Yuan, Y.; Lau, W.Bond.; Yi, D.; Wang, X.; Wang, Y.; Su, H.; Wang, X.; Gao, E.; Koch, W.J.; Ma, X-Liang. 2013: C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation 128(11 Suppl 1: S113-S120
Kim, M.-J.; Lee, W.; Park, E.-J.; Park, S.-Y. 2010: C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages. Molecules and Cells 30(1): 59-64
Lee, W.; Kim, M.-J.; Park, E.-J.; Choi, Y.-J.; Park, S.-Y. 2010: C1qTNF-related protein-6 mediates fatty acid oxidation via the activation of the AMP-activated protein kinase. Febs Letters 584(5): 968-972
Ma, X.-Y.; Yin, Q.-S.; Wu, Z.-H.; Xia, H.; Riew, K.D.; Liu, J.-F. 2010: C2 anatomy and dimensions relative to translaminar screw placement in an Asian population. Spine 35(6): 704-708
Sharples, A.P.; Al-Shanti, N.; Stewart, C.E. 2010: C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?. Journal of Cellular Physiology 225(1): 240-250
Jakobsdottir, J.; Conley, Y.P.; Weeks, D.E.; Ferrell, R.E.; Gorin, M.B. 2008: C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. Plos one 3(5): E2199
Thimineur, M.; De Ridder, D. 2007: C2 area neurostimulation: a surgical treatment for fibromyalgia. Pain Medicine 8(8): 639-646
Rustagi, T.; Katz, D.A.; Lavelle, W.F. 2014: C2 compressive osteochondroma with transient neurologic symptoms in a pediatric patient. Spine Journal: Official Journal of the North American Spine Society 14(10): 2516-2517
Hussain, A.; Prasad, K.S.R.K.; Bhattacharyya, D.; El-Bouri, K. 2007: C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl. Infection 35(4): 287-288
Ward, K.E.; Ropa, J.P.; Adu-Gyamfi, E.; Stahelin, R.V. 2012: C2 domain membrane penetration by group IVA cytosolic phospholipase A₂ induces membrane curvature changes. Journal of Lipid Research 53(12): 2656-2666
Mittelmeier, T.M.; Berthold, P.; Danon, A.; Lamb, M.R.; Levitan, A.; Rice, M.E.; Dieckmann, C.L. 2008: C2 domain protein MIN1 promotes eyespot organization in Chlamydomonas reinhardtii. Eukaryotic Cell 7(12): 2100-2112
Xie, X.; Gong, Z.; Mansuy-Aubert, V.; Zhou, Q.L.; Tatulian, S.A.; Sehrt, D.; Gnad, F.; Brill, L.M.; Motamedchaboki, K.; Chen, Y.; Czech, M.P.; Mann, M.; Krüger, M.; Jiang, Z.Y. 2011: C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane. Cell Metabolism 14(3): 378-389
Martens, S.; McMahon, H.T. 2011: C2 domains and membrane fusion. Current Topics in Membranes 68: 141-159
Remans, K.; Bürger, M.; Vetter, I.R.; Wittinghofer, A. 2014: C2 domains as protein-protein interaction modules in the ciliary transition zone. Cell Reports 8(1): 1-9
Lozano-Duran, R.; Caracuel, Z.; Bejarano, E.R. 2012: C2 from Beet curly top virus meddles with the cell cycle: a novel function for an old pathogenicity factor. Plant Signaling and Behavior 7(12): 1705-1708
Beck, J.M.; Miller, S.M.; Peczuh, M.W.; Hadad, C.M. 2012: C2 hydroxyl group governs the difference in hydrolysis rates of methyl-α-D-glycero-D-guloseptanoside and methyl-β-D-glycero-D-guloseptanoside. Journal of Organic Chemistry 77(9): 4242-4251
Sinha, S.; Jagetia, A.; Shankar, R. 2012: C2 intralaminar (crossing/ipsilateral) fixation as a bailout procedure for failed transpedicular/pars interarticularis screw placement. Acta Neurochirurgica 154(2): 321-323
Senoğlu, M.; Ozbağ, D.; Gümüşalan, Y. 2009: C2 intralaminar screw placement: a quantitative anatomical and morphometric evaluation. Turkish Neurosurgery 19(3): 245-248
Guo, Q.; Liu, J.; Ni, B.; Lu, X.; Zhou, F. 2011: C2 laminar screw and C1-2 transarticular screw combined with C1 laminar hooks for atlantoaxial instability with unilateral vertebral artery injury. Archives of Orthopaedic and Trauma Surgery 131(9): 1207-1210
Pirog, T.P.; Korzh, I.V.; Shevchuk, T.A.; Tarasenko, D.A. 2008: C2 metabolism and intensification of the synthesis of surface-active substances in Rhodococcus erythropolis EK-1 grown on ethanol. Mikrobiologiia 77(6): 749-757
Yi, M.; Lee, J.W.; Yeom, J.S.; Joe, E.; Hong, S.H.; Lee, G.Y.; Kang, H.S. 2014: C2 nerve root on magnetic resonance imaging of occipital neuralgia. Spine 39(13): 1077-1083
Yamagata, T.; Takami, T.; Naito, K.; Ohata, K. 2013: C2 nerve root resection to achieve safe and wide exposure of lateral atlantoaxial joints in posterior C1-2 instrumented fixation: technical note. Neurologia Medico-Chirurgica 53(12): 914-919
Kang, M.M.; Anderer, E.G.; Elliott, R.E.; Kalhorn, S.P.; Frempong-Boadu, A. 2012: C2 nerve root sectioning in posterior C1-2 instrumented fusions. World Neurosurgery 78(1-2): 170-177
Elliott, R.E.; Kang, M.M.; Smith, M.L.; Frempong-Boadu, A. 2012: C2 nerve root sectioning in posterior atlantoaxial instrumented fusions: a structured review of literature. World Neurosurgery 78(6): 697-708
Dewan, M.C.; Godil, S.S.; Mendenhall, S.K.; Devin, C.J.; McGirt, M.J. 2014: C2 nerve root transection during C1 lateral mass screw fixation: does it affect functionality and quality of life?. Neurosurgery 74(5): 475-80; Discussion 480-1
Menezes, A.H. 2011: C2 neurectomy. World Neurosurgery 78(1-2): 80-81
Sonobe, S.; Murakami, K.; Kohama, M.; Watanabe, M.; Kumabe, T.; Tominaga, T. 2009: C2 neurinoma with intracranial extension: a case report. No Shinkei Geka. Neurological Surgery 37(9): 893-897
Eshra, M.A. 2014: C2 pars/pedicle screws in management of craniocervical and upper cervical instability. Asian Spine Journal 8(2): 156-160
Xiao, Z.M.; Zhan, X.L.; Gong, D.F.; Chen, Q.F.; Luo, G.B.; Jiang, H. 2008: C2 pedicle screw and plate combined with C1 titanium cable fixation for the treatment of atlantoaxial instability not suitable for placement of C1 screw. Journal of Spinal Disorders and Techniques 21(7): 514-517
Keerberg, O.; Pärnik, T.; Ivanova, H.; Bassüner, B.; Bauwe, H. 2014: C2 photosynthesis generates about 3-fold elevated leaf CO2 levels in the C3-C4 intermediate species Flaveria pubescens. Journal of Experimental Botany 65(13): 3649-3656
Jeszenszky, D.; Fekete, T.ás.F.ül.öp.; Melcher, R.; Harms, J.ür. 2007: C2 prosthesis: anterior upper cervical fixation device to reconstruct the second cervical vertebra. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 16(10): 1695-1700
Saini, A.; Al-Shanti, N.; Stewart, C. 2010: C2 skeletal myoblast survival, death, proliferation and differentiation: regulation by Adra1d. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 25(2-3): 253-262
Ding, X.; Hua, F.; Sutherly, K.; Ardell, J.L.; Williams, C.A. 2008: C2 spinal cord stimulation induces dynorphin release from rat T4 spinal cord: potential modulation of myocardial ischemia-sensitive neurons. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 295(5): R1519-R1528
De Ridder, D.; Plazier, M.; Menovsky, T.; Kamerling, N.; Vanneste, S. 2013: C2 subcutaneous stimulation for failed back surgery syndrome: a case report. Neuromodulation: Journal of the International Neuromodulation Society 16(6): 610-613
Zhou, F.; Ni, B.; Li, S.; Yang, J.; Guo, X.; Zhu, Z. 2010: C2 translaminar screw as the optimal choice for atlantoaxial dislocation with C2-C3 congenital fusion. Archives of Orthopaedic and Trauma Surgery 130(12): 1505-1509
Wilcock, B.C.; Endo, M.M.; Uno, B.E.; Burke, M.D. 2013: C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. Journal of the American Chemical Society 135(23): 8488-8491
Mortimer, S.A.; Weeks, K.M. 2009: C2'-endo nucleotides as molecular timers suggested by the folding of an RNA domain. Proceedings of the National Academy of Sciences of the United States of America 106(37): 15622-15627
Sau, S.P.; Hrdlicka, P.J. 2012: C2'-pyrene-functionalized triazole-linked DNA: universal DNA/RNA hybridization probes. Journal of Organic Chemistry 77(1): 5-16
Campeau, L.-C.; Bertrand-Laperle, M.ég.; Leclerc, J.-P.; Villemure, E.; Gorelsky, S.; Fagnou, K. 2008: C2, C5, and C4 azole N-oxide direct arylation including room-temperature reactions. Journal of the American Chemical Society 130(11): 3276-3277
Joubert, A.; Van Zyl, H.; Laurens, J.; Lottering, M.-L. 2009: C2- and C4-position 17beta-estradiol metabolites and their relation to breast cancer. Biocell: Official Journal of the Sociedades Latinoamericanas de Microscopia Electronica . Et. Al 33(3): 137-140
Ding, Z.; Yoshikai, N. 2012: C2-Alkylation of N-pyrimidylindole with vinylsilane via cobalt-catalyzed C-H bond activation. Beilstein Journal of Organic Chemistry 8: 1536-1542
St Hill, C.A.; Baharo-Hassan, D.; Farooqui, M. 2011: C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. Plos one 6(1): E16281
Zhu, W.; Wang, X.; Zhou, Y.; Wang, H. 2014: C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells. International Journal of Molecular Sciences 15(2): 3336-3355
Nakao, S.; Moriyama, S.; Segawa, M.; Guo, M.-Y.; Sugiya, H. 2010: C2-ceramide inhibits the prostaglandin E2-induced accumulation of cAMP in human gingival fibroblasts. Biomedical Research 31(2): 97-103
Miñano, A.; Caballero-Benítez, A.; Lluch, M.ón.; Morán, J.; Rodríguez-Alvarez, J.é 2008: C2-ceramide mediates cerebellar granule cells apoptosis by activation of caspases-2, -9, and -3. Journal of Neuroscience Research 86(8): 1734-1747
Makiyama, T.; Nakamura, H.; Nishida, A.; Murayama, T. 2012: C2-di-ethyl-ceramide-1-phosphate as an inhibitor of group IVA cytosolic phospholipase A2. European Journal of Pharmacology 697(1-3): 144-151
Koller, H.; Acosta, F.; Tauber, M.; Komarek, E.; Fox, M.; Moursy, M.; Hitzl, W.; Resch, H. 2009: C2-fractures: part I. Quantitative morphology of the C2 vertebra is a prerequisite for the radiographic assessment of posttraumatic C2-alignment and the investigation of clinical outcomes. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 18(7): 978-991
Koller, H.; Acosta, F.; Forstner, R.; Zenner, J.; Resch, H.; Tauber, M.; Lederer, S.; Auffarth, A.; Hitzl, W. 2009: C2-fractures: part II. a morphometrical analysis of computerized atlantoaxial motion, anatomical alignment and related clinical outcomes. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 18(8): 1135-1153
Pacheco, A.; Azevedo, F.áv.; Rego, A.ón.; Santos, J.úl.; Chaves, S.R.; Côrte-Real, M.; Sousa, M.J.ão. 2013: C2-phytoceramide perturbs lipid rafts and cell integrity in Saccharomyces cerevisiae in a sterol-dependent manner. Plos one 8(9): E74240
Tolnai, G.L.; Ganss, S.; Brand, J.P.; Waser, J.ér.ôm. 2013: C2-selective direct alkynylation of indoles. Organic Letters 15(1): 112-115
Fahrer, J.ör.; Schweitzer, B.; Fiedler, K.; Langer, T.; Gierschik, P.; Barth, H. 2013: C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells. Bioconjugate Chemistry 24(4): 595-603
Iglesias-Sigüenza, J.; Ros, A.; Díez, E.; Magriz, A.; Vázquez, A.; Alvarez, E.; Fernández, R.; Lassaletta, J.é M. 2009: C2-symmetric S/C/S ligands based on N-heterocyclic carbenes: a new ligand architecture for asymmetric catalysis. Dalton Transactions 40: 8485-8488
Bermejo, A.; Ros, A.; Fernández, R.; Lassaletta, J.é M. 2008: C2-symmetric bis-hydrazones as ligands in the asymmetric Suzuki-Miyaura cross-coupling. Journal of the American Chemical Society 130(47): 15798-15799
Akalay, D.; Dürner, G.; Bats, J.W.; Göbel, M.W. 2008: C2-symmetric bisamidines: chiral Brønsted bases catalysing the Diels-Alder reaction of anthrones. Beilstein Journal of Organic Chemistry 4: 28
Fernández, I.; Valdivia, V.; Leal, M.P.ía.; Khiar, N. 2007: C2-symmetric bissulfoxides as organocatalysts in the allylation of benzoyl hydrazones: spacer and concentration effects. Organic Letters 9(11): 2215-2218
Mariz, R.; Poater, A.; Gatti, M.; Drinkel, E.; Bürgi, J.J.; Luan, X.; Blumentritt, S.; Linden, A.; Cavallo, L.; Dorta, R. 2010: C2-symmetric chiral disulfoxide ligands in rhodium-catalyzed 1,4-addition: from ligand synthesis to the enantioselection pathway. Chemistry 16(48): 14335-14347
Chen, F.; Tan, C.K.; Yeung, Y.-Y. 2013: C2-symmetric cyclic selenium-catalyzed enantioselective bromoaminocyclization. Journal of the American Chemical Society 135(4): 1232-1235
Haberhauer, G. 2007: C2-symmetric metacyclophanes: a possible alternative to o,o'-bridged binaphthyls. Angewandte Chemie 46(23): 4397-4399
Ma, S.; Wu, L.; Liu, M.; Wang, Y. 2012: C2-symmetric proline-derived tetraamine as highly effective catalyst for direct asymmetric Michael addition of ketones to chalcones. Organic and Biomolecular Chemistry 10(18): 3721-3729
Saravanan, S.; Sadhukhan, A.; Khan, N.-u.H.; Kureshy, R.I.; Abdi, S.H.R.; Bajaj, H.C. 2012: C2-symmetric recyclable organocatalyst for enantioselective Strecker reaction for the synthesis of α-amino acid and chiral diamine--an intermediate for APN inhibitor. Journal of Organic Chemistry 77(9): 4375-4384
Zhang, X.-H.; Zhao, Q.; Liu, X.-M.; Hu, T.-L.; Han, J.; Ruan, W.-J.; Bu, X.-H. 2013: C2-symmetrical hexaazatriphenylene derivatives as colorimetric and ratiometric fluorescence chemsensors for Zn2+. Talanta 108: 150-156
Dang, D.; Baig, M.N.; Christoforidis, G.; Chiocca, E.A.; Gabriel, J. 2007: C2/C3 pathologic fractures from polyostotic fibrous dysplasia of the cervical spine treated with percutaneous vertebroplasty. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 16(Suppl 3): 250-254
Athanassoglou, V.; Acheson, J.; Poyner, F. 2008: C2/C3 pseudosubluxation in a 27-year-old man following a road traffic accident. Emergency Medicine Journal: Emj 25(10): 665
Vehviläinen, T.T.; Ganchenkova, M.G.; Nieminen, R.M. 2009: C20 based polymers: electronic and elastic properties and stability studies. Journal of Nanoscience and Nanotechnology 9(7): 4360-4366
Ma, L.; Kaufman, Y.; Zhang, J.; Washington, I. 2011: C20-D3-vitamin a slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease. Journal of Biological Chemistry 286(10): 7966-7974
Patel, P.; Gore, V.; Powell, W.S.; Rokach, J. 2011: C20-trifluoro-5-oxo-ETE: a metabolically stable 5-oxo-ETE derivative. Bioorganic and Medicinal Chemistry Letters 21(7): 1987-1990
Kuvychko, I.V.; Dubceac, C.; Deng, S.H.M.; Wang, X.-B.; Granovsky, A.A.; Popov, A.A.; Petrukhina, M.A.; Strauss, S.H.; Boltalina, O.V. 2013: C20H4(C4F8)3: a fluorine-containing annulated corannulene that is a better electron acceptor than C60. Angewandte Chemie 52(29): 7505-7508
Chen, G.; Xu, N.; Pei, Y-Hu. 2009: C21 steroidal glycosides from Cynanchum wallichii Wight. Journal of Asian Natural Products Research 11(2): 177-182
Li, X.; Zhang, M.; Xiang, C.; Qin, Y.; He, J.; Li, B.-C.; Li, P. 2014: C21 steroids from roots of Cynanchum otophyllum. Zhongguo Zhong Yao Za Zhi 39(8): 1450-1456
Kriesel, J.D.; Jones, B.B.; Matsunami, N.; Patel, M.K.; St Pierre, C.A.; Kurt-Jones, E.A.; Finberg, R.W.; Leppert, M.; Hobbs, M.R. 2011: C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. Journal of Infectious Diseases 204(11): 1654-1662
Yamanaka, T.; Vincken, J.-P.; Zuilhof, H.; Legger, A.; Takada, N.; Gruppen, H. 2009: C22 isomerization in alpha-tomatine-to-esculeoside a conversion during tomato ripening is driven by C27 hydroxylation of triterpenoidal skeleton. Journal of Agricultural and Food Chemistry 57(9): 3786-3791
Holliday, M.W.; Cox, S.B.; Kang, M.H.; Maurer, B.J. 2013: C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines. Plos one 8(9): E74768
Tian, H.-Y.; Luo, S.-L.; Liu, J.-S.; Wang, L.; Wang, Y.; Zhang, D.-M.; Zhang, X.-Q.; Jiang, R.-W.; Ye, W.-C. 2013: C23 steroids from the venom of Bufo bufo gargarizans. Journal of Natural Products 76(10): 1842-1847
Casonato, A.; Pontara, E.; Battiston, M.; Morpurgo, M.; Cattini, M.G.; Casarin, E.; Saga, G.; Daidone, V.; De Marco, L. 2013: C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor. Thrombosis and Haemostasis 109(6): 999-1006
Hashad, I.M.; Abdel Rahman, M.F.; Abdel-Maksoud, S.M.; Amr, K.S.; Effat, L.K.; Shaban, G.M.; Gad, M.Z. 2014: C242T polymorphism of NADPH oxidase p22phox gene reduces the risk of coronary artery disease in a random sample of Egyptian population. Molecular Biology Reports 41(4): 2281-2286
Rafiq, A.; Aslam, K.; Malik, R.; Afroze, D. 2014: C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension. Molecular Medicine Reports 9(5): 1857-1862
Cornwell, E.W.; Mirbod, A.; Wu, C.-L.; Kandarian, S.C.; Jackman, R.W. 2014: C26 cancer-induced muscle wasting is IKKβ-dependent and NF-kappaB-independent. Plos one 9(1): E87776
Xu, Q-Ming.; Liu, Y-Li.; Feng, Y-Lin.; Li, X-Ran.; Yang, S-Lin. 2010: C28 sterols with a cyclopentane ring at C-22 and 26 from cape gooseberry (berries of Physalis pubeacens L.). Journal of Asian Natural Products Research 12(9): 752-759
Fernández Rodríguez, A.M.; Gascón, L.H.; García La Orden, I.; Santos, J.P.; Samper, R.G.; Letosa, R.M.; Palop Cubillo, L.; Rodríguez Pérez, J.C.; Rodríguez-Gallego, J.C. 2011: C282Y hemochromatosis gene mutation and iron parameters in dialysis patients. Clinical Nephrology 75(4): 328-335
Ali-Rahmani, F.; Huang, M.A.; Schengrund, C.-L.; Connor, J.R.; Lee, S.Y. 2014: C282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cells. Plos one 9(2): E88724
Spengos, K.; Walter, M.C.; Dekomien, G.; Papadopoulos, K.; Lochmüller, H.; Manta, P. 2010: C283Y mutation in the gamma-sarcoglycan gene in Greek Gypsies with severe limb girdle muscular dystrophy. European Journal of Neurology 17(6): E41-E42
Frias, J.A.; Richman, J.E.; Wackett, L.P. 2009: C29 olefinic hydrocarbons biosynthesized by Arthrobacter species. Applied and Environmental Microbiology 75(6): 1774-1777
Nguyen, H.T.; Chau, V.M.; Tran, T.H.; Phan, V.K.; Hoang, T.H.; Nguyen, T.D.; Nguyen, X.N.; Tai, B.H.; Hyun, J.-H.; Kang, H.-K.; Kim, Y.H. 2009: C29 sterols with a cyclopropane ring at C-25 and 26 from the Vietnamese marine sponge Ianthella sp. and their anticancer properties. Bioorganic and Medicinal Chemistry Letters 19(16): 4584-4588
Diao, J.; Yoon, T.-Y.; Su, Z.; Shin, Y.-K.; Ha, T. 2009: C2AB: a molecular glue for lipid vesicles with a negatively charged surface. Langmuir: the Acs Journal of Surfaces and Colloids 25(13): 7177-7180
Aftabuddin, M.; Mal, C.; Deb, A.; Kundu, S. 2014: C2Analyzer: Co-target-co-function analyzer. Genomics Proteomics and Bioinformatics 12(3): 133-136
Salucci, S.; Battistelli, M.; Burattini, S.; Squillace, C.; Canonico, B.; Gobbi, P.; Papa, S.; Falcieri, E. 2010: C2C12 myoblast sensitivity to different apoptotic chemical triggers. Micron 41(8): 966-973
Guescini, M.; Guidolin, D.; Vallorani, L.; Casadei, L.; Gioacchini, A.M.; Tibollo, P.; Battistelli, M.; Falcieri, E.; Battistin, L.; Agnati, L.F.; Stocchi, V. 2010: C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Experimental Cell Research 316(12): 1977-1984
Nakazawa, M.; Kasai, K.; Yoshida, M. 2008: C2H2 absolutely optical frequency-stabilized and 40 GHz repetition-rate-stabilized, regeneratively mode-locked picosecond erbium fiber laser at 1.53 microm. Optics Letters 33(22): 2641-2643
Moors, M.; Visart de Bocarmé, T.; Kruse, N. 2009: C2H2 interaction with Ni nanocrystals: towards a better understanding of carbon nanotubes nucleation in CVD synthesis. Ultramicroscopy 109(5): 381-384
Dai, Y.; Liu, S.; Zheng, N. 2014: C2H2 treatment as a facile method to boost the catalysis of Pd nanoparticulate catalysts. Journal of the American Chemical Society 136(15): 5583-5586
Muthamilarasan, M.; Bonthala, V.Suresh.; Mishra, A.Kumar.; Khandelwal, R.; Khan, Y.; Roy, R.; Prasad, M. 2014: C2H2 type of zinc finger transcription factors in foxtail millet define response to abiotic stresses. Functional and Integrative Genomics 14(3): 531-543
Shimeld, S.M. 2008: C2H2 zinc finger genes of the Gli, Zic, KLF, SP, Wilms' tumour, Huckebein, Snail, Ovo, Spalt, Odd, Blimp-1, Fez and related gene families from Branchiostoma floridae. Development Genes and Evolution 218(11-12): 639-649
Lu, D. 2013: C2H2 zinc-finger recognition of biomolecules. Yao Xue Xue Bao 48(6): 834-841
Latrasse, C.; Breton, M.; Tetu, M.; Cyr, N.; Roberge, R.; Villeneuve, B. 1994: C2HD and 13C2H2 absorption lines near 1530 nm for semi-conductor-laser frequency locking. Optics Letters 19(22): 1885
Klapötke, T.M.; Martin, F.A.; Stierstorfer, J.ör. 2011: C2N14: an energetic and highly sensitive binary azidotetrazole. Angewandte Chemie 50(18): 4227-4229
Mauxion, F.; Prève, B.; Séraphin, B. 2013: C2ORF29/CNOT11 and CNOT10 form a new module of the CCR4-NOT complex. Rna Biology 10(2): 267-276
Lu, J.; Wen, M.; Huang, Y.; He, X.; Wang, Y.; Wu, Q.; Li, Z.; Castellanos-Martin, A.; Abad, M.; Cruz-Hernandez, J.J.; Rodriguez, C.A.; Pérez-Losada, J.ús.; Mao, J.-H.; Wei, G. 2013: C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes. Epigenetics 8(6): 571-583
Beck, S.; Ng, T. 2014: C2c: turning cancer into chronic disease. Genome Medicine 6(5): 38
Ye, X.; Zeng, H.; Ning, G.; Reiter, J.F.; Liu, A. 2014: C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals. Proceedings of the National Academy of Sciences of the United States of America 111(6): 2164-2169
Hoover, A.N.; Wynkoop, A.; Zeng, H.; Jia, J.; Niswander, L.A.; Liu, A. 2008: C2cd3 is required for cilia formation and Hedgehog signaling in mouse. Development 135(24): 4049-4058
Alazami, A.M.; Schneider, S.A.; Bonneau, D.; Pasquier, L.; Carecchio, M.; Kojovic, M.; Steindl, K.; de Kerdanet, M.; Nezarati, M.M.; Bhatia, K.P.; Degos, B.; Goh, E.; Alkuraya, F.S. 2010: C2orf37 mutational spectrum in Woodhouse-Sakati syndrome patients. Clinical Genetics 78(6): 585-590
Bontems, F.; Fish, R.J.; Borlat, I.; Lembo, F.éd.ér.; Chocu, S.; Chalmel, F.éd.ér.; Borg, J.-P.; Pineau, C.; Neerman-Arbez, M.; Bairoch, A.; Lane, L. 2014: C2orf62 and TTC17 are involved in actin organization and ciliogenesis in zebrafish and human. Plos one 9(1): E86476
Xing, J.-F.; Zheng, M.-L.; Chen, W.-Q.; Dong, X.-Z.; Takeyasu, N.; Tanaka, T.; Zhao, Z.-S.; Duan, X.-M.; Kawata, S. 2012: C2v symmetrical two-photon polymerization initiators with anthracene core: synthesis, optical and initiating properties. Physical Chemistry Chemical Physics: Pccp 14(45): 15785-15792
Nilsson, B.; Hamad, O.A.; Ahlström, H.åk.; Kullberg, J.; Johansson, L.; Lindhagen, L.; Haenni, A.; Ekdahl, K.N.; Lind, L. 2014: C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. European Journal of Clinical Investigation 44(6): 587-596
Mosca, Tá.; Menezes, M.C.S.; Dionigi, Pícia.C.L.; Stirbulov, R.; Forte, W.C.N. 2011: C3 and C4 complement system components as biomarkers in the intermittent atopic asthma diagnosis. Jornal de Pediatria 87(6): 512-516
Carbone, J.; Sarmiento, E.; Rodríguez-Molina, J.; Fernández-Cruz, E. 2008: C3 and C4 hypocomplementemia in obstetric antiphospholipid syndrome. Revista Clinica Espanola 208(3): 170-171
Leban, N.; Haj Khelil, A.; Daimi, H.; Denden, S.; Slimene, F.; Mehdouani, K.; Abdennaji Guenounou, B.; Lefranc, G.; Perrin, P.; Ben Chibani, J. 2007: C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia. Annales de Biologie Clinique 65(3): 251-256
Terkawi, M.A.; Zhang, G.; Jia, H.; Aboge, G.; Goo, Y.K.; Nishikawa, Y.; Yokoyama, N.; Igarashi, I.; Kawazu, S.I.; Fujisaki, K.; Xuan, X. 2008: C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection. Parasite Immunology 30(6-7): 365-370
Ruseva, M.M.; Takahashi, M.; Fujita, T.; Pickering, M.C. 2014: C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo. Clinical and Experimental Immunology 176(1): 84-92
Sugimoto, K.; Fujita, S.; Miyazaki, K.; Okada, M.; Takemura, T. 2012: C3 glomerulonephritis associated with a missense mutation in the factor H gene. Tohoku Journal of Experimental Medicine 227(3): 211-215
Zand, L.; Kattah, A.; Fervenza, F.C.; Smith, R.J.H.; Nasr, S.H.; Zhang, Y.; Vrana, J.A.; Leung, N.; Cornell, L.D.; Sethi, S. 2013: C3 glomerulonephritis associated with monoclonal gammopathy: a case series. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 62(3): 506-514
Deltas, C.; Gale, D.; Cook, T.; Voskarides, K.; Athanasiou, Y.; Pierides, A. 2013: C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families. Advances in Experimental Medicine and Biology 735: 189-196
Rabasco-Ruiz, C.; Huerta-Arroyo, A.; Caro-Espada, J.; Gutiérrez-Martínez, E.; Praga-Terente, M. 2013: C3 glomerulopathies. a new perspective on glomerular diseases. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 33(2): 164-170
Rollino, C. 2014: C3 glomerulopathy. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 31(1)
Touchard, G.; Bridoux, F. 2013: C3 glomerulopathy in adults: monoclonal gammopathy should be considered. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 61(4): 644
Tortajada, Aín.; Yébenes, H.; Abarrategui-Garrido, C.; Anter, J.; García-Fernández, Jús.M.; Martínez-Barricarte, Rén.; Alba-Domínguez, Mía.; Malik, T.H.; Bedoya, R.; Cabrera Pérez, Río.; López Trascasa, M.; Pickering, M.C.; Harris, C.L.; Sánchez-Corral, P.; Llorca, O.; Rodríguez de Córdoba, S. 2013: C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. Journal of Clinical Investigation 123(6): 2434-2446
de Lorenzo, A.; Tallón, S.; Hernández-Sevillano, B.; de Arriba, G. 2014: C3 glomerulopathy: A new complement-based entity. Revista Clinica Espanola 214(5): 266-274
Medjeral-Thomas, N.R.; O'Shaughnessy, M.M.; O'Regan, J.A.; Traynor, C.; Flanagan, M.; Wong, L.; Teoh, C.W.; Awan, A.; Waldron, M.; Cairns, T.; O'Kelly, P.; Dorman, A.M.; Pickering, M.C.; Conlon, P.J.; Cook, H.T. 2014: C3 glomerulopathy: clinicopathologic features and predictors of outcome. Clinical Journal of the American Society of Nephrology: Cjasn 9(1): 46-53
Alvarez, S.; Khanwalkar, H.; Alvarez, R.; Erb, C.; Martínez, C.; Rodríguez-Barrios, F.át.; Germain, P.; Gronemeyer, H.; de Lera, A.R. 2009: C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function. Chemmedchem 4(10): 1630-1640
Tucker, E.S. 1971: C3 lytic factor in nephritis. California Medicine 114(5): 72
Nicolas, C.; Vuiblet, V.; Baudouin, V.; Macher, M.-A.; Vrillon, I.; Biebuyck-Gouge, N.; Dehennault, M.; Gié, S.; Morin, D.; Nivet, H.; Nobili, F.ço.; Ulinski, T.; Ranchin, B.; Marinozzi, M.C.; Ngo, S.ép.; Frémeaux-Bacchi, V.ér.; Pietrement, C. 2014: C3 nephritic factor associated with C3 glomerulopathy in children. Pediatric Nephrology 29(1): 85-94
Niel, O.; Dallocchio, A.; Thouret, M.-C.; Guigonis, V.; Cassuto, Él.; Frémeaux-Bacchi, V.ér.; Bérard, Ét. 2015: C3 nephritic factor can be associated with membranous glomerulonephritis. Pediatric Nephrology 30(2): 353-355
Baudino, L.; Sardini, A.; Ruseva, M.M.; Fossati-Jimack, L.; Cook, H.T.; Scott, D.; Simpson, E.; Botto, M. 2014: C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens. Proceedings of the National Academy of Sciences of the United States of America 111(4): 1503-1508
Boato, F.; Hendrix, S.; Huelsenbeck, S.C.; Hofmann, F.; Grosse, G.; Djalali, S.; Klimaschewski, L.; Auer, M.; Just, I.; Ahnert-Hilger, G.; Höltje, M. 2010: C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. Journal of Cell Science 123(Pt 10): 1652-1662
Huelsenbeck, S.C.; Rohrbeck, A.; Handreck, A.; Hellmich, G.; Kiaei, E.; Roettinger, I.; Grothe, C.; Just, I.; Haastert-Talini, K. 2012: C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 9(1): 185-198
Cerros-Tlatilpa, R.; Columbus, J.T. 2009: C3 photosynthesis in Aristida longifolia: Implication for photosynthetic diversification in Aristidoideae (Poaceae). American Journal of Botany 96(8): 1379-1387
Lawson, T.; Davey, P.A.; Yates, S.A.; Bechtold, U.; Baeshen, M.; Baeshen, N.; Mutwakil, M.Z.; Sabir, J.; Baker, N.R.; Mullineaux, P.M. 2014: C3 photosynthesis in the desert plant Rhazya stricta is fully functional at high temperatures and light intensities. New Phytologist 201(3): 862-873
Busch, F.A.; Sage, T.L.; Cousins, A.B.; Sage, R.F. 2013: C3 plants enhance rates of photosynthesis by reassimilating photorespired and respired CO2. Plant Cell and Environment 36(1): 200-212
Varagunam, M.; Yaqoob, M.M.; Döhler, B.; Opelz, G. 2009: C3 polymorphisms and allograft outcome in renal transplantation. New England Journal of Medicine 360(9): 874-880
Naesens, M.; Butte, A.J.; Sarwal, M.M. 2009: C3 polymorphisms and outcomes of renal allografts. New England Journal of Medicine 360(23): 2478; Author Reply 2478-2479
Nakayama, Y.; Kim, S.-I.; Kim, E.H.; Lambris, J.D.; Sandor, M.; Suresh, M. 2009: C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection. Journal of Immunology 183(5): 2921-2931
Tautzenberger, A.; Förtsch, C.; Zwerger, C.; Dmochewitz, L.; Kreja, L.; Ignatius, A.; Barth, H. 2013: C3 rho-inhibitor for targeted pharmacological manipulation of osteoclast-like cells. Plos one 8(12): E85695
López, F.O.; López O'Rourke, V.J.; Fernández Mariscal, E.; Vilarrasa Sauquet, R.; Sañudo Martín, I. 2011: C3 spinal cord ependymoma C03. Medicina Clinica 136(13): 605
Mba, M.; Pontini, M.; Lovat, S.; Zonta, C.; Bernardinelli, G.; Kündig, P.E.; Licini, G. 2008: C3 vanadium(V) amine triphenolate complexes: vanadium haloperoxidase structural and functional models. Inorganic Chemistry 47(19): 8616-8618
Banerjee, A.; Kumar, V.A. 2013: C3'-endo-puckered pyrrolidine containing PNA has favorable geometry for RNA binding: novel ethano locked PNA (ethano-PNA). Bioorganic and Medicinal Chemistry 21(14): 4092-4101
Hinds, J.W.; McKenna, S.B.; Sharif, E.U.; Wang, H.-Y.L.; Akhmedov, N.G.; O'Doherty, G.A. 2013: C3'/C4'-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity. Chemmedchem 8(1): 63-69
Yu, Y.; Liu, X.; Jiang, D.; Sun, Q.; Zhou, T.; Zhu, M.; Jin, L.; Shi, G. 2011: C3(OH)2mim][BF4]-Au/Pt biosensor for glutamate sensing in vivo integrated with on-line microdialysis system. Biosensors and Bioelectronics 26(7): 3227-3232
Kitamura, H. 2010: C3(beta1C/1A globulin) and C5. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 64-67
Marchand, C.; Bachand, J.; Périnêt, J.; Baraghis, E.; Lamarre, M.; Rivard, G.E.; De Crescenzo, G.; Hoemann, C.D. 2010: C3, C5, and factor B bind to chitosan without complement activation. Journal of Biomedical Materials Research. Part a 93(4): 1429-1441
Holaday, A.S.; Lee, K.W.; Chollet, R. 1984: C3-C 4 Intermediate species in the genus Flaveria: leaf anatomy, ultrastructure, and the effect of O2 on the CO 2 compensation concentration. Planta 160(1): 25-32
El-Sharkawy, M.A.; Cock, J.H. 1987: C3-C 4 intermediate photosynthetic characteristics of cassava (Manihot esculenta Crantz) : I. Gas exchange. Photosynthesis Research 12(3): 219-235
Cock, J.H.; Riaño, N.M.; El-Sharkawy, M.A.; Yamel, L.F.; Bastidas, G. 1987: C3-C 4 intermediate photosynthetic characteristics of cassava (Manihot esculenta Crantz) : II. Initial products of(14)CO 2 fixation. Photosynthesis Research 12(3): 237-241
Connor, S.; O'Brien, M.; Irvine, A.; O'Marcaigh, A.; Smith, O. 2015: C3-C4 shingles post haematopoietic stem-cell transplantation. Archives of Disease in Childhood 100(2): 137
Srivastava, S.K.; Agrawal, K.M.; Sharma, A.K.; Agrawal, M.D.; Bhosale, S.K.; Renganathan, S.Ram. 2010: C3-C4 spondyloptosis without neurological deficit-a case report. Spine Journal: Official Journal of the North American Spine Society 10(7): E16-E20
Takizawa, S.; Hirata, S.; Murai, K.; Fujioka, H.; Sasai, H. 2014: C3-Symmetric chiral trisimidazoline-catalyzed Friedel-Crafts (FC)-type reaction. Organic and Biomolecular Chemistry 12(31): 5827-5830
Dixon, D.D.; Tius, M.A.; Thakur, G.A.; Zhou, H.; Bowman, A.L.; Shukla, V.G.; Peng, Y.; Makriyannis, A. 2012: C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor. Bioorganic and Medicinal Chemistry Letters 22(16): 5322-5325
Ibáñez, S.; Albertí, F.M.; Sanz Miguel, P.J.; Lippert, B. 2011: C3-symmetric Pt3Pd3 purine vases based on a metal coordination motif involving the pyrimidinic N1 and N3 sites. Chemistry 17(34): 9283-9287
Sambasivan, S.; Kim, S.-G.; Choi, S.M.; Rhee, Y.M.; Ahn, K.H. 2010: C3-symmetric cage-like receptors: chiral discrimination of α-chiral amines in a confined space. Organic Letters 12(19): 4228-4231
Arnold, P.L.; Buffet, J.-C.; Blaudeck, R.P.; Sujecki, S.; Blake, A.J.; Wilson, C. 2008: C3-symmetric lanthanide tris(alkoxide) complexes formed by preferential complexation and their stereoselective polymerization of rac-lactide. Angewandte Chemie 47(32): 6033-6036
Frantz, R.; Guillamón, E.; Lacour, J.ér.ôm.; Llusar, R.; Polo, V.; Vicent, C. 2007: C3-symmetric trinuclear molybdenum cluster sulfides: configurational stability, supramolecular stereocontrol, and absolute configuration assignment. Inorganic Chemistry 46(25): 10717-10723
Murai, K.; Nakamura, A.; Matsushita, T.; Shimura, M.; Fujioka, H. 2012: C3-symmetric trisimidazoline-catalyzed enantioselective bromolactonization of internal alkenoic acids. Chemistry 18(27): 8448-8453
Smulders, M.M.J.; Buffeteau, T.; Cavagnat, D.; Wolffs, M.; Schenning, A.P.H.J.; Meijer, E.W. 2008: C3-symmetrical self-assembled structures investigated by vibrational circular dichroism. Chirality 20(9): 1016-1022
Wang, T.; Zhang, Y.-F.; Hou, Q.-Q.; Xu, W.-R.; Cao, X.-P.; Chow, H.-F.; Kuck, D. 2013: C3-symmetrical tribenzotriquinacene derivatives: optical resolution through cryptophane synthesis and supramolecular self-assembly into nanotubes. Journal of Organic Chemistry 78(3): 1062-1069
Peyrard, L.; Chierici, S.; Pinet, S.; Batat, P.; Jonusauskas, G.; Pinaud, N.ël.; Meyrand, P.; Gosse, I. 2011: C3-triiodocyclotriveratrylene as a key intermediate to fluorescent probes: application to selective choline recognition. Organic and Biomolecular Chemistry 9(24): 8489-8494
Yu, L.-P.; Hu, Y.-H.; Sun, B.-G.; Sun, L. 2012: C312M: an attenuated Vibrio anguillarum strain that induces immunoprotection as an oral and immersion vaccine. Diseases of Aquatic Organisms 102(1): 33-42
Cau, M.; Loi, M.; Melis, M.; Congiu, R.; Loi, A.; Meloni, C.; Serrenti, M.; Addis, M.; Melis, M.A. 2009: C329X in KRIT1 is a founder mutation among CCM patients in Sardinia. European Journal of Medical Genetics 52(5): 344-348
Clapp, K.M.; Peng, H.-M.; Morishima, Y.; Lau, M.; Walker, V.J.; Pratt, W.B.; Osawa, Y. 2010: C331A mutant of neuronal nitric-oxide synthase is labilized for Hsp70/CHIP (C terminus of HSC70-interacting protein)-dependent ubiquitination. Journal of Biological Chemistry 285(44): 33642-33651
Groener, J.B.; Reismann, P.; Fleming, T.; Kalscheuer, H.; Lehnhoff, D.; Hamann, A.; Roser, P.; Bierhaus, A.; Nawroth, P.P.; Rudofsky, G. 2013: C332C genotype of glyoxalase 1 and its association with late diabetic complications. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 121(7): 436-439
Zhang, N.; Chen, W.; Zhou, X.; Zhou, X.; Xie, X.; Meng, A.; Li, S.; Wang, L. 2013: C333H ameliorated insulin resistance through selectively modulating peroxisome proliferator-activated receptor γ in brown adipose tissue of db/db mice. Biological and Pharmaceutical Bulletin 36(6): 980-987
Sałagacka, A.; Bartczak, M.; Zebrowska, M.; Jażdżyk, M.; Balcerczak, M.; Janiuk, R.; Mirowski, M.; Balcerczak, E. 2011: C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers. Pharmacological Reports: Pr 63(4): 992-998
Dudarewicz, M.ł; Barańska, M.łg.; Rychlik-Sych, M.; Trzciński, R.ła.; Dziki, A.; Skrętkowicz, J. 2012: C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population. Pharmacological Reports: Pr 64(2): 343-350
Hur, E.-H.; Lee, J.-H.; Lee, M.J.; Choi, S.-J.; Lee, J.-H.; Kang, M.J.; Seol, M.; Jang, Y.E.; Lee, H.-J.; Kang, I.-S.; Shim, S.-K.; Ryu, S.-G.; Kang, Y.-A.; Lee, Y.-S.; Park, C.-J.; Chi, H.-S.; Lee, K.-H. 2008: C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia. Leukemia Research 32(10): 1601-1604
Lucia, A.; Martin, M.A.; Esteve-Lanao, J.; San Juan, A.F.; Rubio, J.C.; Oliván, J.ús.; Arenas, J.ín. 2009: C34T mutation of the AMPD1 gene in an elite white runner. BMJ Case Reports
De Luis, D.A.; Sagrado, M.G.; Aller, R.; Izaola, O.; Conde, R.; Romero, E. 2010: C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2. Diabetes Research and Clinical Practice 88(1): 76-80
De Luis, D.A.; González Sagrado, M.; Aller, R.ío.; Izaola, O.; Conde, R.; Romero, E. 2010: C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 57(2): 54-59
Tao, S.; He, Y.; Ying, Y.; Hong, X.; Xu, X.; Zhu, F.; Lv, H.; Yan, L. 2012: C35T mutation could slightly decrease the activity of human α-(1,2)-fucosyltransferase. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 19(1): 5-10
Wakabayashi, T.; Kosaka, J.; Mochii, M.; Miki, Y.; Mori, T.; Takamori, Y.; Yamada, H. 2010: C38, equivalent to BM88, is developmentally expressed in maturing retinal neurons and enhances neuronal maturation. Journal of Neurochemistry 112(5): 1235-1248
Feng, C.; Duan, W.; Zhang, D.; Zhang, E.; Xu, Z.; Lu, L. 2014: C392T polymorphism of the Wnt10a gene in non-syndromic oral cleft in a northeastern Chinese population. British Journal of Oral and Maxillofacial Surgery 52(8): 751-755
Yu, B.-Y.; Chou, P.-H.; Chen, C.-A.; Sun, Y.-M.; Kung, S.-S. 2007: C3A cell behaviors on micropatterned chitosan collagen gelatin membranes. Journal of Biomaterials Applications 22(3): 255-274
Rhim, M.S.; Meddeb, S.; Kaabia, O.; Jalloul, M.; Sakouhi, M.; Jrzad, B.B.H.; Felah, R. 2015: C3F gene mutation is involved in the susceptibility to pre-eclampsia. Archives of Gynecology and Obstetrics 291(5): 1023-1027
Gutiérrez-Uzquiza, A.; Arechederra, M.ía.; Molina, I.; Baños, R.ío.; Maia, V.; Benito, M.; Guerrero, C.; Porras, A. 2010: C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: involvement in cell death. Cellular Signalling 22(3): 533-542
Radha, V.; Rajanna, A.; Mitra, A.; Rangaraj, N.; Swarup, G. 2007: C3G is required for c-Abl-induced filopodia and its overexpression promotes filopodia formation. Experimental Cell Research 313(11): 2476-2492
Zhang, X.; Li, G.; Zhang, L.; Yang, D.; Zhang, Z.; Yan, A.; Linghu, H. 2013: C3G overexpression promotes the survival of rat-derived H9C2 cardiomyocytes by p-ERK1/2. Cell Biology International 37(10): 1106-1113
Pal, S.; Sarcon, A.K.; de la Maza, L.M. 2009: C3H male mice with severe combined immunodeficiency cannot clear a urethral infection with a human serovar of Chlamydia trachomatis. Infection and Immunity 77(12): 5602-5607
Wu, W.; Cheng, Z.; Liu, M.; Yang, X.; Qiu, D. 2014: C3HC4-type RING finger protein NbZFP1 is involved in growth and fruit development in Nicotiana benthamiana. Plos one 9(6): E99352
Liu, Y.; Ye, X.; Jiang, F.; Liang, C.; Chen, D.; Peng, J.; Kinch, L.N.; Grishin, N.V.; Liu, Q. 2009: C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science 325(5941): 750-753
Schraufstatter, I.U.; Discipio, R.G.; Zhao, M.; Khaldoyanidi, S.K. 2009: C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. Journal of Immunology 182(6): 3827-3836
Tang, Z.; Lu, B.; Hatch, E.; Sacks, S.H.; Sheerin, N.S. 2009: C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. Journal of the American Society of Nephrology: Jasn 20(3): 593-603
Asgari, E.; Le Friec, G.; Yamamoto, H.; Perucha, E.; Sacks, S.S.; Köhl, J.ör.; Cook, H.T.; Kemper, C. 2013: C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 122(20): 3473-3481
Li, L.; Yin, Q.; Tang, X.; Bai, L.; Zhang, J.; Gou, S.; Zhu, H.; Cheng, J.; Fu, P.; Liu, F. 2014: C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway. Plos one 9(11): E113639
Kumar, L.; Lu, B.; Gerard, C.; Geha, R.S. 2013: C3a receptor promotes viral containment in mice inoculated with vaccinia virus at sites of allergic skin inflammation. Journal of Allergy and Clinical Immunology 132(3): 746-748.E3
Liu, L.; Zhang, Y.; Duan, X.; Peng, Q.; Liu, Q.; Zhou, Y.; Quan, S.; Xing, G. 2014: C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy. Journal of Clinical Immunology 34(2): 224-232
Pomara, C.; Neri, M.; Bello, S.; Pennella, A.; Turillazzi, E.; Fineschi, V. 2010: C3a, TNF-alpha and interleukin myocardial expression in a case of fatal sudden cardiac failure during clinic reactivation of systemic lupus erythematosus. Lupus 19(10): 1246-1249
Péterfy, H.; Tóth, G.áb.; Pecht, I.; Erdei, A. 2008: C3a-derived peptide binds to the type i FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. International Immunology 20(10): 1239-1245
Jacob, A.; Bao, L.; Brorson, J.; Quigg, R.J.; Alexander, J.J. 2010: C3aR inhibition reduces neurodegeneration in experimental lupus. Lupus 19(1): 73-82
Jokiranta, T.Sakari. 2006: C3b and factor H: key components of the complement system. Expert Review of Clinical Immunology 2(5): 775-786
Karnchanaphanurach, P.; Mirchev, R.; Ghiran, I.; Asara, J.M.; Papahadjopoulos-Sternberg, B.; Nicholson-Weller, A.; Golan, D.E. 2009: C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex. Journal of Clinical Investigation 119(4): 788-801
Carlson, M.; Venge, P.; Lampinen, M. 2011: C3b-induced eosinophil degranulation involves PI3-kinases and is inhibited by protein kinase C activity. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 119(2): 119-126
Hyams, C.; Tam, J.C.H.; Brown, J.S.; Gordon, S.B. 2010: C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection. Plos one 5(1): E8902
Padilla-Docal, B.; Dorta-Contreras, A.J.; Bu-Coifiú Fanego, R. 2009: C3c activation and intrathecal biosynthesis in children suffering from eosinophilic meningoencephalitis due to Angiostrongylus cantonensis. Revista de Neurologia 48(12): 632-635
Padilla-Docal, B.ár.; Dorta-Contreras, A.J.; Fundora-Hernández, H.; Noris-García, E.; Bu-Coifiu-Fanego, R.; González-Hernández, M.; Rodríguez-Rey, A. 2007: C3c intrathecal synthesis evaluation in patients with multiple sclerosis. Arquivos de Neuro-Psiquiatria 65(3b): 800-802
Toapanta, F.R.; DeAlmeida, D.R.; Dunn, M.D.; Ross, T.M. 2010: C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunology Letters 129(1): 32-38
Wiwanitkit, V. 2010: C3d and C4d complement and graft rejection. Annals of Transplantation 15(2): 76
Zhang, R.; Lin, J.; Qu, L.; Zheng, F.; Zheng, Z. 2014: C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy. Annals of Diagnostic Pathology 18(2): 104-108
Feldman, E.A. 2018: Baby M Turns 30: the Law and Policy of Surrogate Motherhood. American Journal of Law and Medicine 44(1): 7-22
Pfaltz, K.; Mertz, K.; Rose, C.; Scheidegger, P.; Pfaltz, M.; Kempf, W. 2010: C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin. Journal of Cutaneous Pathology 37(6): 654-658
Urschel, S.; Ryan, L.A.; Larsen, I.M.; Derkatz, K.; Rebeyka, I.M.; Ross, D.B.; West, L.J. 2014: C3d plasma levels and CD21 expressing B-cells in children after ABO-incompatible heart transplantation: Alterations associated with blood group tolerance. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 33(11): 1149-1156
Fan, H.; Liu, Z.; Tong, T.; Liu, X.; Guo, A. 2009: C3d-M28 enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus. Sheng Wu Gong Cheng Xue Bao 25(7): 987-992
Georghiou, P.E.; Dawe, L.N.; Tran, H.-A.; Strübe, J.ör.; Neumann, B.; Stammler, H.-G.; Kuck, D. 2008: C3v-symmetrical tribenzotriquinacenes as hosts for C60 and C70 in solution and in the solid state. Journal of Organic Chemistry 73(22): 9040-9047
Zhou, L.; Zhang, T.-X.; Li, B.-R.; Cao, X.-P.; Kuck, D. 2007: C3v-symmetrical tribenzotriquinacenes extended by six C1-functional groups and the first triquinacene-based tris(dithiametacyclophanes). Journal of Organic Chemistry 72(17): 6382-6389
Iacumin, P.; Galli, E.; Cavalli, F.; Cecere, L. 2014: C4 -consumers in southern Europe: the case of Friuli V.G. (NE-Italy) during early and central Middle Ages. American Journal of Physical Anthropology 154(4): 561-574
Yammani, R.D.; Leyva, M.A.; Jennings, R.N.; Haas, K.M. 2014: C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. Journal of Immunology 193(11): 5434-5443
Obeid, I.; Boissière, L.; Vital, J.-M. 2013: C4 anterior cervical corpectomy with fusion for cervical spondylotic myelopathy. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 22(12): 2907-2909
Li, Y.; Mondal, K.C.; Samuel, P.P.; Zhu, H.; Orben, C.M.; Panneerselvam, S.; Dittrich, B.; Schwederski, B.; Kaim, W.; Mondal, T.; Koley, D.; Roesky, H.W. 2014: C4 cumulene and the corresponding air-stable radical cation and dication. Angewandte Chemie 53(16): 4168-4172
Langdale, J.A. 2011: C4 cycles: past, present, and future research on C4 photosynthesis. Plant Cell 23(11): 3879-3892
Sethi, S.; Sullivan, A.; Smith, R.J.H. 2014: C4 dense-deposit disease. New England Journal of Medicine 370(8): 784-786
Smith, W.K. 2008: C4 leaf curling--coupling incident light, stomatal and photosynthetic asymmetries. New phytologist 177(1): 5-8
Ghannoum, O. 2009: C4 photosynthesis and water stress. Annals of Botany 103(4): 635-644
Spriggs, E.L.; Christin, P.-A.; Edwards, E.J. 2014: C4 photosynthesis promoted species diversification during the Miocene grassland expansion. Plos one 9(5): E97722
Zhao, Q.; Chen, S.; Dai, S. 2013: C4 photosynthetic machinery: insights from maize chloroplast proteomics. Frontiers in Plant Science 4: 85
Byrt, C.S.; Grof, C.P.L.; Furbank, R.T. 2011: C4 plants as biofuel feedstocks: optimising biomass production and feedstock quality from a lignocellulosic perspective. Journal of Integrative Plant Biology 53(2): 120-135
Kubásek, J.ří; Urban, O.; Šantrůček, J.ří 2013: C4 plants use fluctuating light less efficiently than do C3 plants: a study of growth, photosynthesis and carbon isotope discrimination. Physiologia Plantarum 149(4): 528-539
Park, J.; Hwang, H.-S.; Buckley, K.J.; Park, J.-B.; Auh, C.-K.; Kim, D.-G.; Lee, S.; Davis, K.R. 2010: C4 protein of Beet severe curly top virus is a pathomorphogenetic factor in Arabidopsis. Plant Cell Reports 29(12): 1377-1389
Zhu, X.-G.; Shan, L.; Wang, Y.; Quick, W.P. 2010: C4 rice - an ideal arena for systems biology research. Journal of Integrative Plant Biology 52(8): 762-770
Drozak, A.; Wasilewska, W.; Buczyńska, A.; Romanowska, E. 2012: C4 type photosynthesis. Postepy Biochemii 58(1): 44-53
Saxena, S.; Stanek, J.; Cevec, M.; Plavec, J.; Koźmiński, W. 2014: C4'/H4' selective, non-uniformly sampled 4D HC(P)CH experiment for sequential assignments of (13)C-labeled RNAs. Journal of Biomolecular NMR 60(2-3): 91-98
Kitamura, H. 2010: C4(beta1E globulin) and C2. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 86-89
Gasco, J.; Dilorenzo, D.J.; Patterson, J.T. 2013: C4-C5 post-traumatic spondyloptosis with in situ fusion: systematic literature review and case report. Spine 38(10): E621-E625
Panzer, M.B.; Cronin, D.S. 2009: C4-C5 segment finite element model development, validation, and load-sharing investigation. Journal of Biomechanics 42(4): 480-490
Döhler, G. 1974: C4-Pathway of photosynthesis in the blue-green alga Anacystis nidulans. Planta 118(3): 259-269
Hatch, M.D. 1975: C4-Pathway photosynthesis in Portulaca oleracea and the significance of alanine labelling. Planta 125(3): 273-279
Tsuchikama, K.; Zhu, J.; Lowery, C.A.; Kaufmann, G.F.; Janda, K.D. 2012: C4-alkoxy-HPD: a potent class of synthetic modulators surpassing nature in AI-2 quorum sensing. Journal of the American Chemical Society 134(33): 13562-13564
Kostova, M.B.; Myers, C.J.; Beck, T.N.; Plotkin, B.J.; Green, J.M.; Boshoff, H.I.M.; Barry, C.E.; Deschamps, J.R.; Konaklieva, M.I. 2011: C4-alkylthiols with activity against Moraxella catarrhalis and Mycobacterium tuberculosis. Bioorganic and Medicinal Chemistry 19(22): 6842-6852
Albrecht, M. 2008: C4-bound imidazolylidenes: from curiosities to high-impact carbene ligands. Chemical Communications 31: 3601-3610
Zhou, Y.-F.; Nan, B.; Nan, J.; Ma, Q.; Panjikar, S.; Liang, Y.-H.; Wang, Y.; Su, X.-D. 2008: C4-dicarboxylates sensing mechanism revealed by the crystal structures of DctB sensor domain. Journal of Molecular Biology 383(1): 49-61
Tsotinis, A.; Zouroudis, S.; Moreau, D.; Roussakis, C. 2007: C4-substituted isoquinolines: synthesis and cytotoxic action. Open Medicinal Chemistry Journal 1: 1-3
Jacobsen, B.; Kriegbaum, M.C.; Santoni-Rugiu, E.; Ploug, M. 2014: C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma. World Journal of Clinical Oncology 5(4): 621-632
Ohtsuka, M.; Yamamoto, H.; Masuzawa, T.; Takahashi, H.; Uemura, M.; Haraguchi, N.; Nishimura, J.; Hata, T.; Yamasaki, M.; Miyata, H.; Takemasa, I.; Mizushima, T.; Takiguchi, S.; Doki, Y.; Mori, M. 2013: C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma. Annals of Surgical Oncology 20(8): 2699-2705
Porway, J.; Zhu, S-Chun. 2011: C4: Exploring Multiple Solutions in Graphical Models by Cluster Sampling. IEEE Transactions on Pattern Analysis and Machine Intelligence 33(9): 1713-1727
Wu, J.; Liu, N.; Geyer, C.; Rehg, J.M. 2013: C4: a real-time object detection framework. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 22(10): 4096-4107
Kainulainen, L.; Peltola, V.; Seppänen, M.; Viander, M.; He, Q.; Lokki, M.-L.; Ruuskanen, O. 2012: C4A deficiency in children and adolescents with recurrent respiratory infections. Human Immunology 73(5): 498-501
Buil, A.; Trégouët, D-Alexandre.; Souto, J.Carlos.; Saut, Némie.; Germain, M.; Rotival, M.; Tiret, L.; Cambien, Fçcois.; Lathrop, M.; Zeller, T.; Alessi, M-Christine.; Rodriguez de Cordoba, S.; Münzel, T.; Wild, P.; Fontcuberta, J.; Gagnon, F.; Emmerich, J.; Almasy, L.; Blankenberg, S.; Soria, Jé-Manuel.; Morange, P-Emmanuel. 2010: C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 115(23): 4644-4650
Arias, L.F.; Fernández, R.; Fernández, D.; Jaramillo, J.C.; Gil, M.; López García-Asenjo, J.A. 2010: C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts. Transplantation Proceedings 42(5): 1793-1796
Dal'Molin, C.G.d.O.; Quek, L.-E.; Palfreyman, R.W.; Brumbley, S.M.; Nielsen, L.K. 2010: C4GEM, a genome-scale metabolic model to study C4 plant metabolism. Plant Physiology 154(4): 1871-1885
Wolff, M.; Meyer, J.; Feldmann, C. 2011: C4MPyr]2[Br20]: ionic-liquid-based synthesis of a three-dimensional polybromide network. Angewandte Chemie 50(21): 4970-4973
Endele, S.; Nelkenbrecher, C.; Bördlein, A.; Schlickum, S.; Winterpacht, A. 2011: C4ORF48, a gene from the Wolf-Hirschhorn syndrome critical region, encodes a putative neuropeptide and is expressed during neocortex and cerebellar development. Neurogenetics 12(2): 155-163
Robinson, R.; Badieyan, S.; Sobrado, P. 2013: C4a-hydroperoxyflavin formation in N-hydroxylating flavin monooxygenases is mediated by the 2'-OH of the nicotinamide ribose of NADP⁺. Biochemistry 52(51): 9089-9091
Blom, A.M.; Nandakumar, K.S.; Holmdahl, R. 2009: C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Annals of the Rheumatic Diseases 68(1): 136-142
Trouw, L.A.; Nielsen, H.M.; Minthon, L.; Londos, E.; Landberg, G.ör.; Veerhuis, R.; Janciauskiene, S.; Blom, A.M. 2008: C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells. Molecular Immunology 45(13): 3649-3660
Trouw, L.A.; Okroj, M.; Kupreishvili, K.; Landberg, Göran.; Johansson, B.; Niessen, H.W.M.; Blom, A.M. 2008: C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3. Plos one 3(8): E2886
Dorwal, P.; Pande, A.; Mehra, S.; Tyagi, N.; Jain, D.; Raina, V. 2014: C4d FlowPRA is a useful tool in live related renal transplants. Pathology 46(5): 471-472
Suzuki, T.; Horita, S.; Kadoya, K.; Mitsuiki, K.; Aita, K.; Harada, A.; Nitta, K.; Nagata, M. 2007: C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clinical and Experimental Nephrology 11(4): 287-291
Boffini, M.; Ricci, D.; Bonato, R.; Ribezzo, M.; Simonato, E.; Saviolo, R.; Checco, L.; Comoglio, C.; Rinaldi, M. 2011: C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?. Transplantation Proceedings 43(4): 1168-1170
Val-Bernal, J.Fernando.; Garijo, M.Francisca.; Val, D.; Rodrigo, E.; Arias, M. 2012: C4d as a diagnostic tool in membranous nephropathy. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 32(4): 536; Author Reply 536-7
Mizutani, K.; Gotoh, M. 2010: C4d binding correlated with strong HLA antibodies involved in graft failures. Transplantation Proceedings 42(10): 4021-4025
Wang, R.; Wang, H.; Chen, J.; Wu, J.; Wang, Y.; Huang, H.; He, Q. 2009: C4d deposition in allograft renal biopsies is an independent risk factor for graft failure. Nephrology 14(5): 527-532
Yang, L.; Lu, Y.P.; Luo, G.H.; Song, J.; Shi, Y.J.; Li, Y.P. 2008: C4d deposition is associated with chronic allograft nephropathy in rats and could be influenced by immunosuppressants. Transplantation Proceedings 40(8): 2782-2785
Yang, L.; Lu, Y.P.; Luo, G.H.; Song, J.; Tu, Z.D.; Li, Y.P. 2008: C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy. Transplantation Proceedings 40(8): 2786-2789
Haas, M.; Segev, D.L.; Racusen, L.C.; Bagnasco, S.M.; Locke, J.E.; Warren, D.S.; Simpkins, C.E.; Lepley, D.; King, K.E.; Kraus, E.S.; Montgomery, R.A. 2009: C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. Journal of the American Society of Nephrology: Jasn 20(1): 197-204
Sampaio, W.L.V.; Mazzali, M. 2014: C4d deposits in borderline rejection: an early marker for chronic renal dysfunction?. Transplantation Proceedings 46(6): 1710-1712
Muroya, T.; Kannan, L.; Ghiran, I.C.; Shevkoplyas, S.S.; Paz, Z.; Tsokos, M.; Dalle Lucca, J.J.; Shapiro, N.I.; Tsokos, G.C. 2014: C4d deposits on the surface of RBCs in trauma patients and interferes with their function. Critical Care Medicine 42(5): E364-E372
Smith, J.D.; Hamour, I.M.; Banner, N.R.; Rose, M.L. 2007: C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7(12): 2809-2815
Chandler, W.; Zone, J.; Florell, S. 2009: C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. Journal of Cutaneous Pathology 36(6): 655-659
Val-Bernal, J.F.; Garijo, M.F.; Val, D.; Rodrigo, E.; Arias, M. 2011: C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histology and Histopathology 26(11): 1391-1397
Hui, M.; Uppin, M.S.; Prayaga, A.K.; Raju, S.B.; Rajasekhar, L. 2014: C4d immunohistochemistry in membranous nephropathy. Journal of Laboratory Physicians 6(2): 76-79
Gierej, B.; Kobryń, K.; Gierej, P.; Górnicka, B. 2014: C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence. Annals of Transplantation 19: 373-381
Pytel, P. 2014: C4d staining as immunohistochemical marker in inflammatory myopathies. Applied Immunohistochemistry and Molecular Morphology: Aimm 22(9): 696-704
Kulkarni, P.; Uppin, M.S.; Prayaga, A.K.; Das, U.; Dakshinamurthy, K.V. 2012: C4d staining in allograft biopsies. Indian Journal of Nephrology 22(2): 155-156
David-Neto, E.; David, D.S.R.; Ginani, G.F.; Rodrigues, H.; Souza, P.S.; Castro, M.C.R.; Kanashiro, H.; Saito, F.; Falci, R.; Antonopoulos, I.M.; Piovesan, A.C.; Nahas, W.C. 2011: C4d staining in post-reperfusion renal biopsy is not useful for the early detection of antibody-mediated rejection when CDC crossmatching is negative. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 26(4): 1388-1392
Botermans, J.M.; de Kort, H.; Eikmans, M.; Koop, K.; Baelde, H.J.; Mallat, M.J.K.; Zuidwijk, K.; van Kooten, C.; de Heer, E.; Goemaere, N.N.T.; Claas, F.H.J.; Bruijn, J.A.; de Fijter, J.W.; Bajema, I.M.; van Groningen, M.C. 2011: C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome. Clinical Journal of the American Society of Nephrology: Cjasn 6(5): 1207-1213
Hönger, G.; Wahrmann, M.; Amico, P.; Hopfer, H.; Böhmig, G.A.; Schaub, S. 2010: C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection. Transplantation 89(12): 1471-1475
Haas, M. 2011: C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clinical Nephrology 75(4): 271-278
Samaniego, M.; Mezrich, J.; Torrealba, J.; Lorentzen, D.; Schadde, E.; Djamali, A.; Zachariah, M.; Sollinger, H.; Pirsch, J. 2006: C4d-positive acute antibody-mediated rejection due to anti-HLA-DP antibody: a tale of one patient and a review of the University of Wisconsin experience. Clinical transplants 2006: 503-507
Torrealba, J.R.; Samaniego, M.; Pascual, J.; Becker, Y.; Pirsch, J.; Sollinger, H.; Odorico, J. 2008: C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation 86(12): 1849-1856
Valente, M.; Furian, L.; Marchini, F.; Marino, S.; Cardillo, M.; Rigotti, P.; Aiello, F.B. 2010: C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome. Transplantation Proceedings 42(6): 2214-2217
Ciszek, M.ł; Ptasińska, A.P.; Durlik, M.; Paczek, L. 2006: C4d-positive renal transplants: single-center clinical outcomes. Clinical Transplants 2006: 405-412
De Gouveia, R.H.; Vitorino, E.; Ramos, S.; Rebocho, M.J.; Queirós E Melo, J.; Martins, A.P.; Moura, M.L.C. 2009: C4d-the witness of humoral rejection. Transplantation Proceedings 41(3): 866-867
Scrivens, P.J.; Noueihed, B.; Shahrzad, N.; Hul, S.; Brunet, S.; Sacher, M. 2011: C4orf41 and TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-Golgi trafficking. Molecular Biology of the Cell 22(12): 2083-2093
Wang, C.; Zhou, L.; Li, S.; Wei, J.; Wang, W.; Zhou, T.; Liao, S.; Weng, D.; Deng, D.; Weng, Y.; Wang, S.; Ma, D. 2010: C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion. Oncology Reports 24(4): 933-939
Faleiros, A.T.d.S.; Resende, L.A.d.L.; Zanini, M.A.; Castro, H.A.él.d.L.; Gabarra, R.C. 2009: C5 and C6 human dermatomes: a clinical, electromyographical, imaging and surgical findings. Arquivos de Neuro-Psiquiatria 67(2a): 262-264
Wani, N.A.; Gupta, V.K.; Kant, R.; Aravinda, S.; Rai, R. 2013: C5 and C7 intramolecular hydrogen bonds stabilize the structure of N-pyrazinoyl-gabapentin (Pyr-Gpn-OH). Acta Crystallographica. Section C Crystal Structure Communications 69(Part 10): 1170-1172
Rother, R.P.; Arp, J.; Jiang, J.; Ge, W.; Faas, S.J.; Liu, W.; Gies, D.R.; Jevnikar, A.M.; Garcia, B.; Wang, H. 2008: C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(6): 1129-1142
Halstead, S.K.; Humphreys, P.D.; Zitman, F.M.P.; Hamer, J.; Plomp, J.J.; Willison, H.J. 2008: C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. Journal of the Peripheral Nervous System: Jpns 13(3): 228-235
Takemitsu, M.; Cheung, K.M.C.; Wong, Y.Wa.; Cheung, W-Yuen.; Luk, K.D.K. 2008: C5 nerve root palsy after cervical laminoplasty and posterior fusion with instrumentation. Journal of Spinal Disorders and Techniques 21(4): 267-272
Guzman, J.Z.; Baird, E.O.; Fields, A.C.; McAnany, S.J.; Qureshi, S.A.; Hecht, A.C.; Cho, S.K. 2014: C5 nerve root palsy following decompression of the cervical spine: a systematic evaluation of the literature. Bone and Joint Journal 96-B(7): 950-955
Imagama, S.; Matsuyama, Y.; Yukawa, Y.; Kawakami, N.; Kamiya, M.; Kanemura, T.; Ishiguro, N. 2010: C5 palsy after cervical laminoplasty: a multicentre study. Journal of Bone and Joint Surgery. British Volume 92(3): 393-400
Yang, C.-W.; Fuh, J.-L. 2013: C5 palsy after cervical spine decompression surgery. Journal of the Chinese Medical Association: Jcma 76(7): 363-364
Chen, Y.; Chen, D.; Wang, X.; Guo, Y.; He, Z. 2007: C5 palsy after laminectomy and posterior cervical fixation for ossification of posterior longitudinal ligament. Journal of Spinal Disorders and Techniques 20(7): 533-535
Miller, J.A.; Lubelski, D.; Alvin, M.D.; Benzel, E.C.; Mroz, T.E. 2014: C5 palsy after posterior cervical decompression and fusion: cost and quality-of-life implications. Spine Journal: Official Journal of the North American Spine Society 14(12): 2854-2860
Hashimoto, M.; Mochizuki, M.; Aiba, A.; Okawa, A.; Hayashi, K.; Sakuma, T.; Takahashi, H.; Koda, M.; Takahashi, K.; Yamazaki, M. 2010: C5 palsy following anterior decompression and spinal fusion for cervical degenerative diseases. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 19(10): 1702-1710
Nagayama, D.; Murano, T.; Saiki, A.; Shirai, K.; Tatsuno, I. 2014: C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemia. International Journal of Clinical Pharmacology and Therapeutics 52(6): 471-477
Wang, H.-Y.L.; Qi, Z.; Wu, B.; Kang, S.-W.; Rojanasakul, Y.; O'Doherty, G.A. 2011: C5'-Alkyl Substitution Effects on Digitoxigenin α-l-Glycoside Cancer Cytotoxicity. Acs Medicinal Chemistry Letters 2(4): 259-263
Bertelli, J.A.; Ghizoni, M.F.áv. 2012: C5-8 brachial plexus root injury: the "T-1 hand". Journal of Neurosurgery 116(2): 409-413
Kudo, Y.; Yamashita, Y.; Mebs, D.; Cho, Y.; Konoki, K.; Yasumoto, T.; Yotsu-Yamashita, M. 2014: C5-C10 directly bonded tetrodotoxin analogues: possible biosynthetic precursors of tetrodotoxin from newts. Angewandte Chemie 53(52): 14546-14549
Kuntasal, O.Oğuz.; Kilavuz, S.Aslan.; Karman, D.; Wang, D.; Tuncel, Gürdal. 2013: C5-C12 volatile organic compounds at roadside, residential, and background locations in Ankara, Turkey: temporal and spatial variations and sources. Journal of the Air and Waste Management Association 63(10): 1148-1162
Lee, Y.-S.; Park, S.M.; Kim, H.M.; Park, S.-K.; Lee, K.; Lee, C.W.; Kim, B.H. 2009: C5-Modified nucleosides exhibiting anticancer activity. Bioorganic and Medicinal Chemistry Letters 19(16): 4688-4691
Kumar, P.; Baral, B.; Anderson, B.A.; Guenther, D.C.; Østergaard, M.E.; Sharma, P.K.; Hrdlicka, P.J. 2014: C5-alkynyl-functionalized α-L-LNA: synthesis, thermal denaturation experiments and enzymatic stability. Journal of Organic Chemistry 79(11): 5062-5073
Guenther, D.C.; Kumar, P.; Anderson, B.A.; Hrdlicka, P.J. 2014: C5-amino acid functionalized LNA: positively poised for antisense applications. Chemical Communications 50(64): 9007-9009
Mori, S.; Morihiro, K.; Obika, S. 2014: C5-azobenzene-substituted 2'-deoxyuridine-containing oligodeoxynucleotides for photo-switching hybridization. Molecules 19(4): 5109-5118
Yahyaoui, R.; Rueda, I.; Dayaldasani, A.; Boemer, F.ço. 2015: C5-carnitine false positive results in newborn screening: what is the cause?. Medicina Clinica 144(4): 181-182
Østergaard, M.E.; Kumar, P.; Baral, B.; Guenther, D.C.; Anderson, B.A.; Ytreberg, F.M.; Deobald, L.; Paszczynski, A.J.; Sharma, P.K.; Hrdlicka, P.J. 2011: C5-functionalized DNA, LNA, and α-L-LNA: positional control of polarity-sensitive fluorophores leads to improved SNP-typing. Chemistry 17(11): 3157-3165
Østergaard, M.E.; Kumar, P.; Baral, B.; Raible, D.J.; Kumar, T.S.; Anderson, B.A.; Guenther, D.C.; Deobald, L.; Paszczynski, A.J.; Sharma, P.K.; Hrdlicka, P.J. 2009: C5-functionalized LNA: unparalleled hybridization properties and enzymatic stability. Chembiochem: a European Journal of Chemical Biology 10(17): 2740-2743
Wang, A.-X.; Hu, Y.; Liu, H.-X.; Qi, X.-Y.; Liu, Y.; Tu, C.-X.; Yang, L. 2011: C5-hydroxylation of liquiritigenin is catalyzed selectively by CYP1A2. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 41(5): 349-357
Xu, Z.; Liu, F.; Yue, Y.; Ye, T.; Zhang, B.; Zuo, M.; Xu, M.; Hao, R.; Xu, Y.; Yang, N.; Che, X. 2009: C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial. Anesthesia and Analgesia 108(2): 478-483
Xue, C.; Nie, W.; Xu, J.; Dai, B.; Mei, C.-l. 2013: C509T and T869C polymorphisms of transforming growth factor β1 and the risk of IgA nephropathy: a meta-analysis. Chinese Medical Journal 126(23): 4562-4567
Fang, J.; Nurden, P.; North, P.; Nurden, A.T.; Du, L.M.; Valentin, N.; Wilcox, D.A. 2013: C560Rβ3 caused platelet integrin αIi b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. Journal of Thrombosis and Haemostasis: Jth 11(6): 1163-1171
Sibold, J.S.; Hammack, S.E.; Falls, W.A. 2011: C57 mice increase wheel-running behavior following stress: preliminary findings. Perceptual and Motor Skills 113(2): 605-618
Bernal-Reynaga, R.; Thompson-Bonilla, R.; Lopez-Saucedo, C.; Pech-Armenta, M.; Estrada-Parra, S.; Estrada-Garcia, T. 2013: C57-CD40 ligand deficient mice: a potential model for enterotoxigenic Escherichia coli (H10407) colonization. Veterinary Immunology and Immunopathology 152(1-2): 50-56
De Vries, M.R.; Seghers, L.; van Bergen, J.; Peters, H.A.B.; de Jong, R.C.M.; Hamming, J.F.; Toes, R.E.M.; van Hinsbergh, V.W.M.; Quax, P.H.A. 2013: C57BL/6 NK cell gene complex is crucially involved in vascular remodeling. Journal of Molecular and Cellular Cardiology 64: 51-58
Lu, X.; Li, N.; Shushakova, N.; Schmitt, R.; Menne, J.; Susnik, N.; Meier, M.; Leitges, M.; Haller, H.; Gueler, F.; Rong, S. 2012: C57BL/6 and 129/Sv mice: genetic difference to renal ischemia-reperfusion. Journal of Nephrology 25(5): 738-743
Lebedev, I.V.; Pleskacheva, M.G.; Anokhin, K.V. 2012: C57BL/6 mice open field behaviour qualitatively depends on arena size. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 62(4): 485-496
Hatzipetros, T.; Bogdanik, L.P.; Tassinari, V.R.; Kidd, J.D.; Moreno, A.J.; Davis, C.; Osborne, M.; Austin, A.; Vieira, F.G.; Lutz, C.; Perrin, S. 2014: C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Research 1584: 59-72
Pearson, B.L.; Defensor, E.B.; Blanchard, D.Caroline.; Blanchard, R.J. 2010: C57BL/6J mice fail to exhibit preference for social novelty in the three-chamber apparatus. Behavioural Brain Research 213(2): 189-194
Porciatti, V.; Chou, T.-H.; Feuer, W.J. 2010: C57BL/6J, DBA/2J, and DBA/2J.Gpnmb mice have different visual signal processing in the inner retina. Molecular Vision 16: 2939-2947
Zevnik, B.; Uyttersprot, N.C.; Perez, A.V.; Bothe, G.W.M.; Kern, H.; Kauselmann, G. 2014: C57BL/6N albino/agouti mutant mice as embryo donors for efficient germline transmission of C57BL/6 ES cells. Plos one 9(3): E90570
Kumar, V.; Kim, K.; Joseph, C.; Kourrich, Sïd.; Yoo, S-Hee.; Huang, H.Chung.; Vitaterna, M.H.; de Villena, F.Pardo-Manuel.; Churchill, G.; Bonci, A.; Takahashi, J.S. 2013: C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science 342(6165): 1508-1512
Hata, K.; Kubota, M.; Shimizu, M.; Moriwaki, H.; Kuno, T.; Tanaka, T.; Hara, A.; Hirose, Y. 2011: C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms. International Journal of Molecular Sciences 12(11): 8133-8145
Cyr, S.L.; Jones, T.; Stoica-Popescu, I.; Burt, D.; Ward, B.J. 2007: C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine. Vaccine 25(16): 3228-3232
Bajales, N.; Schmaus, S.; Miyamashi, T.; Wulfhekel, W.; Wilhelm, J.; Walz, M.; Stendel, M.; Bagrets, A.; Evers, F.; Ulas, S.; Kern, B.; Böttcher, A.; Kappes, M.M. 2013: C58 on Au(111): a scanning tunneling microscopy study. Journal of Chemical Physics 138(10): 104703
Li, Y.; Kaneko, T.; Hatakeyama, R. 2013: C59N peapods sensing the temperature. Sensors 13(1): 966-974
Miyamoto, K. 2014: C5: eculizumab. Brain and Nerve 66(10): 1191-1199
Cannone, M. 2012: C5A receptor: a new potential therapeutic target for immune-mediated glomerulonephritis. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(6): 645
Hsu, W.-C.; Yang, F.-C.; Lin, C.-H.; Hsieh, S.-L.; Chen, N.-J. 2014: C5L2 is required for C5a-triggered receptor internalization and ERK signaling. Cellular Signalling 26(7): 1409-1419
Johswich, K.; Klos, A. 2007: C5L2--an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)?. Advances in Experimental Medicine and Biology 598: 159-180
Li, R.; Coulthard, L.G.; Wu, M.C.L.; Taylor, S.M.; Woodruff, T.M. 2013: C5L2: a controversial receptor of complement anaphylatoxin, C5a. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(3): 855-864
Pan, S.; Contreras, M.; Romero, J.; Reyes, A.; Chattaraj, P.K.; Merino, G. 2013: C5Li7(+) and O2Li5(+) as noble-gas-trapping agents. Chemistry 19(7): 2322-2329
Jacob, A.; Hack, B.; Chiang, E.; Garcia, J.G.N.; Quigg, R.J.; Alexander, J.J. 2010: C5a alters blood-brain barrier integrity in experimental lupus. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 24(6): 1682-1688
Kambas, K.; Markiewski, M.M.; Pneumatikos, I.A.; Rafail, S.S.; Theodorou, V.; Konstantonis, D.; Kourtzelis, I.; Doumas, M.N.; Magotti, P.; Deangelis, R.A.; Lambris, J.D.; Ritis, K.D. 2008: C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. Journal of Immunology 180(11): 7368-7375
Schmitz, V.; Almeida, L.N.; Svensjö, E.; Monteiro, A.C.; Köhl, J.ör.; Scharfstein, J. 2014: C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection. Journal of Immunology 193(7): 3613-3623
Hu, M.; Liu, B.; Jawad, S.; Ling, D.; Casady, M.; Wei, L.; Nussenblatt, R.B. 2011: C5a contributes to intraocular inflammation by affecting retinal pigment epithelial cells and immune cells. British Journal of Ophthalmology 95(12): 1738-1744
Okazaki, N.; Hazeki, K.; Izumi, T.; Nigorikawa, K.; Hazeki, O. 2011: C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. Journal of Biochemistry 149(3): 265-274
Conroy, A.; Serghides, L.; Finney, C.; Owino, S.O.; Kumar, S.; Gowda, D.C.; Liles, W.C.; Moore, J.M.; Kain, K.C. 2009: C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. Plos one 4(3): E4953
Tokodai, K.; Goto, M.; Imura, T.; Ogawa, N.; Fujimori, K.; Kurokawa, Y.; Okada, H.; Satomi, S. 2009: C5a inhibitory peptide combined with gabexate mesilate is a clinically available candidate for preventing the instant blood-mediated inflammatory reaction. Transplantation Proceedings 41(1): 67-68
Qi, H.; Tüzün, E.; Allman, W.; Saini, S.S.; Penabad, Z.R.; Pierangeli, S.; Christadoss, P. 2008: C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis. Journal of Neuroimmunology 196(1-2): 101-106
Conway Morris, A.; Kefala, K.; Wilkinson, T.S.; Dhaliwal, K.; Farrell, L.; Walsh, T.; Mackenzie, S.J.; Reid, H.; Davidson, D.J.; Haslett, C.; Rossi, A.G.; Sallenave, J.-M.; Simpson, A.J. 2009: C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. American Journal of Respiratory and Critical Care Medicine 180(1): 19-28
Kurihara, R.; Yamaoka, K.; Sawamukai, N.; Shimajiri, S.; Oshita, K.; Yukawa, S.; Tokunaga, M.; Iwata, S.; Saito, K.; Chiba, K.; Tanaka, Y. 2010: C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflammation Research: Official Journal of the European Histamine Research Society . 59(8): 659-666
Cai, K.; Wan, Y.; Wang, Z.; Wang, Y.; Zhao, X.; Bao, X. 2014: C5a promotes the proliferation of human nasopharyngeal carcinoma cells through PCAF-mediated STAT3 acetylation. Oncology Reports 32(5): 2260-2266
Xiao, H.; Dairaghi, D.J.; Powers, J.P.; Ertl, L.S.; Baumgart, T.; Wang, Y.; Seitz, L.C.; Penfold, M.E.T.; Gan, L.; Hu, P.; Lu, B.; Gerard, N.P.; Gerard, C.; Schall, T.J.; Jaen, J.C.; Falk, R.J.; Jennette, J.C. 2014: C5a receptor (CD88) blockade protects against MPO-ANCA GN. Journal of the American Society of Nephrology: Jasn 25(2): 225-231
Roy, C.; Gupta, A.; Fisette, A.; Lapointe, M.; Poursharifi, P.; Richard, D.; Lu, H.; Lu, B.; Gerard, N.; Gerard, C.; Cianflone, K. 2013: C5a receptor deficiency alters energy utilization and fat storage. Plos one 8(5): E62531
Nigrovic, P.A.; Malbec, O.; Lu, B.; Markiewski, M.M.; Kepley, C.; Gerard, N.; Gerard, C.; Daëron, M.; Lee, D.M. 2010: C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation. Arthritis and Rheumatism 62(11): 3322-3333
Schreiber, A.; Xiao, H.; Jennette, J.C.; Schneider, W.; Luft, F.C.; Kettritz, R. 2009: C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. Journal of the American Society of Nephrology: Jasn 20(2): 289-298
Shagdarsuren, E.; Bidzhekov, K.; Mause, S.F.; Simsekyilmaz, S.; Polakowski, T.; Hawlisch, H.; Gessner, J.Engelbert.; Zernecke, A.; Weber, C. 2010: C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 122(10): 1026-1036
Weaver, D.J.; Reis, E.S.; Pandey, M.K.; Köhl, G.; Harris, N.; Gerard, C.; Köhl, J.ör. 2010: C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. European Journal of Immunology 40(3): 710-721
Romay-Penabad, Z.; Liu, X.X.; Montiel-Manzano, G.; Papalardo De Martínez, E.; Pierangeli, S.S. 2007: C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies. Annals of the new York Academy of Sciences 1108: 554-566
Kim, S.-H.; Yang, I.-Y.; Jang, S.-H.; Kim, J.; Truong, T.T.; Van Pham, T.; Truong, N.U.; Lee, K.-Y.; Jang, Y.-S. 2013: C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization. Microbes and Infection 15(13): 895-902
Ma, N.; Xing, C.; Xiao, H.; Wang, Y.; Wang, K.; Hou, C.; Han, G.; Chen, G.; Marrero, B.; Wang, Y.; Shen, B.; Li, Y.; Wang, R. 2013: C5a regulates IL-12+ DC migration to induce pathogenic Th1 and Th17 cells in sepsis. Plos one 8(7): E69779
Lu, Y.; Hu, X.-B. 2014: C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation. Oncology Reports 32(6): 2817-2823
Tayman, C.; Tonbul, A.; Kahveci, H.; Uysal, S.; Koseoğlu, B.; Tatli, M.Mansur.; Dilmen, U. 2011: C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku Journal of Experimental Medicine 224(2): 143-150
Guo, R.-F.; Ward, P.A. 2006: C5a, a therapeutic target in sepsis. Recent Patents on AntI-Infective Drug Discovery 1(1): 57-65
Cortright, D.N.; Meade, R.; Waters, S.M.; Chenard, B.L.; Krause, J.E. 2009: C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells. Current Eye Research 34(1): 57-61
Cui, W.; Simaan, M.; Laporte, S.; Lodge, R.; Cianflone, K. 2009: C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Molecular Immunology 46(15): 3086-3098
Korosec, P.; Subic, T.; Adamic, K.; Silar, M.; Kosnik, M. 2009: C5a-induced in vitro basophil activation in patients with chronic urticaria: a pilot study. Wiener Klinische Wochenschrift 121(9-10): 339-343
Tokodai, K.; Goto, M.; Inagaki, A.; Nakanishi, W.; Okada, N.; Okada, H.; Satomi, S. 2010: C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation. Transplantation Proceedings 42(6): 2102-2103
Yan, C.; Zhu, M.; Staiger, J.; Johnson, P.F.; Gao, H. 2012: C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages. Journal of Biological Chemistry 287(5): 3217-3230
Van Lith, L.H.C.; Oosterom, J.; Van Elsas, A.; Zaman, G.J.R. 2009: C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. Journal of Biomolecular Screening 14(9): 1067-1075
Xu, G.-l.; Chen, J.; Yang, F.; Li, G.-q.; Zheng, L.-x.; Wu, Y.-z. 2014: C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression. Hepatology 60(1): 114-124
Jacob, A.; Hack, B.; Chen, P.; Quigg, R.J.; Alexander, J.J. 2011: C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB. Journal of Neurochemistry 119(5): 1041-1051
Lim, J.; Iyer, A.; Suen, J.Y.; Seow, V.; Reid, R.C.; Brown, L.; Fairlie, D.P. 2013: C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(2): 822-831
Poursharifi, P.; Lapointe, M.; Fisette, A.; Lu, H.; Roy, C.; Munkonda, M.N.; Fairlie, D.P.; Cianflone, K. 2014: C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue. Molecular and Cellular Endocrinology 382(1): 325-333
Liu, J.; Tan, Y.; Zhang, J.; Zou, L.; Deng, G.; Xu, X.; Wang, F.; Ma, Z.; Zhang, J.; Zhao, T.; Liu, Y.; Li, Y.; Zhu, B.; Guo, B. 2015: C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis. Journal of Hepatology 62(2): 354-362
Stangou, M.; Alexopoulos, E.; Pantzaki, A.; Leonstini, M.; Memmos, D. 2008: C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scandinavian Journal of Urology and Nephrology 42(4): 373-380
Lopez, E.; Thauvin-Robinet, C.; Reversade, B.; Khartoufi, N.E.; Devisme, L.; Holder, M.; Ansart-Franquet, H.él.èn.; Avila, M.; Lacombe, D.; Kleinfinger, P.; Kaori, I.; Takanashi, J.-I.; Le Merrer, M.; Martinovic, J.; Noël, C.; Shboul, M.; Ho, L.; Güven, Y.; Razavi, F.é; Burglen, L.; Gigot, N.èg.; Darmency-Stamboul, V.ér.; Thevenon, J.; Aral, B.; Kayserili, H.ül.; Huet, F.éd.ér.; Lyonnet, S.; Le Caignec, C.éd.; Franco, B.; Rivière, J.-B.; Faivre, L.; Attié-Bitach, T. 2014: C5orf42 is the major gene responsible for OFD syndrome type Vi. Human Genetics 133(3): 367-377
Yu, T.; Li, J.; Sun, H. 2010: C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro. Cancer ChemoTherapy and Pharmacology 66(5): 999-1003
Zhu, X.; Du, X.; Deng, X.; Yi, H.; Cui, S.; Liu, W.; Shen, A.; Cui, Z. 2014: C6 ceramide sensitizes pemetrexed-induced apoptosis and cytotoxicity in osteosarcoma cells. Biochemical and Biophysical Research Communications 452(1): 72-78
Sta, M.; Cappaert, N.L.M.; Ramekers, D.; Ramaglia, V.; Wadman, W.J.; Baas, F. 2014: C6 deficiency does not alter intrinsic regeneration speed after peripheral nerve crush injury. Neuroscience Research 87: 26-32
Kim, Y.-J.; Hwang, S.-Y.; Hwang, J.-S.; Lee, J.-W.; Oh, E.-S.; Han, I.-O. 2008: C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells. Journal of Biological Chemistry 283(5): 2526-2533
Carrera-Marín, A.; Romay-Penabad, Z.; Papalardo, E.; Reyes-Maldonado, E.; García-Latorre, E.; Vargas, G.; Shilagard, T.; Pierangeli, S. 2012: C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus 21(14): 1497-1505
Wang, X.-R.; Zhang, C.; Xu, R.; Tang, L.-N.; Sun, H.-F. 2011: C6 oral glucose metabolism and differentially expressed genes in livers of 1 type diabetic mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi 27(4): 406-408
Sumanasekera, C.; Kelemen, O.; Beullens, M.; Aubol, B.E.; Adams, J.A.; Sunkara, M.; Morris, A.; Bollen, M.; Andreadis, A.; Stamm, S. 2012: C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1. Nucleic Acids Research 40(9): 4025-4039
Tan, W-Han.; Egyhazi, R.; Isaac, Z. 2012: C6 radiculopathy: the initial presentation of fibromuscular dysplasia. Pm and R: the Journal of Injury Function and Rehabilitation 4(7): 527-529
Tozaki, K.; Kimura, J.; Yasuda, M.; Ryu, N.; Nasu, T.; Pernthaner, A.; Hein, W.R. 2013: C6, a new monoclonal antibody, reacts with the follicle-associated epithelium of calf ileal Peyer's patches. Journal of Veterinary Science 14(1): 1-6
Vital, J.-M.; Boissière, L.; Obeid, I. 2013: C6-C7 cervical disc arthroplasty in cervical disc herniation. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 22(9): 2136-2138
Zhan, W.; Jiang, Y.; Sharma, S.; Brodie, P.J.; Bane, S.; Kingston, D.G.I.; Liotta, D.C.; Snyder, J.P. 2011: C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle. Chemistry 17(52): 14792-14804
Kue, C.S.; Jung, M.Y.; Cho, D.; Kim, T.S. 2012: C6-ceramide enhances Interleukin-12-mediated T helper type 1 cell responses through a cyclooxygenase-2-dependent pathway. Immunobiology 217(6): 601-609
Ryland, L.K.; Doshi, U.A.; Shanmugavelandy, S.S.; Fox, T.E.; Aliaga, C.; Broeg, K.; Baab, K.T.; Young, M.; Khan, O.; Haakenson, J.K.; Jarbadan, N.R.; Liao, J.; Wang, H.-G.; Feith, D.J.; Loughran, T.P.; Liu, X.; Kester, M. 2013: C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia. Plos one 8(12): E84648
Santucci, M.A.; Corradi, V.; Mancini, M.; Manetti, F.; Radi, M.; Schenone, S.; Botta, M. 2009: C6-unsubstituted pyrazolo[3,4-d]pyrimidines are dual Src/Abl inhibitors effective against imatinib mesylate resistant chronic myeloid leukemia cell lines. Chemmedchem 4(1): 118-126
Brackney, D.E.; Scott, J.C.; Sagawa, F.; Woodward, J.E.; Miller, N.A.; Schilkey, F.D.; Mudge, J.; Wilusz, J.; Olson, K.E.; Blair, C.D.; Ebel, G.D. 2010: C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. Plos Neglected Tropical Diseases 4(10): E856
Rana, M.; Reddy, R.B.; Rath, B.B.; Gautam, U.K. 2014: C60 -mediated molecular shape sorting: separation and purification of geometrical isomers. Angewandte Chemie 53(49): 13523-13527
Lee, J.; Mackeyev, Y.; Cho, M.; Wilson, L.J.; Kim, J.-H.; Alvarez, P.J.J. 2010: C60 aminofullerene immobilized on silica as a visible-light-activated photocatalyst. Environmental Science and Technology 44(24): 9488-9495
Bansal, S.; Kumar, N. 2011: C60 and C70 electronic absorption spectra in different solvents and matrices. Journal of Biomedical Nanotechnology 7(1): 199-201
Curl, R.F.; Lee, M.K.; Scuseria, G.E. 2008: C60 buckminsterfullerene high yields unraveled. Journal of Physical Chemistry. a 112(46): 11951-11955
Li, P.; Zhang, W.; Zhou, X.; Zhang, L. 2015: C60 carboxyfullerene-based functionalised nanohybrids as signal-amplifying tags for the ultrasensitive electrochemical detection of procalcitonin. Clinical Biochemistry 48(3): 156-161
Van Der Ploeg, M.J.C.; Handy, R.D.; Heckmann, L.-H.; Van Der Hout, A.; Van Den Brink, N.W. 2013: C60 exposure induced tissue damage and gene expression alterations in the earthworm Lumbricus rubellus. Nanotoxicology 7(4): 432-440
Prylutskyy, Y.I.; Buchelnikov, A.S.; Voronin, D.P.; Kostjukov, V.V.; Ritter, U.; Parkinson, J.A.; Evstigneev, M.P. 2013: C60 fullerene aggregation in aqueous solution. Physical Chemistry Chemical Physics: Pccp 15(23): 9351-9360
Lin, C-Mao.; Lu, T-Yi. 2012: C60 fullerene derivatized nanoparticles and their application to therapeutics. Recent Patents on Nanotechnology 6(2): 105-113
Thomas, M.; Worfolk, B.J.; Rider, D.A.; Taschuk, M.T.; Buriak, J.M.; Brett, M.J. 2011: C60 fullerene nanocolumns--polythiophene heterojunctions for inverted organic photovoltaic cells. Acs Applied Materials and Interfaces 3(6): 1887-1894
Avanasi, R.; Jackson, W.A.; Sherwin, B.; Mudge, J.F.; Anderson, T.A. 2014: C60 fullerene soil sorption, biodegradation, and plant uptake. Environmental Science and Technology 48(5): 2792-2797
Lee, C-Ming.; Huang, S-Tung.; Huang, S-Hao.; Lin, H-Wen.; Tsai, H-Ping.; Wu, J-Yu.; Lin, C-Mao.; Chen, C-Tsu. 2011: C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide. Nanomedicine: Nanotechnology Biology and Medicine 7(1): 107-114
Spohn, P.; Hirsch, C.; Hasler, F.; Bruinink, A.; Krug, H.F.; Wick, P. 2009: C60 fullerene: a powerful antioxidant or a damaging agent? the importance of an in-depth material characterization prior to toxicity assays. Environmental Pollution 157(4): 1134-1139
Sun, Y.-B.; Cao, C.-Y.; Yang, S.-L.; Huang, P.-P.; Wang, C.-R.; Song, W.-G. 2014: C60 fullerenol as an active and stable catalyst for the synthesis of cyclic carbonates from CO2 and epoxides. Chemical Communications 50(71): 10307-10310
Zhang, H.L.; Chen, W.; Chen, L.; Huang, H.; Wang, X.S.; Yuhara, J.; Wee, A.T.S. 2007: C60 molecular chains on alpha-sexithiophene nanostripes. Small 3(12): 2015-2018
Boukari, K.; Duverger, E.; Stephan, R.ég.; Hanf, M.-C.; Sonnet, P. 2014: C60 molecules grown on a Si-supported nanoporous supramolecular network: a DFT study. Physical Chemistry Chemical Physics: Pccp 16(28): 14722-14729
Teobaldi, G.; Zerbetto, F. 2007: C60 on gold: adsorption, motion, and viscosity. Small 3(10): 1694-1698
Murdianti, B.S.; Damron, J.T.; Hilburn, M.E.; Maples, R.D.; Hikkaduwa Koralege, R.S.; Kuriyavar, S.I.; Ausman, K.D. 2012: C60 oxide as a key component of aqueous C60 colloidal suspensions. Environmental Science and Technology 46(14): 7446-7453
Aroua, S.; Schweizer, W.B.; Yamakoshi, Y. 2014: C60 pyrrolidine bis-carboxylic acid derivative as a versatile precursor for biocompatible fullerenes. Organic Letters 16(6): 1688-1691
Shi, W.-J.; Menn, F.-M.; Xu, T.; Zhuang, Z.T.; Beasley, C.; Ripp, S.; Zhuang, J.; Layton, A.C.; Sayler, G.S. 2014: C60 reduces the bioavailability of mercury in aqueous solutions. Chemosphere 95: 324-328
Johnson, R.D.; Yannoni, C.S.; Dorn, H.C.; Salem, J.R.; Bethune, D.S. 1992: C60 rotation in the solid state: dynamics of a faceted spherical top. Science 255(5049): 1235-1238
Smith, D.F.; Robinson, E.W.; Tolmachev, A.V.; Heeren, R.M.A.; Paša-Tolić, L. 2011: C60 secondary ion Fourier transform ion cyclotron resonance mass spectrometry. Analytical Chemistry 83(24): 9552-9556
Carado, A.; Passarelli, M.K.; Kozole, J.; Wingate, J.E.; Winograd, N.; Loboda, A.V. 2008: C60 secondary ion mass spectrometry with a hybrid-quadrupole orthogonal time-of-flight mass spectrometer. Analytical Chemistry 80(21): 7921-7929
Wei, P.; Zhang, L.; Lu, Y.; Man, N.; Wen, L. 2010: C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy. Nanotechnology 21(49): 495101
Klerk, L.A.; Lockyer, N.P.; Kharchenko, A.; MacAleese, L.; Dankers, P.Y.W.; Vickerman, J.C.; Heeren, R.M.A. 2010: C60+ secondary ion microscopy using a delay line detector. Analytical Chemistry 82(3): 801-807
Wang, Z.; Chen, J.; Sun, Q.; Peijnenburg, W.J.G.M. 2011: C60-DOM interactions and effects on C60 apparent solubility: a molecular mechanics and density functional theory study. Environment International 37(6): 1078-1082
Whitnall, W.; Cademartiri, L.; Ozin, G.A. 2007: C60-PMO: periodic mesoporous buckyballsilica. Journal of the American Chemical Society 129(50): 15644-15649
Piwowar, A.M.; Keskin, S.; Delgado, M.O.; Shen, K.; Hue, J.J.; Lanekoff, I.; Ewing, A.G.; Winograd, N. 2013: C60-ToF SIMS imaging of frozen hydrated Hela cells. Surface and Interface Analysis: Sia 45(1): 302-304
Dos Santos, S.G.; Pires, M.S.; Lemos, V.; Freire, V.N.; Caetano, E.W.S.; Galvão, D.S.; Sato, F.; Albuquerque, E.L. 2009: C60-derived nanobaskets: stability, vibrational signatures, and molecular trapping. Nanotechnology 20(39): 395701
Baweja, L.; Gurbani, D.; Shanker, R.; Pandey, A.K.; Subramanian, V.; Dhawan, A. 2011: C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase Ii alpha. Journal of Biomedical Nanotechnology 7(1): 177-178
Fischnaller, M.; Bakry, R.; Vallant, R.M.; Huber, L.A.; Bonn, G.ün.K. 2013: C60-fullerene bound silica for the preconcentration and the fractionation of multiphosphorylated peptides. Analytica Chimica Acta 761: 92-101
Yeh, W.-Y. 2011: C60-induced alkyne-alkyne coupling and alkyne scission reactions of a tungsten tris(diphenylacetylene) complex. Chemical Communications 47(5): 1506-1508
Qian, Z.; Li, S.; Pathak, B.; Araújo, C.M.és.; Ahuja, R.; Jena, P. 2012: C60-mediated hydrogen desorption in Li-N-H systems. Nanotechnology 23(48): 485406
Jin, W.; Dougherty, D.B.; Cullen, W.G.; Robey, S.; Reutt-Robey, J.E. 2009: C60-pentacene network formation by 2-D co-crystallization. Langmuir: the Acs Journal of Surfaces and Colloids 25(17): 9857-9862
Li, G.; Jiang, B.; Li, X.; Lian, Z.; Xiao, S.; Zhu, J.; Zhang, D.; Li, H. 2013: C60/Bi2TiO4F2 heterojunction photocatalysts with enhanced visible-light activity for environmental remediation. Acs Applied Materials and Interfaces 5(15): 7190-7197
Xiao, W.; Passerone, D.; Ruffieux, P.; Aït-Mansour, K.; Gröning, O.; Tosatti, E.; Siegel, J.S.; Fasel, R. 2008: C60/corannulene on Cu(110): a surface-supported bistable buckybowl-buckyball host-guest system. Journal of the American Chemical Society 130(14): 4767-4771
Singh, R.; Singh, P.; Gupta, N.J.; Chakrabarty, B.; Singh, L.; Thangaraj, K. 2010: C601S mutation in the androgen receptor results in partial loss of androgen function. Journal of Steroid Biochemistry and Molecular Biology 122(5): 359-363
Nagata, M.; Kimura, T.; Suzumura, T.; Kira, Y.; Nakai, T.; Umekawa, K.; Tanaka, H.; Matsuura, K.; Mitsuoka, S.; Yoshimura, N.; Oka, T.; Kudoh, S.; Hirata, K. 2013: C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin. Clinical Medicine Insights. Oncology 7: 31-39
Takakuwa, O.; Oguri, T.; Ozasa, H.; Uemura, T.; Kunii, E.; Kasai, D.; Miyazaki, M.; Maeno, K.; Sato, S. 2011: C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 6(11): 1826-1832
Royall, C.P.; Williams, S.R. 2011: C60: the first one-component gel?. Journal of Physical Chemistry. B 115(22): 7288-7293
Gao, D.; Helander, M.G.; Wang, Z.-B.; Puzzo, D.P.; Greiner, M.T.; Lu, Z.-H. 2010: C60:LiF blocking layer for environmentally stable bulk heterojunction solar cells. Advanced Materials 22(47): 5404-5408
Wang, Z.B.; Helander, M.G.; Qiu, J.; Gao, D.; Chang, Y.L.; Lu, Z.H. 2012: C60:LiF nanocomposite for high power efficiency fluorescent organic light-emitting diodes. Nanotechnology 23(34): 344010
Calvaresi, M.; Arnesano, F.; Bonacchi, S.; Bottoni, A.; Calò, V.; Conte, S.; Falini, G.; Fermani, S.; Losacco, M.; Montalti, M.; Natile, G.; Prodi, L.; Sparla, F.; Zerbetto, F. 2014: C60@Lysozyme: direct observation by nuclear magnetic resonance of a 1:1 fullerene protein adduct. Acs Nano 8(2): 1871-1877
Henderson, C.C.; Cahill, P.A. 1993: C60H2: Synthesis of the Simplest C60 Hydrocarbon Derivative. Science 259(5103): 1885-1887
Cox, D.M.; Trevor, D.J.; Reichmann, K.C.; Kaldor, A. 1986: C60La: a deflated soccer ball?. Journal of the American Chemical Society 108(9): 2457-2458
Benazzouz, B.; Hafidi, A.ïc.; Benkhira, S.ïd.; Chraibi, A.; Kadiri, A.; Hilal, L. 2008: C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family. Bulletin du Cancer 95(4): 457-463
Oike, T.; Komachi, M.; Ogiwara, H.; Amornwichet, N.; Saitoh, Y.; Torikai, K.; Kubo, N.; Nakano, T.; Kohno, T. 2014: C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 111(2): 222-227
Shan, G.-J.; Tan, Y.-Z.; Zhou, T.; Zou, X.-M.; Li, B.-W.; Xue, C.; Chu, C.-X.; Xie, S.-Y.; Huang, R.-B.; Zhen, L.-S. 2012: C64Cl8: a strain-relief pattern to stabilize fullerenes containing triple directly fused pentagons. Chemistry An Asian Journal 7(9): 2036-2039
Arzaghi, S.Masoud.; Hossein-Nezhad, A.; Shariat, S.Vahid.; Ghodsipour, A.; Shams, J.; Larijani, B. 2011: C677T Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism in Schizophrenia and Bipolar Disorder: An Association Study in Iranian Population. Iranian Journal of Psychiatry 6(1): 1-6
De Mattia, E.; Toffoli, G. 2009: C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. European Journal of Cancer 45(8): 1333-1351
Arsene, D.; Găină, G.; Bălescu, C.; Ardeleanu, C. 2011: C677T and A1298C methylenetetrahydropholate reductase (MTHFR) polymorphisms as factors involved in ischemic stroke. Romanian Journal of Morphology and Embryology 52(4): 1203-1207
Osian, G.; Procopciuc, L.; Vlad, L.; Iancu, C.; Mocan, T.; Mocan, L. 2009: C677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer. Journal of Gastrointestinal and Liver Diseases: Jgld 18(4): 455-460
Oliveira, K.C.; Verreschi, I.T.N.; Sugawara, E.K.; Silva, V.C.; Galera, B.B.; Galera, M.F.; Bianco, B.; Lipay, M.V.N. 2012: C677T and A1298C polymorphisms of MTHFR gene and their relation to homocysteine levels in Turner syndrome. Genetic Testing and Molecular Biomarkers 16(5): 396-400
Eissa, D.S.; Ahmed, T.M. 2013: C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 24(2): 181-188
Krumdieck, C.L.; Fernandez, J.R.; Desmond, R.A.; Kleinstein, R.N.; Shipp, M.D.; Prince, C.W. 2008: C677T methylene-H4-folate-reductase variant decreases binocular accommodation. Optometry and Vision Science: Official Publication of the American Academy of Optometry 85(3): 196-200
Kajanachumpol, S.; Atamasirikul, K.; Tantibhedhyangkul, P. 2013: C677T methylenetetrahydrofolate reductase and plasma homocysteine levels among Thai vegans and omnivores. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 83(2): 86-91
Yin, G.; Yan, L.; Zhang, Z.; Chen, K.; Jin, X. 2012: C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: a population-based case-control study. Molecular Medicine Reports 6(6): 1271-1275
Chen, Z.; Liu, Y.; Zhang, D.; Liu, Z.; Wang, P.; Zhou, D.; Zhao, T.; Wang, T.; Xu, H.; Li, S.; Feng, G.; He, L.; Yu, L. 2009: C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: an association study in the Chinese population and a meta-analysis of genetic association studies. Neuroscience Letters 449(1): 48-51
Chen, H.; Zhu, J. 2013: C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model. Medical Hypotheses 80(5): 679-683
Isordia-Salas, I.; Trejo-Aguilar, A.; Valadés-Mejía, M.G.; Santiago-Germán, D.; Leaños-Miranda, A.; Mendoza-Valdéz, L.; Jáuregui-Aguilar, R.; Borrayo-Sánchez, G.; Majluf-Cruz, A. 2010: C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction. Archives of Medical Research 41(4): 246-250
Zúñiga-Noriega, J.R.úl.; Velazco-Campos, M.ía.d.R.; Aguirre-Rodríguez, A.; Villarreal, L.M.ín.-d.; Garza-González, E.; Maldonado-Garza, H.éc.J.ús.; Bosques-Padilla, F.J. 2007: C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Revista de Gastroenterologia de Mexico 72(4): 355-358
Goracy, I.; Cyryłowski, L.; Kaczmarczyk, M.; Fabian, A.; Koziarska, D.; Goracy, J.; Ciechanowicz, A. 2009: C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. Journal of Applied Genetics 50(1): 63-67
Erdogan, M.O.; Yildiz, S.H.; Solak, M.; Eser, O.; Cosar, E.; Eser, B.; Koken, R.; Buyukbas, S. 2010: C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects. Genetics and Molecular Research: Gmr 9(2): 1197-1203
Morales-Machín, A.; Borjas-Fajardo, L.; Quintero, J.é M.; Zabala, W.; Alvarez, F.; Delgado, W.; Hernández, M.ía.L.; Solis-Añez, E.; Sánchez, Y.y.; Butrón, Z. 2009: C677T polymorphism of the methylentetrahydrofolate reductase gene as risk factor in women with recurrent abortion. Investigacion Clinica 50(3): 327-333
Gara, S.; Ochi, H.; Chango, A.; Najjar, L.; Feki, M.; B'chir, F.; Kaabachi, N.; Ben Becher, S.; Boukthir, S.; Abdennebi, M. 2011: C677t polymorphism of MTHFR and G80A polymorphism of RFC genes and their relation with homocysteine levels in obese Tunisian children. La Tunisie Medicale 89(6): 565-568
Contursi, P.; D'Ambrosio, K.; Pirone, L.; Pedone, E.; Aucelli, T.; She, Q.; De Simone, G.; Bartolucci, S. 2011: C68 from the Sulfolobus islandicus plasmid-virus pSSVx is a novel member of the AbrB-like transcription factor family. Biochemical Journal 435(1): 157-166
Chen, D.-L.; Tian, W.Q.; Feng, J.-K.; Sun, C.-C. 2008: C68 fullerene isomers, anions, and their metallofullerenes: charge-stabilizing different isomers. Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry 9(3): 454-461
Bilir, V.; Frohn, H.-J. 2013: C6F5XeY molecules (Y = F and Cl): new synthetic approaches. first structural proof of the organoxenon halide molecule C6F5XeF. Acta Chimica Slovenica 60(3): 505-512
Koppe, K.; Frohn, H.-J.; Mercier, H.él.èn. P.A.; Schrobilgen, G.J. 2008: C6F5Xe]+ and [C6F5XeNCCH3]+ salts of the weakly coordinating borate anions, [BY4]- (Y = CN, CF3, or C6F5). Inorganic Chemistry 47(8): 3205-3217
Zhao, D.; Haddad, M.A.; Linnartz, H.; Ubachs, W. 2011: C6H and C6D: electronic spectra and Renner-Teller analysis. Journal of Chemical Physics 135(4): 044307
Bakus, R.C.; Atwood, D.A.; Parkin, S.; Brock, C.P.; Petricek, V. 2013: C6H4S2AsCl: description and interpretation of an incommensurately modulated molecular crystal structure. Acta Crystallographica Section B Structural Science Crystal Engineering and Materials 69(Part 5): 496-508
Abad, E.; Dappe, Y.J.; Martínez, J.I.; Flores, F.; Ortega, J. 2011: C6H6/Au(111): interface dipoles, band alignment, charging energy, and van der Waals interaction. Journal of Chemical Physics 134(4): 044701
Jacobsson, J.A.; Stephansson, O.; Fredriksson, R. 2010: C6ORF192 forms a unique evolutionary branch among solute carriers (SLC16, SLC17, and SLC18) and is abundantly expressed in several brain regions. Journal of Molecular Neuroscience: Mn 41(2): 230-242
Barroso, S.; López-Trascasa, M.; Merino, D.; Alvarez, A.J.; Núñez-Roldán, A.; Sánchez, B. 2010: C7 deficiency and meningococcal infection susceptibility in two spanish families. Scandinavian Journal of Immunology 72(1): 38-43
Koltz, M.T.; Maulucci, C.M.; Sansur, C.A.; Hamilton, D.Kojo. 2014: C7 intralaminar screw placement, an alternative to lateral mass or pedicle fixation for treatment of cervical spondylytic myelopathy, kyphotic deformity, and trauma: A case report and technical note. Surgical Neurology International 5: 4
Bossi, F.; Rizzi, L.; Bulla, R.; Debeus, A.; Tripodo, C.; Picotti, P.; Betto, E.; Macor, P.; Pucillo, C.; Würzner, R.; Tedesco, F. 2009: C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood 113(15): 3640-3648
Li, R.; Machol, J.A.; Liu, X.; Hettinger, P.C.; Flugstad, N.A.; Yan, J.-g.; Matloub, H.S.; Hyde, J.S. 2014: C7 nerve root sensory distribution in peripheral nerves: a bold functional magnetic resonance imaging investigation at 9.4 T. Muscle and Nerve 49(1): 40-46
Halim, A.; Grauer, J. 2014: C7 pars fracture subadjacent to C7 pedicle screw instrumentation at the caudal end of a posterior cervical instrumentation construct. American Journal of Orthopedics 43(7): E137-E139
Jang, S.Hoon.; Hong, J.Taek.; Kim, I.Sup.; Yeo, I.Sung.; Son, B.Chul.; Lee, S.Won. 2010: C7 posterior fixation using intralaminar screws : early clinical and radiographic outcome. Journal of Korean Neurosurgical Society 48(2): 129-133
Kose, K.Cagri.; Caliskan, I.; Bal, E.; Inanmaz, M.Erkan.; Isik, C. 2014: C7-T1 anterior closing wedge bone-disc-bone osteotomy for the treatment of cervical hyperlordosis in muscular dystrophy: a new technique for correction of a rare deformity. Spine 39(18): E1066-E1072
Loach, R.P.; Fenton, O.S.; Amaike, K.; Siegel, D.S.; Ozkal, E.; Movassaghi, M. 2014: C7-derivatization of C3-alkylindoles including tryptophans and tryptamines. Journal of Organic Chemistry 79(22): 11254-11263
Wunsch, C.; Zou, H.-X.; Linne, U.; Li, S.-M. 2015: C7-prenylation of tryptophanyl and O-prenylation of tyrosyl residues in dipeptides by an Aspergillus terreus prenyltransferase. Applied Microbiology and Biotechnology 99(4): 1719-1730
Deak, D.S.; Porfyrakis, K.; Castell, M.R. 2007: C70 ordering on nanostructured SrTiO3(001). Chemical Communications 28: 2941-2943
Bodner, M.; Patera, J.ří; Szajewska, M. 2013: C70, C80, C90 and carbon nanotubes by breaking of the icosahedral symmetry of C60. Acta Crystallographica. Section a Foundations of Crystallography 69(Part 6): 583-591
Liu, Q.; Zhang, X.; Zhang, X.; Zhang, G.; Zheng, J.; Guan, M.; Fang, X.; Wang, C.; Shu, C. 2013: C70-carboxyfullerenes as efficient antioxidants to protect cells against oxidative-induced stress. Acs Applied Materials and Interfaces 5(21): 11101-11107
Moor, K.; Kim, J.-H.; Snow, S.; Kim, J.-H. 2013: C70] fullerene-sensitized triplet-triplet annihilation upconversion. Chemical Communications 49(92): 10829-10831
Sundholm, D. 2013: C72: gaudiene, a hollow and aromatic all-carbon molecule. Physical Chemistry Chemical Physics: Pccp 15(23): 9025-9028
Tan, Y.-Z.; Zhou, T.; Bao, J.; Shan, G.-J.; Xie, S.-Y.; Huang, R.-B.; Zheng, L.-S. 2010: C72Cl4: a pristine fullerene with favorable pentagon-adjacent structure. Journal of the American Chemical Society 132(48): 17102-17104
Hong, X.-Z.; Yin, Y.-L.; Xu, X.-G.; Ma, K.-R.; Lan, X.-F.; Liu, Y.; Zhu, F.-M.; Lü, H.-J.; Yan, L.-X. 2011: C742T mutation of α1, 3 N-acetyl-D-galactosaminyltransferase gene is responsible for A2 subgroup. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19(3): 702-705
Mera, P.; Bentebibel, A.; López-Viñas, E.; Cordente, A.G.; Gurunathan, C.; Sebastián, D.; Vázquez, I.; Herrero, L.; Ariza, X.; Gómez-Puertas, P.; Asins, G.; Serra, D.; García, J.; Hegardt, F.G. 2009: C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight. Biochemical Pharmacology 77(6): 1084-1095
Ioffe, I.N.; Mazaleva, O.N.; Chen, C.; Yang, S.; Kemnitz, E.; Troyanov, S.I. 2011: C76 fullerene chlorides and cage transformations. Structural and theoretical study. Dalton Transactions 40(41): 11005-11011
Ghasemi, A.; Aghajani, H.; Fallah, S.; Assadi, M.; Seifi, M. 2015: C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study. Anatolian Journal of Cardiology 15(1): 8-12
Popov, A.A.; Krause, M.; Yang, S.; Wong, J.; Dunsch, L. 2007: C78 cage isomerism defined by trimetallic nitride cluster size: a computational and vibrational spectroscopic study. Journal of Physical Chemistry. B 111(13): 3363-3369
Zhou, Z.-x.; Zhang, J.; Sun, L. 2014: C7: a CpG oligodeoxynucleotide that induces protective immune response against megalocytivirus in Japanese flounder (Paralichthys olivaceus) via Toll-like receptor 9-mediated signaling pathway. Developmental and Comparative Immunology 44(1): 124-132
Laisné, A.; Pompon, D.; Leroy, J-Louis. 2010: C7GC4]4 association into supra molecular i-motif structures. Nucleic Acids Research 38(11): 3817-3826
Ewing, S.J.; Powell, A.V.; Vaqueiro, P. 2012: C7H10N][In3Se5]: a layered selenide with two indium coordination environments. Inorganic Chemistry 51(13): 7404-7409
Rasul, G.; Olah, G.A.; Prakash, G.K.S. 2012: C7H12(2+): a prototype hexacoordinate carbonium ion. Journal of Physical Chemistry. a 116(1): 756-760
Meng, X.; Schoggins, J.; Rose, L.; Cao, J.; Ploss, A.; Rice, C.M.; Xiang, Y. 2012: C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. Journal of Virology 86(8): 4538-4547
Guimaraes-Correa, A.B.; Crawford, L.B.; Figueiredo, C.R.; Gimenes, K.P.; Pinto, L.A.; Grassi, M.F.R.; Feuer, G.; Travassos, L.R.; Caires, A.C.F.; Rodrigues, E.G.; Marriott, S.J. 2011: C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses 3(7): 1041-1058
Ohno, Y.; Hattori, A.; Kakeya, H. 2012: C7orf24/gamma-glutamyl cyclotransferase as a molecular target for cancer chemotherapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 723-727
Wanschers, B.F.J.; Szklarczyk, R.; Pajak, A.; van den Brand, Mël.A.M.; Gloerich, J.; Rodenburg, R.J.T.; Lightowlers, R.N.; Nijtmans, L.G.; Huynen, M.A. 2012: C7orf30 specifically associates with the large subunit of the mitochondrial ribosome and is involved in translation. Nucleic Acids Research 40(9): 4040-4051
Chiba, T.; Konoeda, F.; Higashihara, M.; Kamiya, H.; Oishi, C.; Hatanaka, Y.; Sonoo, M. 2015: C8 and T1 innervation of forearm muscles. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 126(4): 837-842
Kreps, C.E.; Rynders, S.D.; Chhabra, A.B.; Jenkins, J.G. 2012: C8 myotome herpes zoster paresis. American Journal of Orthopedics 41(5): 220-222
Rankin, K.M.; Sproviero, M.; Rankin, K.; Sharma, P.; Wetmore, S.D.; Manderville, R.A. 2012: C8-heteroaryl-2'-deoxyguanosine adducts as conformational fluorescent probes in the Nari recognition sequence. Journal of Organic Chemistry 77(23): 10498-10508
Millen, A.L.; Sharma, P.; Wetmore, S.D. 2012: C8-linked bulky guanosine DNA adducts: experimental and computational insights into adduct conformational preferences and resulting mutagenicity. Future Medicinal Chemistry 4(15): 1981-2007
Simeonov, K.S.; Amsharov, K.Y.; Jansen, M. 2009: C80Cl12: a chlorine derivative of the chiral D2-C80 isomer--empirical rationale of halogen-atom addition pattern. Chemistry 15(8): 1812-1815
Lelonek, M.; Pietrucha, T.; Matyjaszczyk, M.; Goch, J.H. 2008: C825T G-protein beta3 subunit gene polymorphism, tilt test results and point score in syncopal patients. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society 18(3): 158-161
Li, X.-X.; A-Yi-Gu-Li, Y.-N.-S.; Huang, J.-J.; Zhang, J.-P.; Ka-Si-Mu-Jiang, A.-X.-M.-J.; Ku-Re-Xi, Y.-N.-S. 2014: C825T polymorphism of G protein beta3 subunit gene and Uygur Hilit type of essential hypertension: a correlation study. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 34(3): 297-302
Khamidullaeva, G.A.; Eliseyeva, M.R.; Nagay, A.V.; Abdullaeva, G.J. 2011: C825T polymorphism of the G-protein β3 subunit and its association with essential hypertension in Uzbek males. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir 39(3): 198-204
Chang, H.H.; Gean, P.W.; Chou, C.H.; Yang, Y.K.; Tsai, H.C.; Lu, R.B.; Chen, P.S. 2010: C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients. Journal of Clinical Psychopharmacology 30(5): 512-517
Choi, R.Y.; Fowke, K.R.; Juno, J.; Lohman-Payne, B.; Oyugi, J.O.; Brown, E.R.; Bosire, R.; John-Stewart, G.; Farquhar, C. 2012: C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya. Aids Research and Human Retroviruses 28(6): 566-570
Salamian, A.; Mohamadynejad, P.; Ghaedi, K.; Nejati, A.S.; Shafeghati, Y.; Ahnak, M.B.; Nematollahi, M.; Karbalaie, K.; Hadipour, F.; Baharvand, H.; Nasr-Esfahani, M.H. 2013: C86Y: as a destructive homozygous mutation deteriorating Pex7p function causing rhizomelic chondrodysplasia punctata type i. Annals of Clinical and Laboratory Science 43(1): 76-80
Nishiguchi, K.M.; Yasuma, T.R.; Tomida, D.; Nakamura, M.; Ishikawa, K.; Kikuchi, M.; Ohmi, Y.; Niwa, T.; Hamajima, N.; Furukawa, K.; Terasaki, H. 2012: C9-R95X polymorphism in patients with neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science 53(1): 508-512
Buehler, E.; Chen, Y.-C.; Martin, S. 2012: C911: a bench-level control for sequence specific siRNA off-target effects. Plos one 7(12): E51942
Credidio, L.; Lima, C.S.P.; Leal, R.; de Ayrizono, M.L.S.; Fagundes, J.ão.J.é; Magna, L.A.; Coy, C.S.R. 2014: C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma. Bmc Research Notes 7: 768
Sonmez, M.; Kazaz, N.ı; Yucel, B.; Topbas, M.; Ucar, F. 2014: C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease. Hematology 19(4): 213-216
Hirvonen, M.M.; Laakso, A.; Någren, K.; Rinne, J.O.; Pohjalainen, T.; Hietala, J. 2009: C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63(10): 907-912
Hirvonen, M.M.; Lumme, V.; Hirvonen, J.; Pesonen, U.; Någren, K.; Vahlberg, T.; Scheinin, H.; Hietala, J. 2009: C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33(4): 630-636
Solje, E.; Hartikainen, P.äi.; Valori, M.; Vanninen, R.; Tiihonen, J.; Hakola, P.; Tienari, P.J.; Remes, A.M. 2014: C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Neurobiology of Aging 35(7): 1780.E13-17
O'Dowd, S.án.; Curtin, D.; Waite, A.J.; Roberts, K.; Pender, N.; Reid, V.; O'Connell, M.; Williams, N.M.; Morris, H.R.; Traynor, B.J.; Lynch, T. 2012: C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Movement Disorders: Official Journal of the Movement Disorder Society 27(8): 1072-1074
Fogel, B.L.; Pribadi, M.; Pi, S.; Perlman, S.L.; Geschwind, D.H.; Coppola, G. 2012: C9ORF72 expansion is not a significant cause of sporadic spinocerebellar ataxia. Movement Disorders: Official Journal of the Movement Disorder Society 27(14): 1832-1833
Cooper-Knock, J.; Frolov, A.; Highley, J.R.; Charlesworth, G.; Kirby, J.; Milano, A.; Hartley, J.; Ince, P.G.; McDermott, C.J.; Lashley, T.; Revesz, T.; Shaw, P.J.; Wood, N.W.; Bandmann, O. 2013: C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology 81(9): 808-811
Geevasinga, N.; Burrell, J.R.; Hibbert, M.; Vucic, S.; Ng, K. 2014: C9ORF72 familial motor neuron disease - frontotemporal dementia associated with lung adenocarcinoma and anti-Ma2/Ta antibodies: a chance association?. European Journal of Neurology 21(4): e31-e33
Gómez-Tortosa, E.; Gallego, J.ús.; Guerrero-López, R.; Marcos, A.; Gil-Neciga, E.; Sainz, M.ía.J.é; Díaz, A.ón.; Franco-Macías, E.; Trujillo-Tiebas, M.ía.J.é; Ayuso, C.; Pérez-Pérez, J.án. 2013: C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration. Neurology 80(4): 366-370
Galimberti, D.; Reif, A.; Dell'Osso, B.; Palazzo, C.; Villa, C.; Fenoglio, C.; Kittel-Schneider, S.; Leonhard, C.; Olmes, D.G.; Serpente, M.; Paoli, R.A.; Altamura, A.C.; Scarpini, E. 2014: C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disorders 16(4): 448-449
Galimberti, D.; Reif, A.; Dell'osso, B.; Kittel-Schneider, S.; Leonhard, C.; Herr, A.; Palazzo, C.; Villa, C.; Fenoglio, C.; Serpente, M.; Cioffi, S.M.G.; Prunas, C.; Paoli, R.A.; Altamura, A.C.; Scarpini, E. 2014: C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiology of Aging 35(5): 1214.E7-1214.E10
Koutsis, G.; Karadima, G.; Kartanou, C.; Kladi, A.; Panas, M. 2015: C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population. Neurobiology of Aging 36(1): 547.E13-16
Rutherford, N.J.; DeJesus-Hernandez, M.; Baker, M.C.; Kryston, T.B.; Brown, P.E.; Lomen-Hoerth, C.; Boylan, K.; Wszolek, Z.K.; Rademakers, R. 2012: C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository. Neurology 79(5): 482-483
Sabatelli, M.; Conforti, F.L.; Zollino, M.; Mora, G.; Monsurrò, M.R.; Volanti, P.; Marinou, K.; Salvi, F.; Corbo, M.; Giannini, F.; Battistini, S.; Penco, S.; Lunetta, C.; Quattrone, A.; Gambardella, A.; Logroscino, G.; Simone, I.; Bartolomei, I.; Pisano, F.; Tedeschi, G.; Conte, A.; Spataro, R.; La Bella, V.; Caponnetto, C.; Mancardi, G.; Mandich, P.; Sola, P.; Mandrioli, J.; Renton, A.E.; Majounie, E.; Abramzon, Y.; Marrosu, F.; Marrosu, M.G.; Murru, M.R.; Sotgiu, M.A.; Pugliatti, M.; Rodolico, C.; Moglia, C.; Calvo, A.; Ossola, I.; Brunetti, M.; Traynor, B.J.; Borghero, G.; Restagno, G.; Chiò, A.; Cammarosano, S.; Fuda, G.; Gallo, S.; Papetti, L.; Pinter, G.L.; Luigetti, M.; Lattante, S.; Marangi, G.; Colletti, T.; Ricci, C.; Origone,; 2012: C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiology of Aging 33(8): 1848.E15-20
Yokoyama, J.S.; Sirkis, D.W.; Miller, B.L. 2014: C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. American Journal of Neurodegenerative Disease 3(1): 1-18
Robinson, A.; Davidson, Y.; Snowden, J.S.; Mann, D.M.A. 2014: C9ORF72 in dementia with Lewy bodies. Journal of Neurology Neurosurgery and Psychiatry 85(12): 1435-1436
Floris, G.; Di Stefano, F.; Pisanu, C.; Chillotti, C.; Murru, M.R.; Congiu, D.; Cuccu, S.; Ruiu, E.; Borghero, G.; Cannas, A.; Marrosu, M.G.; Marrosu, F.; Del Zompo, M.; Squassina, A. 2014: C9ORF72 repeat expansion and bipolar disorder - is there a link? no mutation detected in a Sardinian cohort of patients with bipolar disorder. Bipolar Disorders 16(6): 667-668
Dobson-Stone, C.; Hallupp, M.; Loy, C.T.; Thompson, E.M.; Haan, E.; Sue, C.M.; Panegyres, P.K.; Razquin, C.; Seijo-Martínez, M.; Rene, R.; Gascon, J.; Campdelacreu, J.; Schmoll, B.; Volk, A.E.; Brooks, W.S.; Schofield, P.R.; Pastor, P.; Kwok, J.B.J. 2013: C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. Plos one 8(2): E56899
Ishiura, H.; Takahashi, Y.; Mitsui, J.; Yoshida, S.; Kihira, T.; Kokubo, Y.; Kuzuhara, S.; Ranum, L.P.W.; Tamaoki, T.; Ichikawa, Y.; Date, H.; Goto, J.; Tsuji, S. 2012: C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Archives of Neurology 69(9): 1154-1158
Dobson-Stone, C.; Hallupp, M.; Bartley, L.; Shepherd, C.E.; Halliday, G.M.; Schofield, P.R.; Hodges, J.R.; Kwok, J.B.J. 2012: C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79(10): 995-1001
Fenoglio, C.; De Riz, M.; Villa, C.; Serpente, M.; Ridolfi, E.; Bonsi, R.; Cioffi, S.M.G.; Barone, C.; Pietroboni, A.; Calvi, A.; Scarpini, E.; Galimberti, D. 2014: C9ORF72 repeat expansion not detected in patients with multiple sclerosis. Neurobiology of Aging 35(5): 1213.E1-2
Wojtas, A.; Heggeli, K.A.; Finch, N.; Baker, M.; Dejesus-Hernandez, M.; Younkin, S.G.; Dickson, D.W.; Graff-Radford, N.R.; Rademakers, R. 2012: C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. American Journal of Neurodegenerative Disease 1(1): 107-118
Van Blitterswijk, M.; Baker, M.C.; DeJesus-Hernandez, M.; Ghidoni, R.; Benussi, L.; Finger, E.; Hsiung, G.-Y.R.; Kelley, B.J.; Murray, M.E.; Rutherford, N.J.; Brown, P.E.; Ravenscroft, T.; Mullen, B.; Ash, P.E.A.; Bieniek, K.F.; Hatanpaa, K.J.; Karydas, A.; Wood, E.M.; Coppola, G.; Bigio, E.H.; Lippa, C.; Strong, M.J.; Beach, T.G.; Knopman, D.S.; Huey, E.D.; Mesulam, M.; Bird, T.; White, C.L.; Kertesz, A.; Geschwind, D.H.; Van Deerlin, V.M.; Petersen, R.C.; Binetti, G.; Miller, B.L.; Petrucelli, L.; Wszolek, Z.K.; Boylan, K.B.; Graff-Radford, N.R.; Mackenzie, I.R.; Boeve, B.F.; Dickson, D.W.; Rademakers, R. 2013: C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology 81(15): 1332-1341
Le Ber, I.; Camuzat, A.ès.; Guillot-Noel, L.; Hannequin, D.; Lacomblez, L.; Golfier, V.ér.; Puel, M.èl.; Martinaud, O.; Deramecourt, V.; Rivaud-Pechoux, S.; Millecamps, S.ép.; Vercelletto, M.; Couratier, P.; Sellal, F.ço.; Pasquier, F.; Salachas, F.ço.; Thomas-Antérion, C.; Didic, M.; Pariente, J.ér.ém.; Seilhean, D.; Ruberg, M.; Wargon, I.; Blanc, F.éd.ér.; Camu, W.; Michel, B.-F.ço.; Berger, E.; Sauvée, M.; Thauvin-Robinet, C.; Mondon, K.; Tournier-Lasserve, E.; Goizet, C.; Fleury, M.; Viennet, G.; Verpillat, P.; Meininger, V.; Duyckaerts, C.; Dubois, B.; Brice, A. 2013: C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. Journal of Alzheimer's Disease: Jad 34(2): 485-499
Konno, T.; Tada, M.; Shiga, A.; Tsujino, A.; Eguchi, H.; Masuda-Suzukake, M.; Hasegawa, M.; Nishizawa, M.; Onodera, O.; Kakita, A.; Takahashi, H. 2014: C9ORF72 repeat-associated non-ATG-translated polypeptides are distributed independently of TDP-43 in a Japanese patient with c9ALS. Neuropathology and Applied Neurobiology 40(6): 783-788
Cooper-Knock, J.; Higginbottom, A.; Connor-Robson, N.; Bayatti, N.; Bury, J.J.; Kirby, J.; Ninkina, N.; Buchman, V.L.; Shaw, P.J. 2013: C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology 81(19): 1719-1721
Farg, M.A.; Sundaramoorthy, V.; Sultana, J.M.; Yang, S.; Atkinson, R.A.K.; Levina, V.; Halloran, M.A.; Gleeson, P.A.; Blair, I.P.; Soo, K.Y.; King, A.E.; Atkin, J.D. 2014: C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Human Molecular Genetics 23(13): 3579-3595
Bigio, E.H. 2011: C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathology. Acta Neuropathologica 122(6): 653-655
Türk, M.; Haaker, G.; Winter, L.; Just, W.; Nickel, F.T.; Linker, R.A.; Chevessier, F.éd.ér.; Schröder, R. 2014: C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle. Muscle and Nerve 50(3): 454-455
Mann, D. 2014: C9ORF72: grabbing a tiger by the tail. Acta Neuropathologica 127(3): 311-318
Kobayashi, Y.; Suzuki, K.; Kobayashi, H.; Ohashi, S.; Koike, K.; Macchi, P.; Kiebler, M.; Anzai, K. 2008: C9orf10 protein, a novel protein component of Puralpha-containing mRNA-protein particles (Puralpha-mRNPs): characterization of developmental and regional expressions in the mouse brain. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 56(8): 723-731
Wang, H.; Li, Y.; Wang, Y.; Han, Z-Guang.; Cai, B. 2012: C9orf100, a new member of the Dbl-family guanine nucleotide exchange factors, promotes cell proliferation and migration in hepatocellular carcinoma. Molecular Medicine Reports 5(5): 1169-1174
May, S.; Hornburg, D.; Schludi, M.H.; Arzberger, T.; Rentzsch, K.; Schwenk, B.M.; Grässer, F.A.; Mori, K.; Kremmer, E.; Banzhaf-Strathmann, J.; Mann, M.; Meissner, F.; Edbauer, D. 2014: C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathologica 128(4): 485-503
Mizielinska, S.; Isaacs, A.M. 2014: C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?. Current Opinion in Neurology 27(5): 515-523
Diekstra, F.P.; Van Deerlin, V.M.; van Swieten, J.C.; Al-Chalabi, A.; Ludolph, A.C.; Weishaupt, J.H.; Hardiman, O.; Landers, J.E.; Brown, R.H.; van Es, M.A.; Pasterkamp, R.J.; Koppers, M.; Andersen, P.M.; Estrada, K.; Rivadeneira, F.; Hofman, A.; Uitterlinden, A.é G.; van Damme, P.; Melki, J.; Meininger, V.; Shatunov, A.; Shaw, C.E.; Leigh, P.N.; Shaw, P.J.; Morrison, K.E.; Fogh, I.; Chiò, A.; Traynor, B.J.; Czell, D.; Weber, M.; Heutink, P.; de Bakker, P.I.W.; Silani, V.; Robberecht, W.; van den Berg, L.H.; Veldink, J.H. 2014: C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Annals of Neurology 76(1): 120-133
Kostić, V.S.; Dobričić, V.; Stanković, I.; Ralić, V.; Stefanova, E. 2014: C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. Journal of Neurology 261(10): 1917-1921
Hensman Moss, D.J.; Poulter, M.; Beck, J.; Hehir, J.; Polke, J.M.; Campbell, T.; Adamson, G.; Mudanohwo, E.; McColgan, P.; Haworth, A.; Wild, E.J.; Sweeney, M.G.; Houlden, H.; Mead, S.; Tabrizi, S.J. 2014: C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 82(4): 292-299
Mizielinska, S.; Lashley, T.; Norona, F.E.; Clayton, E.L.; Ridler, C.E.; Fratta, P.; Isaacs, A.M. 2013: C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathologica 126(6): 845-857
Luo, Y.; Jiao, B.; Wang, J.; Du, J.; Yan, X.; Xia, K.; Tang, B.; Shen, L. 2014: C9orf72 hexanucleotide repeat expansion analysis in Chinese spastic paraplegia patients. Journal of the Neurological Sciences 347(1-2): 104-106
Dombroski, B.A.; Galasko, D.R.; Mata, I.F.; Zabetian, C.P.; Craig, U.-K.; Garruto, R.M.; Oyanagi, K.; Schellenberg, G.D. 2013: C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurology 70(6): 742-745
Daoud, H.; Suhail, H.; Sabbagh, M.; Belzil, V.; Szuto, A.; Dionne-Laporte, A.; Khoris, J.; Camu, W.; Salachas, F.; Meininger, V.; Mathieu, J.; Strong, M.; Dion, P.A.; Rouleau, G.A. 2012: C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia. Archives of Neurology 69(9): 1159-1163
Harms, M.; Benitez, B.A.; Cairns, N.; Cooper, B.; Cooper, P.; Mayo, K.; Carrell, D.; Faber, K.; Williamson, J.; Bird, T.; Diaz-Arrastia, R.; Foroud, T.M.; Boeve, B.F.; Graff-Radford, N.R.; Mayeux, R.; Chakraverty, S.; Goate, A.M.; Cruchaga, C.; Green, R.; Kowall, N.; Farrer, L.; Williamson, J.; Santana, V.; Schmechel, D.; Gaskell, P.; Welsh-Bohmer, K.; Pericak-Vance, M.; Ghetti, B.; Farlow, M.R.; Horner, K.; Growdon, J.H.; Blacker, D.; Tanzi, R.E.; Hyman, B.T.; Boeve, B.; Kuntz, K.; Norgaard, L.; Larson, N.; Kistler, D.; Parfitt, F.; Haddwow, J.; Silverman, J.; Beeri, M.S.; Sano, M.; Wang, J.; Lally, R.; Johnson, N.; Mesulum, M.; Weintraub, S.; Bigio, E.; Kaye, J.; Kramer, P.; Payne-Murphy, J.; Bennett, D.; Jacobs, H.; Chang, J.-S.; Arends, 2013: C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurology 70(6): 736-741
Liu, E.Y.; Russ, J.; Wu, K.; Neal, D.; Suh, E.; McNally, A.G.; Irwin, D.J.; Van Deerlin, V.M.; Lee, E.B. 2014: C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathologica 128(4): 525-541
Tomiyama, H. 2013: C9orf72 in Japanese amyotrophic lateral sclerosis (ALS). Rinsho Shinkeigaku 53(11): 1074-1076
Jiao, B.; Guo, J.-F.; Wang, Y.-Q.; Yan, X.-X.; Zhou, L.; Liu, X.-Y.; Zhang, F.-F.; Zhou, Y.-F.; Xia, K.; Tang, B.-S.; Shen, L. 2013: C9orf72 mutation is rare in Alzheimer's disease, Parkinson's disease, and essential tremor in China. Frontiers in Cellular Neuroscience 7: 164
Liu, R.; Tang, L.; Cai, B.; Liu, X.; Ye, S.; Ma, Y.; Zhang, H.; Fan, D. 2013: C9orf72 repeat expansions are not detected in Chinese patients with familial ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14(7-8): 630-631
Ticozzi, N.; Tiloca, C.; Calini, D.; Gagliardi, S.; Altieri, A.; Colombrita, C.; Cereda, C.; Ratti, A.; Pezzoli, G.; Borroni, B.; Goldwurm, S.; Padovani, A.; Silani, V. 2014: C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiology of Aging 35(4): 936.E13
Mizielinska, S.; Grönke, S.; Niccoli, T.; Ridler, C.E.; Clayton, E.L.; Devoy, A.; Moens, T.; Norona, F.E.; Woollacott, I.O.C.; Pietrzyk, J.; Cleverley, K.; Nicoll, A.J.; Pickering-Brown, S.; Dols, J.; Cabecinha, M.; Hendrich, O.; Fratta, P.; Fisher, E.M.C.; Partridge, L.; Isaacs, A.M. 2014: C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345(6201): 1192-1194
Rademakers, R. 2012: C9orf72 repeat expansions in patients with ALS and FTD. LANCET. Neurology 11(4): 297-298
Daoud, H.; Postuma, R.B.; Bourassa, C.V.; Rochefort, D.; Gauthier, M.T.; Montplaisir, J.; Gagnon, J.-F.; Arnulf, I.; Dauvilliers, Y.; Charley, C.M.; Inoue, Y.; Sasai, T.; Högl, B.; Desautels, A.; Frauscher, B.; Cochen De Cock, V.ér.; Rouleau, G.A.; Dion, P.A. 2014: C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 41(6): 759-762
Todd, P.K.; Paulson, H.L. 2013: C9orf72-associated FTD/ALS: when less is more. Neuron 80(2): 257-258
Heutink, P.; Jansen, I.E.; Lynes, E.M. 2014: C9orf72; abnormal RNA expression is the key. Experimental Neurology 262 Pt B: 102-110
Wu, X.; Bi, W.; Hua, Y.; Sun, J.'e.; Xiao, Z.; Wang, L.; Yin, S. 2013: C60/N,N'-bis(1-naphthyl)-N,N'-diphenyl-1,1'-biphenyl-4,4'-diamine:MoO3 as the interconnection layer for high efficient tandem blue fluorescent organic light-emitting diodes. Applied Physics Letters 102(24): 243302
Ivorra-Deleuze, D. 2009: C= new horizons in screening. Gynecologie Obstetrique and Fertilite 37(2): 204
Dong, F.; Heinbuch, S.; Xie, Y.; Bernstein, E.R.; Rocca, J.J.; Wang, Z.-C.; Ding, X.-L.; He, S.-G. 2009: C=C bond cleavage on neutral VO3(V2O5)n clusters. Journal of the American Chemical Society 131(3): 1057-1066
Liu, J.; Li, Y.; Jiang, J.; Huang, X. 2010: C@ZnO nanorod array-based hydrazine electrochemical sensor with improved sensitivity and stability. Dalton Transactions 39(37): 8693-8697
Babacan, A.; Kizilaslan, C.; Gun, I.; Muhcu, M.; Mungen, E.; Atay, V. 2014: CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics. International Journal of Clinical and Experimental Medicine 7(4): 1078-1083
Bast, R.C. 2010: CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease. Cancer 116(12): 2850-2853
Szwedziak, K.; Szymański, D.; Strzelczyk, J. 2013: CA 125 concentration in portal blood as a predictor of resectability in pancreatic tumor. Contemporary Oncology 17(4): 394-399
He, S.-m.; Xing, F.-q.; Sui, H.; Wang, Y.-l.; Mai, X.-f.; Luo, Z.-q.; Chen, X.-q.; Chen, G.-h.; Kong, Z.-j. 2010: CA 125 expression in cervical and vaginal secretions in women in normal reproductive period. Nan Fang Yi Ke da Xue Xue Bao 30(1): 173-175
Yilmaz, H.; Gürel, O.ül.M.; Celik, H.üs.T.; Sahiner, E.; Yildirim, M.E.; Bilgiç, M.A.şe.; Bavbek, N.; Akcay, A. 2014: CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis. Renal Failure 36(2): 210-216
Hoskins, P.J.; Le, N.; Correa, R. 2011: CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer. Gynecologic Oncology 120(1): 52-55
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction. Ginekologia Polska 79(2): 108-114
Patrelli, T.S.; Berretta, R.; Gizzo, S.; Pezzuto, A.; Franchi, L.; Lukanovic, A.; Nardelli, G.B.; Modena, A.B. 2011: CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertility and Sterility 95(1): 393-396
Vizzardi, E.; Nodari, S.; D'Aloia, A.; Chiari, E.; Faggiano, P.; Metra, M.; Dei Cas, L. 2008: CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Echocardiography 25(9): 955-960
Gu, P.; Pan, L.-L.; Wu, S.-Q.; Sun, L.; Huang, G. 2009: CA 125, PET alone, PET-CT, CT and MRi in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. European Journal of Radiology 71(1): 164-174
Goldman, P.A. 2010: CA 125: Value or addiction?. Cancer 116(12): 2854-2855
Begum, M.; Karim, S.; Malik, A.; Khurshid, R.; Asif, M.; Salim, A.; Nagra, S.A.; Zaheer, A.; Iqbal, Z.; Abuzenadah, A.M.; Alqahtani, M.H.; Rasool, M. 2012: CA 15-3 (Mucin-1) and physiological characteristics of breast cancer from Lahore, Pakistan. Asian Pacific Journal of Cancer Prevention: Apjcp 13(10): 5257-5261
Kruit, A.; Gerritsen, W.B.M.; Pot, N.; Grutters, J.C.; van den Bosch, J.M.M.; Ruven, H.J.T. 2010: CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 27(2): 138-146
Manuali, E.; De Giuseppe, A.; Feliziani, F.; Forti, K.; Casciari, C.; Marchesi, M.C.; Pacifico, E.; Pawłowski, K.M.; Majchrzak, K.; Król, M. 2012: CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. Bmc Veterinary Research 8: 86
Fahmueller, Y.N.; Nagel, D.; Hoffmann, R.-T.; Tatsch, K.; Jakobs, T.; Stieber, P.; Holdenrieder, S. 2013: CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation Therapy. International Journal of Clinical Pharmacology and Therapeutics 51(1): 63-66
González-Sistal, A.; Arias, J.é I.; Ruibal, A. 2012: CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers. International Journal of Biological Markers 27(1): 47-52
Duffy, M.J.; Evoy, D.; McDermott, E.W. 2010: CA 15-3: uses and limitation as a biomarker for breast cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(23-24): 1869-1874
Kruse, V.; Van de Wiele, C.; Borms, M.; Maes, A.; Pottel, H.; Sathekge, M.; Cocquyt, V. 2014: CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve. NUKLEARMEDIZIN. Nuclear Medicine 53(4): 131-138
Atkins, C.D. 2009: CA 19-9 and Lewis antigens in pancreatic cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27(15): 2572-3; author reply 2573
Wu, E.; Zhou, S.; Bhat, K.; Ma, Q. 2013: CA 19-9 and pancreatic cancer. Clinical Advances in Hematology and Oncology: H&o 11(1): 53-55
Chan, W.-X.; Hoi, W.-H.; Lee, C.-H. 2008: CA 19-9 and right heart failure secondary to chronic pulmonary embolism. International Journal of Cardiology 125(1): E10-E11
Ali, C.W.; Kaye, T.F.; Adamson, D.J.A.; Tait, I.S.; Polignano, F.M.; Highley, M.S. 2007: CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma. Journal of Gastrointestinal Cancer 38(2-4): 108-114
Koom, W.S.; Seong, J.; Kim, Y.B.; Pyun, H.O.; Song, S.Y. 2009: CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. International Journal of Radiation Oncology Biology Physics 73(4): 1148-1154
Pall, M.; Iqbal, J.; Singh, S.K.; Rana, S.V. 2012: CA 19-9 as a serum marker in urothelial carcinoma. Urology Annals 4(2): 98-101
Coskun, A.; Kiran, G.; Ozdemir, O. 2008: CA 19-9 can be a useful tumor marker in ovarian dermoid cysts. Clinical and Experimental Obstetrics and Gynecology 35(2): 137-139
Szwedziak, K.; Strzelczyk, J. 2013: CA 19-9 concentration in peripheral and portal blood of patients operated on for pancreatic tumor. Polski Przeglad Chirurgiczny 85(1): 20-28
Stintzing, S.; Herold, C.; Hahn, E.G.; Boxberger, F. 2008: CA 19-9 in the differential diagnosis of pancreatic lesions. Der Internist 49(2): 225-227
Esteghamati, A.; Hafezi-Nejad, N.; Zandieh, A.; Sheikhbahaei, S.; Emamzadeh-Fard, S.; Nakhjavani, M. 2014: CA 19-9 is associated with poor glycemic control in diabetic patients: role of insulin resistance. Clinical Laboratory 60(3): 441-447
Kim, T.Hyun.; Han, S-Sik.; Park, S-Jae.; Lee, W.Jin.; Woo, S.Myung.; Yoo, T.; Moon, S.Ho.; Kim, S.Hoon.; Hong, E.Kyung.; Kim, D.Yong.; Park, J-Won. 2011: CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. International Journal of Radiation Oncology Biology Physics 81(5): E743-E748
Gul, K.; Nas, S.; Ozdemir, D.; Gumus, M.; Ersoy, R.; Cakir, B. 2011: CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications. American Journal of the Medical Sciences 341(1): 28-32
Hayman, A.V.; Stocker, S.J.; Baker, M.S.; Bentrem, D.J.; Prinz, R.A.; Marsh, R.de.W.; Talamonti, M.S. 2014: CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. American Journal of Clinical Oncology 37(6): 550-554
Nakai, Y.; Kawabe, T.; Isayama, H.; Sasaki, T.; Yagioka, H.; Yashima, Y.; Kogure, H.; Arizumi, T.; Togawa, O.; Ito, Y.; Matsubara, S.; Hirano, K.; Sasahira, N.; Tsujino, T.; Tada, M.; Omata, M. 2008: CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer. Oncology 75(1-2): 120-126
Bedi, M.M.S.; Gandhi, M.D.; Jacob, G.; Lekha, V.; Venugopal, A.; Ramesh, H. 2009: CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 28(1): 24-27
Wu, Z.; Kuntz, A.I.; Wadleigh, R.G. 2013: CA 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer. Clinical Advances in Hematology and Oncology: H&o 11(1): 50-52
Hess, V.; Glimelius, B.; Grawe, P.; Dietrich, D.; Bodoky, G.ör.; Ruhstaller, T.; Bajetta, E.; Saletti, P.; Figer, A.; Scheithauer, W.; Herrmann, R. 2008: CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. LANCET. Oncology 9(2): 132-138
Hernandez, J.M.; Cowgill, S.M.; Al-Saadi, S.; Collins, A.; Ross, S.B.; Cooper, J.; Villadolid, D.é; Zervos, E.; Rosemurgy, A. 2009: CA 19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 13(2): 349-353
Wiwanitkit, V. 2012: CA 19-9, PSA, oxidative stress and chronic pancreatitis. Clinical Biochemistry 45(6): 512
Galli, C.; Basso, D.; Plebani, M. 2013: CA 19-9: handle with care. Clinical Chemistry and Laboratory Medicine 51(7): 1369-1383
Prieto de Paula, J.é M.ía.; Mayor Toranzo, E.; Sanmamed Salgado, N.; Franco Hidalgo, S. 2013: CA 19.9 elevation in the absence of pancreatic tumor. Gastroenterologia y Hepatologia 36(7): 495-496
Kurian, S.; Khan, M.; Grant, M. 2008: CA 27-29 in patients with breast cancer with pulmonary fibrosis. Clinical Breast Cancer 8(6): 538-540
Demirci, H.; Erdamar, H.; Karakoc, A.; Akturk, M.; Yilmaz, M.; Arslan, M. 2010: CA 72-4 levels in patients with type 2 diabetes mellitus. International Journal of Clinical Practice 64(1): 34-38
Zhou, R.; Huang, W.; Yao, Y.; Wang, Y.; Li, Z.; Shao, B.; Zhong, J.; Tang, M.; Liang, S.; Zhao, X.; Tong, A.; Yang, J. 2013: CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells. International Journal of Oncology 43(2): 611-621
Razera, F.; De Stefani, S.; Bonamigo, R.Rangel.; Olm, G.Silveira.; Dias, Cícero.Armídio.Gomes.; Narvaez, G.Azambuja. 2009: CA MRSA in furunculosis: case report of southern Brazil. Anais Brasileiros de Dermatologia 84(5): 515-518
Anonymous 2007: CA hospital brands image with a vibrant, colorful campaign. Effort promotes hospital's service lines with "always first" campaign. Profiles in Healthcare Communications 23(3): 8
Nair, G.; Lobo, I.; Laxmi, T.K.J.; Uppe, A.G.; Swami, S.; Jain, A. 2011: CA lung presenting with vasculitis. Journal of the Association of Physicians of India 59: 455-456
Khattri, A.; Pandey, R.K.; Gupta, N.J.; Chakravarty, B.; Deendayal, M.; Singh, L.; Thangaraj, K. 2009: CA repeat and Rsai polymorphisms in ERbeta gene are not associated with infertility in Indian men. International Journal of Andrology 32(1): 81-87
Anonymous 2008: CA's streamlined HIV testing uncovering hidden infections. Stigma becomes a non-issue. Aids Alert 23(8): 85-87
Newman, Z.L.; Leppla, S.H.; Moayeri, M. 2009: CA-074Me protection against anthrax lethal toxin. Infection and Immunity 77(10): 4327-4336
Zieliński, T. 2010: CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?. Kardiologia Polska 68(7): 779-780
Cebesoy, F.Bahar.; Balat, O.; Dikensoy, E.; Kalayci, H.; Ibar, Y. 2009: CA-125 and CRP are elevated in preeclampsia. Hypertension in Pregnancy 28(2): 201-211
Ege, M.R.; Zorlu, A.; Yılmaz, M.B. 2011: CA-125 and heart failure. International Journal of Cardiology 147(3): 453-454
Topatan, B.ül.; Basaran, A. 2011: CA-125 and heart failure: Déjà vu continues. International Journal of Cardiology 147(2): 344-345
Topatan, B.ül.; Basaran, A. 2010: CA-125 and heart failure: déjà vu or "still to be seen". International Journal of Cardiology 145(3): 626-629
Topatan, B.ül.; Basaran, A. 2011: CA-125 and heart failure: reiteration and reappraisal. International Journal of Cardiology 153(1): 76-78
Wiwanitkit, V. 2013: CA-125 and risk of malignancy index for screening for malignancy in fertile aged females with ovarian cyst, which is more cost effectiveness?. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 34(2): 72-73
Check, J.H. 2009: CA-125 as a biomarker for malignant transformation of endometriosis. Fertility and Sterility 91(5): E35; Author Reply E36
Tian, C.; Markman, M.; Zaino, R.; Ozols, R.F.; McGuire, W.P.; Muggia, F.M.; Rose, P.G.; Spriggs, D.; Armstrong, D.K. 2009: CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study. Cancer 115(7): 1395-1403
Szubert, M.; Suzin, J.; Wierzbowski, T.; Kowalczyk-Amico, K. 2012: CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results. Archives of Medical Science: Ams 8(3): 504-508
Furukawa, N.; Sasaki, Y.; Shigemitsu, A.; Akasaka, J.; Kanayama, S.; Kawaguchi, R.; Kobayashi, H. 2013: CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer. Journal of Gynecologic Oncology 24(2): 141-145
Basaran, A. 2010: CA-125 for diagnosis of acute appendicitis: new possibility for an old tumor marker. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 12(2): 155-156
Ayaslioglu, E. 2009: CA-125 in the Diagnosis of Pulmonary Tuberculosis. Japanese Journal of Infectious Diseases 62(6): 485
Chen, X.; Zhang, J.; Cheng, W.; Chang, D.Y.; Huang, J.; Wang, X.; Jia, L.; Rosen, D.G.; Zhang, W.; Yang, D.; Gershenson, D.M.; Sood, A.K.; Bast, R.C.; Liu, J. 2013: CA-125 level as a prognostic indicator in type i and type Ii epithelial ovarian cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23(5): 815-822
Uz, O.; Kardesoglu, E.; Tas, D.; Acar, G.; Isilak, Z.; Yiginer, O.; Aparci, M.; Cingozbay, B.Y.; Cebeci, B.S. 2011: CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD. Southern Medical Journal 104(9): 624-628
Raspollini, M.Rosaria. 2007: CA-125 level preoperative assessment in early and advanced ovarian carcinoma. Gynecologic oncology 107(2): 356-7; author reply 357-8
Markman, M.; Petersen, J.; Belland, A.; Burg, K. 2010: CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial. Oncology 78(1): 1-2
Oaknin, A.; Barretina, P.; Pérez, X.; Jimenez, L.; Velasco, M.; Alsina, M.; Brunet, J.; Germà, J.R.; Beltran, M. 2010: CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD). International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 20(1): 87-91
Zorlu, A.; Tandogan, I.; Yilmaz, M.Birhan. 2011: CA-125, an omitted part of the heart. Heart Lung and Circulation 20(5): 345; Author Reply 346
Schmidt, C. 2011: CA-125: a biomarker put to the test. Journal of the National Cancer Institute 103(17): 1290-1291
Wani, A.M.; Akhtar, M. 2008: CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis. Annals of Saudi Medicine 28(2): 142-143
Dean, W.L. 1982: CA-ATPase-Detergent Interactions: a Good Model for Protein-Lipid Interactions. Biophysical Journal 37(1): 56-57
Ball, C. 2007: CA-MRSA education important. Nurse Practitioner 32(4): 11
McBride, D. 2008: CA-MRSA lesions: what works, what doesn't. Journal of Family Practice 57(9): 588-592
Pérez, Aés.; Orta, L.; Padilla, E.; Mesquida, X. 2013: CA-MRSA puerperal mastitis and breast abscess: a potential problem emerging in Europe with many unanswered questions. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 26(9): 949-951
Girard, N.J. 2014: CA-MRSA skin infections: An ounce of prevention is worth a pound of cure. AORN Journal 99(5): 664 569
Kurkowski, C. 2007: CA-MRSA. the new sports pathogen. Orthopedic Nursing 26(5): 310-314; Quiz: 315-316
Wang, T. 2011: CA-tree: a hierarchical structure for efficient and scalable coassociation-based cluster ensembles. IEEE Transactions on Systems Man and Cybernetics. Part B Cybernetics: a Publication of the IEEE Systems Man and Cybernetics Society 41(3): 686-698
Ronco, C.; Garzotto, F.; Ricci, Z. 2012: CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants. a personal journey. Pediatric Nephrology 27(8): 1203-1211
Xiao, K.; Jehle, F.; Peters, C.; Reinheckel, T.; Schirmer, R.H.; Dandekar, T. 2009: CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis. Biological Chemistry 390(11): 1185-1197
Modi, M.N.; Dhawale, A.K.; Bhalla, U.S. 2014: CA1 cell activity sequences emerge after reorganization of network correlation structure during associative learning. Elife 3: E01982
Ognjanovski, N.; Maruyama, D.; Lashner, N.; Zochowski, M.; Aton, S.J. 2014: CA1 hippocampal network activity changes during sleep-dependent memory consolidation. Frontiers in Systems Neuroscience 8: 61
Bartsch, T.; Döhring, J.; Rohr, A.; Jansen, O.; Deuschl, G.ün. 2011: CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness. Proceedings of the National Academy of Sciences of the United States of America 108(42): 17562-17567
Younts, T.J.; Chevaleyre, V.; Castillo, P.E. 2013: CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33(34): 13743-13757
Schlichting, M.L.; Zeithamova, D.; Preston, A.R. 2014: CA1 subfield contributions to memory integration and inference. Hippocampus 24(10): 1248-1260
Boivin, M.; Lane, D.; Piché, A.; Rancourt, C. 2009: CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecologic Oncology 115(3): 407-413
Presl, J.; Novotny, Z.; Topolcan, O.; Vlasak, P.; Kucera, R.; Fuchsova, R.; Vrzalova, J.; Betincova, L.; Svobodova, S. 2014: CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management. Anticancer Research 34(1): 327-331
Wiwanitkit, V. 2010: CA125 and acute appendicitis. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 12(4): 387; author reply 387-8
Miñana, G.; Núñez, J.; Sanchis, J.; Bodí, V.; Núñez, E.; Llàcer, A. 2010: CA125 and immunoinflammatory activity in acute heart failure. International Journal of Cardiology 145(3): 547-548
Richardson, D.L.; Seamon, L.G.; Carlson, M.J.; O'Malley, D.M.; Fowler, J.M.; Copeland, L.J.; Cohn, D.E. 2008: CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy. Gynecologic Oncology 111(2): 233-236
Wiwanitkit, V. 2010: CA125 for following up carcinoma of the bladder. Urologic Oncology 28(2): 226
Cramer, D.W.; O'Rourke, D.J.; Vitonis, A.F.; Matulonis, U.A.; Dijohnson, D.A.; Sluss, P.M.; Crum, C.P.; Liu, B.C.-S. 2010: CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clinical Chemistry 56(12): 1889-1892
Turgut, O.; Tandogan, I.; Yilmaz, M.B.; Gul, I.; Zorlu, A. 2011: CA125 in heart failure: implications for immunoinflammatory activity. International Journal of Cardiology 146(1): 99-100
Scholler, N.; Urban, N. 2007: CA125 in ovarian cancer. Biomarkers in Medicine 1(4): 513-523
Luo, G.; Xiao, Z.; Long, J.; Liu, Z.; Liu, L.; Liu, C.; Xu, J.; Ni, Q.; Yu, X. 2013: CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 17(12): 2092-2098
Pelissier, A.él.; Bonneau, C.; Chéreau, E.; de La Motte Rouge, T.; Fourchotte, V.; Daraï, E.; Rouzier, R. 2014: CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Gynecologic Oncology 135(3): 542-546
Won, E.; Hurria, A.; Feng, T.; Mohile, S.; Owusu, C.; Klepin, H.D.; Gross, C.P.; Lichtman, S.M.; Gajra, A.; Tew, W.P. 2013: CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 23(6): 1022-1028
Turgut, O.; Tandogan, I.; Yilmaz, M.B.; Gul, I.; Gurlek, A. 2010: CA125 levels among patients with advanced heart failure: an emerging independent predictor for survival. International Journal of Cardiology 145(1): 71
Van Altena, A.M.; Kolwijck, E.; Spanjer, M.J.B.; Hendriks, J.C.M.; Massuger, L.F.A.G.; de Hullu, J.A. 2010: CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study. Gynecologic Oncology 119(2): 265-269
Cartei, G.; Cartei, F.; Bertin, M.; Padoan, A.; Zustovich, F.; Nicoletto, M.Ornella.; Plebani, M. 2013: CA125 reference values change in male and postmenopausal female subjects. Clinical Chemistry and Laboratory Medicine 51(2): 413-419
Bradford, L.S.; Schorge, J.O. 2011: CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?. Menopause 18(2): 123-124
Cliby, B. 2011: CA125 surveillance and outcomes at secondary surgery: more here than meets the eye. Gynecologic Oncology 121(2): 245-246
Fleming, N.D.; Cass, I.; Walsh, C.S.; Karlan, B.Y.; Li, A.J. 2011: CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecologic Oncology 121(2): 249-252
Sikaris, K.A. 2011: CA125--a test with a change of heart. Heart Lung and Circulation 20(10): 634-640
Shih, C.-M.; Huang, C.-T.; Chi, C.-H.; Lin, J.-W.; Pan, C.-C. 2010: CA125-producing clear cell adenocarcinoma arising from the upper ureter and renal pelvis. Journal of the Chinese Medical Association: Jcma 73(1): 40-43
Colloca, G.; Venturino, A.; Addamo, G.; Coccorullo, Z.; Ratti, R.; Caltabiano, G.; Guarneri, D. 2013: CA125-related measures of tumor kinetics and outcome of patients with recurrent ovarian cancer receiving chemotherapy: a retrospective evaluation. Japanese Journal of Clinical Oncology 43(12): 1203-1209
Akita, K.; Tanaka, M.; Tanida, S.; Mori, Y.; Toda, M.; Nakada, H. 2013: CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. European Journal of Cell Biology 92(8-9): 257-263
Cheon, D.-J.; Wang, Y.; Deng, J.M.; Lu, Z.; Xiao, L.; Chen, C.-M.; Bast, R.C.; Behringer, R.R. 2009: CA125/MUC16 is dispensable for mouse development and reproduction. Plos one 4(3): E4675
Incoronato, M.; Mirabelli, P.; Catalano, O.; Aiello, M.; Parente, C.; Soricelli, A.; Nicolai, E. 2014: CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients. Bmc Cancer 14: 356
Ruibal, Ál.; Aguiar, P.; Del Río, M.ía.C.; Padín-Iruegas, M.ía.E.; Arias, J.é I.; Herranz, M. 2014: CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast. International Journal of Molecular Sciences 15(11): 19870-19876
Morris-Stiff, G.; Teli, M.; Jardine, N.; Puntis, M.C. 2009: CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(6): 620-626
He, Z.; Lu, H.; Du, X.; Hu, W.; Zhaoda, B.T. 2013: CA19-9 as a predictor of resectability in patients with borderline resectable pancreatic cancer. Hepato-Gastroenterology 60(124): 900-903
Hammad, N.; Heilbrun, L.K.; Philip, P.A.; Shields, A.F.; Zalupski, M.M.; Venkatramanamoorthy, R.; El-Rayes, B.F. 2010: CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. Asia-Pacific Journal of Clinical Oncology 6(2): 98-105
Cho, H.-y.; Kim, K.; Jeon, Y.-T.; Kim, Y.-B.; No, J.H. 2013: CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 19: 230-235
Hartwig, W.; Strobel, O.; Hinz, U.; Fritz, S.; Hackert, T.; Roth, C.; Büchler, M.W.; Werner, J. 2013: CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Annals of Surgical Oncology 20(7): 2188-2196
Narita, Y.; Taniguchi, H.; Komori, A.; Nitta, S.; Yamaguchi, K.; Kondo, C.; Nomura, M.; Kadowaki, S.; Takahari, D.; Ura, T.; Andoh, M.; Muro, K. 2014: CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy. Cancer ChemoTherapy and Pharmacology 73(2): 409-416
Klapdor, R.; Bahlo, M.; Babinski, A.; Klapdor, S. 2010: CA19-9 serum concentrations--analysis of the serum kinetics during first-line therapy of pancreatic cancer in relation to overall survival. Anticancer Research 30(5): 1869-1874
Marrelli, D.; Caruso, S.; Pedrazzani, C.; Neri, A.; Fernandes, E.; Marini, M.; Pinto, E.; Roviello, F. 2009: CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. American Journal of Surgery 198(3): 333-339
Yamaguchi, E.; Makino, Y.; Sato, T.; Uchida, M.; Harada, Y.; Maruyama, R. 2014: CA19-9-producing lung metastasis after surgery for papillary thyroid carcinoma: report of a case. Surgery Today 44(11): 2157-2161
Hegele, A.; Mecklenburg, V.; Varga, Z.; Olbert, P.; Hofmann, R.; Barth, P. 2010: CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings. Anticancer Research 30(12): 5195-5200
Mare, L.; Caretti, A.; Albertini, R.; Trinchera, M. 2013: CA19.9 antigen circulating in the serum of colon cancer patients: where is it from?. International Journal of Biochemistry and Cell Biology 45(4): 792-797
McHugh, T.J.; Tonegawa, S. 2009: CA3 NMDA receptors are required for the rapid formation of a salient contextual representation. Hippocampus 19(12): 1153-1158
Chater, T.E.; Goda, Y. 2013: CA3 mossy fiber connections: giant synapses that gain control. Neuron 77(1): 4-6
Neunuebel, J.P.; Knierim, J.J. 2014: CA3 retrieves coherent representations from degraded input: direct evidence for CA3 pattern completion and dentate gyrus pattern separation. Neuron 81(2): 416-427
Newman, E.L.; Hasselmo, M.E. 2014: CA3 sees the big picture while dentate gyrus splits hairs. Neuron 81(2): 226-228
Chadwick, M.J.; Bonnici, H.M.; Maguire, E.A. 2014: CA3 size predicts the precision of memory recall. Proceedings of the National Academy of Sciences of the United States of America 111(29): 10720-10725
Yang, A.-P.; Liu, J.; Lei, H.-Y.; Zhang, Q.-W.; Zhao, L.; Yang, G.-H. 2014: CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry 437: 183-186
Türkmen, S.; Guo, G.; Garshasbi, M.; Hoffmann, K.; Alshalah, A.J.; Mischung, C.; Kuss, A.; Humphrey, N.; Mundlos, S.; Robinson, P.N. 2009: CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait. Plos Genetics 5(5): E1000487
Bahia, D.; Rodrigues, N.B.; Araújo, F.áv.M.G.; Romanha, A.J.é; Ruiz, J.ôn.C.; Johnston, D.A.; Oliveira, G. 2010: CA88, a nuclear repetitive DNA sequence identified in Schistosoma mansoni, aids in the genotyping of nine Schistosoma species of medical and veterinary importance. Memorias do Instituto Oswaldo Cruz 105(4): 391-397
Li, G.; Bilal, I.; Gentil-Perret, A.; Feng, G.; Zhao, A.; Peoc'h, M.; Genin, C.; Tostain, J.; Gigante, M. 2012: CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urologic Oncology 30(4): 463-468
De Martino, M.; Klatte, T.; Seligson, D.B.; LaRochelle, J.; Shuch, B.; Caliliw, R.; Li, Z.; Kabbinavar, F.F.; Pantuck, A.J.; Belldegrun, A.S. 2009: CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. Journal of Urology 182(2): 728-734
Li, G.; Feng, G.; Cuilleron, M.; Zhao, A.; Gentil-Perret, A.; Cottier, M.èl.; Genin, C.; Tostain, J. 2009: CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours. Histopathology 54(7): 880-884
Qi, Z.; Wang, Y.; Zhou, X. 2012: CA916798 gene participates in cisplatin resistance of human lung adenocarcinoma A549 cells through PI3K/AKT/mTOR pathway. Nan Fang Yi Ke da Xue Xue Bao 32(9): 1290-1293
Wang, H.-J.; Yang, H.-P.; Zhou, X.-D.; Dai, X.-T.; Chen, Y.-F.; Xiong, W. 2011: CA916798 regulates multidrug resistance of lung cancer cells. Asian Pacific Journal of Cancer Prevention: Apjcp 12(12): 3403-3408
Anonymous 2012: CA: Catheter accidently pulled: injury resulted: judgment for hospital reversed on appeal. Harry v. South Coast Medical Center, GO44770 CAAPP4-3 (5/11/2012)-CA. Nursing Law's Regan Report 53(3): 3
Janssen, P. 2010: Can eating disorders cause functional gastrointestinal disorders?. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 22(12): 1267-1269
James, A.S.; Hall, S.; Greiner, K.A.; Buckles, D.; Born, W.K.; Ahluwalia, J.S. 2008: The impact of socioeconomic status on perceived barriers to colorectal cancer testing. American Journal of Health Promotion: Ajhp 23(2): 97-100
Anonymous 2010: CA: Infected arm virtually ignored by staff: pt. failed to produce required expert opinion. Phillips v. City & County of San Francisco, A125769 CAAP1 (6/28/2010)-CA. Nursing Law's Regan Report 51(2): 3
Anonymous 2009: CA: np testified as to welts in child abuse case: abusive mother lost custody of children. Nursing law's Regan report 50(2): 3
Monot, J.; Fensterbank, L.; Malacria, M.; Lacôte, E.; Geib, S.J.; Curran, D.P. 2010: CAAC Boranes. Synthesis and characterization of cyclic (alkyl) (amino) carbene borane complexes from BF₃ and BH₃. Beilstein Journal of Organic Chemistry 6: 709-712
Aronson, S.M. 2013: The vocabulary of gender. Rhode Island Medical Journal 96(10): 56
Lin, Y.-D.; Chen, S.; Yue, P.; Zou, W.; Benbrook, D.M.; Liu, S.; Le, T.C.; Berlin, K.D.; Khuri, F.R.; Sun, S.-Y. 2008: CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Cancer Research 68(13): 5335-5344
Tomita, T.; Kido, T.; Kurotani, R.; Iemura, S.-I.; Sterneck, E.; Natsume, T.; Vinson, C.; Kimura, S. 2008: CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression. Journal of Biological Chemistry 283(37): 25617-25627
Gao, J.; Liao, J.; Yang, G.-Y. 2009: CAAX-box protein, prenylation process and carcinogenesis. American Journal of Translational Research 1(3): 312-325
Deperas, J.; Szluinska, M.; Deperas-Kaminska, M.; Edwards, A.; Lloyd, D.; Lindholm, C.; Romm, H.; Roy, L.; Moss, R.; Morand, J.; Wojcik, A. 2007: CABAS: a freely available PC program for fitting calibration curves in chromosome aberration dosimetry. Radiation Protection Dosimetry 124(2): 115-123
Miller, A.R.; Blower, D.E. 1946: Primary diphtheria of the conjunctiva. Lancet 2(6419): 345
Mitka, M. 2013: CABG again outshines stenting for some patients with coronary artery blockage. JAMA 309(1): 17-18
Mitka, M. 2011: CABG and medical therapy perform equally well in patients with heart failure. JAMA 305(19): 1949-1950
Yokota, T.; Kuribara, K.; Tokuhara, T.; Zschieschang, U.; Klauk, H.; Takimiya, K.; Sadamitsu, Y.; Hamada, M.; Sekitani, T.; Someya, T. 2013: Flexible low-voltage organic transistors with high thermal stability at 250 °C. Advanced Materials 25(27): 3639-3644
Osaka, S-ichi. 2010: CABG for patients on hemodialysis: comments at present. Annals of thoracic and cardiovascular surgery: official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 16(2): 69-71
Taggart, D.P. 2012: CABG in 2012: Evidence, practice and the evolution of guidelines. Global Cardiology Science and Practice 2012(2): 21-28
Berger, A.K.; Herzog, C.A. 2010: CABG in CKD: untangling the letters of risk. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(11): 3477-3479
Rawat, S.K.S.; Mehta, Y.; Yaseen, T.; Sharma, J.; Kohli, V.; Trehan, N. 2009: CABG in a patient recovering from dengue fever. Indian Heart Journal 61(4): 386-388
Majure, D.T. 2011: CABG in patients with left ventricular dysfunction. New England Journal of Medicine 365(5): 469-470; Author Reply 470-471
Palmas, W. 2011: CABG in patients with left ventricular dysfunction. New England Journal of Medicine 365(5): 469; Author Reply 470-471
Silva, R.R.E.; Truffa, M.ár.A.; Birolli, J.é R.B.d.M.; Silva, T.ár.F.; De Mola, R.; Oliveira, J.ão.B.d. 2009: CABG late angiographic grafting patency analysis in patients with recurrent symptoms. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 24(2): 138-142
Velicki, L.; Cemerlic-Adjic, N.; Panic, G.; Jung, R.; Redzek, A.; Nicin, S. 2013: CABG mortality is not influenced by prior PCi in low risk patients. Journal of Cardiac Surgery 28(4): 353-358
Cohn, A. 2012: Junior doctors take heart: you do everything as well as we did. Bmj 345: E7646
Kappetein, A.P.; Head, S.J. 2013: CABG or PCi for revascularisation in patients with diabetes?. LANCET. Diabetes and Endocrinology 1(4): 266-268
Taggart, D.P. 2013: CABG or stents in coronary artery disease: end of the debate?. Lancet 381(9867): 605-607
Schmitto, J.D.; Kolat, P.; Ortmann, P.; Popov, A.F.; Coskun, K.O.; Sohns, C.; Hinz, J.; Schoendube, F.A. 2010: CABG surgery with long coronary endarterectomy of the LAD. Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 16(6): 445-447
Hillegass, W. 2009: CABG versus DES PCi in diabetics with multivessel disease: back to the BARi registry. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 73(1): 59-60
Sedrakyan, A. 2009: CABG versus PCi for multivessel coronary artery disease. Lancet 373(9682): 2199
Capodanno, D.; Capranzano, P.; Tamburino, C. 2014: CABG versus PCi in diabetic patients with multivessel disease after risk stratification by the SYNTAX score: a pooled analysis of the SYNTAX and FREEDOM trials. International Journal of Cardiology 173(3): 548-549
Nicolini, F.; Agostinelli, A.; Vezzani, A.; Benassi, F.; Gherli, T. 2014: CABG versus PCi in the treatment of diabetic patients affected by coronary artery disease. International Heart Journal 55(6): 469-473
Anonymous 2012: CABG vs angioplasty in kidney disease. Harvard heart letter: from Harvard Medical School 23(4): 8
Lee, T.H.; Hillis, L.David.; Nabel, E.G. 2009: CABG vs. stenting--clinical implications of the SYNTAX trial. New England Journal of Medicine 360(8): E10
Boeken, U.; Litmathe, J.; Kurt, M.; Feindt, P.; Gams, E. 2008: CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?. International Journal of Cardiology 127(2): 257-259
Singhal, M.; Domico, K. 2007: CABIN: collective analysis of biological interaction networks. Computational Biology and Chemistry 31(3): 222-225
Verdú-Andrés, S.; Amaldi, U.; Faus-Golfe, A. 2013: CABOTO, a high-gradient linac for hadrontherapy. Journal of Radiation Research 54(Suppl 1): I155-I161
Khan, A.O. 2014: CABP4 mutations do not cause congenital stationary night blindness. Ophthalmology 121(3): E15
Latek, D.; Kolinski, A. 2011: CABS-NMR--de novo tool for rapid global fold determination from chemical shifts, residual dipolar couplings and sparse methyl-methyl NOEs. Journal of Computational Chemistry 32(3): 536-544
Jamroz, M.; Kolinski, A.; Kmiecik, S. 2014: CABS-flex predictions of protein flexibility compared with NMR ensembles. Bioinformatics 30(15): 2150-2154
Jamroz, M.; Kolinski, A.; Kmiecik, S. 2013: CABS-flex: Server for fast simulation of protein structure fluctuations. Nucleic Acids Research 41(Web Server Issue): W427-W431
Blaszczyk, M.; Jamroz, M.; Kmiecik, S.; Kolinski, A. 2013: CABS-fold: Server for the de novo and consensus-based prediction of protein structure. Nucleic Acids Research 41(Web Server Issue): W406-W411
Kawashima, A.; Osman, B.A.H.; Takashima, M.; Kikuchi, A.; Kohchi, S.; Satoh, E.; Tamba, M.; Matsuda, M.; Okamura, N. 2009: CABS1 is a novel calcium-binding protein specifically expressed in elongate spermatids of mice. Biology of Reproduction 80(6): 1293-1304
Shi, L.-X.; He, Y.-M.; Fang, L.; Meng, H.-B.; Zheng, L.-J. 2010: CABYR RNAi plasmid construction and NF-κB signal transduction pathway. World Journal of Gastroenterology 16(39): 4980-4985
Li, Y.-F.; He, W.; Kim, Y.-H.; Mandal, A.; Digilio, L.; Klotz, K.; Flickinger, C.J.; Herr, J.C. 2010: CABYR isoforms expressed in late steps of spermiogenesis bind with AKAPs and ropporin in mouse sperm fibrous sheath. Reproductive Biology and Endocrinology: Rb&e 8: 101
Takeuchi, K.; Frueh, D.P.; Sun, Z.-Y.J.; Hiller, S.; Wagner, G. 2010: CACA-TOCSY with alternate 13C-12C labeling: a 13Calpha direct detection experiment for mainchain resonance assignment, dihedral angle information, and amino acid type identification. Journal of Biomolecular NMR 47(1): 55-63
Kim, D.-S.; Kim, D.-W.; Kim, M.-Y.; Nam, S.-H.; Choi, S.-H.; Kim, R.N.; Kang, A.; Kim, A.; Park, H.-S. 2012: CACG: a database for comparative analysis of conjoined genes. Genomics 100(1): 14-17
Labauge, P.; Fogli, A.; Niel, F.; Rodriguez, D.; Boespflug-Tanguy, O. 2007: CACH/VWM syndrome and leucodystrophies related to EIF2B mutations. Revue Neurologique (Paris) 163(8-9): 793-799
Tannoury, H.; Rodriguez, V.; Kovacevic, I.; Ibourk, M.; Lee, M.; Cram, E.J. 2010: CACN-1/Cactin interacts genetically with MIG-2 GTPase signaling to control distal tip cell migration in C. elegans. Developmental Biology 341(1): 176-185
LaBonty, M.; Szmygiel, C.; Byrnes, L.E.; Hughes, S.; Woollard, A.; Cram, E.J. 2014: CACN-1/Cactin plays a role in Wnt signaling in C. elegans. Plos one 9(7): E101945
Stam, A.H.; Vanmolkot, K.R.J.; Kremer, H.P.H.; Gärtner, J.; Brown, J.; Leshinsky-Silver, E.; Gilad, R.; Kors, E.E.; Frankhuizen, W.S.; Ginjaar, H.B.; Haan, J.; Frants, R.R.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Terwindt, G.M. 2008: CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clinical Genetics 74(5): 481-485
Gerola, S.; Battistini, S.; Stenirri, S.; Nicolodi, M.; Arnetoli, G.; Canova, S.; Binelli, G.; Bernardi, A.; Balan, S.; Ferrari, M.; Carrera, P. 2009: CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology. Clinical Chemistry and Laboratory Medicine 47(6): 783-785
Robbins, M.S.; Lipton, R.B.; Laureta, E.C.; Grosberg, B.M. 2009: CACNA1A nonsense mutation is associated with basilar-type migraine and episodic ataxia type 2. Headache 49(7): 1042-1046
Groen, J.L.; Andrade, A.; Ritz, K.; Jalalzadeh, H.; Haagmans, M.; Bradley, T.E.J.; Jongejan, A.; Verbeek, D.S.; Nürnberg, P.; Denome, S.; Hennekam, R.C.M.; Lipscombe, D.; Baas, F.; Tijssen, M.A.J. 2015: CACNA1B mutation is linked to unique myoclonus-dystonia syndrome. Human Molecular Genetics 24(4): 987-993
Beitelshees, A.L.; Navare, H.; Wang, D.; Gong, Y.; Wessel, J.; Moss, J.I.; Langaee, T.Y.; Cooper-DeHoff, R.M.; Sadee, W.; Pepine, C.J.; Schork, N.J.; Johnson, J.A. 2009: CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circulation. Cardiovascular Genetics 2(4): 362-370
Wolf, C.; Mohr, H.; Schneider-Axmann, T.; Reif, A.; Wobrock, T.; Scherk, H.; Kraft, S.; Schmitt, A.; Falkai, P.; Gruber, O. 2014: CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 264(2): 93-102
Balog, Z.; Kiss, I.; Kéri, S. 2010: CACNA1C risk allele for psychotic disorders is related to the activation of the AKT-pathway. American Journal of Psychiatry 167(10): 1276-1277
Tesli, M.; Skatun, K.C.; Ousdal, O.T.; Brown, A.A.; Thoresen, C.; Agartz, I.; Melle, I.; Djurovic, S.; Jensen, J.; Andreassen, O.A. 2013: CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. Plos one 8(2): E56970
He, K.; An, Z.; Wang, Q.; Li, T.; Li, Z.; Chen, J.; Li, W.; Wang, T.; Ji, J.; Feng, G.; Lin, H.; Yi, Q.; Shi, Y. 2014: CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. British Journal of Psychiatry: the Journal of Mental Science 204(1): 36-39
Trombetta, M.; Bonetti, S.; Boselli, M.; Turrini, F.; Malerba, G.; Trabetti, E.; Pignatti, P.; Bonora, E.; Bonadonna, R.C. 2012: CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. Plos one 7(3): E32755
Yang, Q.; Li, Z.; Li, W.; Ku, L.; Wang, C.; Ye, J.; Li, K.; Yang, N.; Li, Y.; Zhong, T.; Li, J.; Chen, Y.; Yan, J.; Yang, X.; Xu, M. 2013: CACTA-like transposable element in ZmCCT attenuated photoperiod sensitivity and accelerated the postdomestication spread of maize. Proceedings of the National Academy of Sciences of the United States of America 110(42): 16969-16974
Bevan, W. 1972: CACTAL: Cooperation for Progress. Science 175(4026): 1067
Glynn, L.H.; Hallgren, K.A.; Houck, J.M.; Moyers, T.B. 2012: CACTI: free, open-source software for the sequential coding of behavioral interactions. Plos one 7(7): E39740
Fraioli, F.; Serra, G.; Passariello, R. 2010: CAD (computed-aided detection) and CADx (computer aided diagnosis) systems in identifying and characterising lung nodules on chest CT: overview of research, developments and new prospects. La Radiologia Medica 115(3): 385-402
Ueda, Y. 2007: CAD (computer aided detection) for digital mammography. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(12): 1412-1417
Fuster-Torres, M.Angeles.; Albalat-Estela, S.; Alcañiz-Raya, M.; Peñarrocha-Diago, Mía. 2009: CAD / CAM dental systems in implant dentistry: update. Medicina Oral Patologia Oral y Cirugia Bucal 14(3): E141-E145
Destounis, S.V.; Arieno, A.L.; Morgan, R.C. 2012: CAD May Not be Necessary for Microcalcifications in the Digital era, CAD May Benefit Radiologists for Masses. Journal of Clinical Imaging Science 2: 45
Wang, Y.; Jiang, S.; Wang, H.; Guo, Y.H.; Liu, B.; Hou, Y.; Cheng, H.; Tian, J. 2010: CAD algorithms for solid breast masses discrimination: evaluation of the accuracy and interobserver variability. Ultrasound in Medicine and Biology 36(8): 1273-1281
Arnetzl, G. 2010: CAD all over and everywhere?. International Journal of Computerized Dentistry 13(4): 295-297
Bettencourt, N.; Ferreira, N.D.; Leite, D.; Carvalho, M.ón.; Ferreira, W.d.S.; Schuster, A.; Chiribiri, A.; Leite-Moreira, A.; Silva-Cardoso, J.é; Nagel, E.; Gama, V. 2013: CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol. JACC. Cardiovascular Imaging 6(10): 1062-1071
Uchiyama, Y. 2007: CAD for brain MR-CT. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(12): 1454-1459
Niki, N. 2007: CAD for chest CT screening. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(12): 1396-1403
Li, B.; Tian, L.; Ou, S. 2009: CAD for identifying malignant lung nodules in early diagnosis: a survey. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(5): 1141-1145; 1157
Nakagawa, T. 2007: CAD for retinal fundus images. Nihon Hoshasen Gijutsu Gakkai Zasshi 63(12): 1464-1468
Sohns, C.; Angic, B.Cetin.; Sossalla, S.; Konietschke, F.; Obenauer, S. 2010: CAD in full-field digital mammography-influence of reader experience and application of CAD on interpretation of time. Clinical Imaging 34(6): 418-424
Boyer, B.; Balleyguier, C.; Granat, O.; Pharaboz, C. 2009: CAD in questions/answers Review of the literature. European Journal of Radiology 69(1): 24-33
Linguraru, M.G.; Zhao, S.; Van Uitert, R.L.; Liu, J.; Fletcher, J.G.; Manduca, A.; Summers, R.M. 2008: CAD of colon cancer on CT colonography cases without cathartic bowel preparation. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2008: 2996-2999
Komarov, V.V.; Yakovlev, V.V. 2007: CAD of efficient TMmn0 single-mode elliptical applicators with coaxial excitation. Journal of Microwave Power and Electromagnetic Energy: a Publication of the International Microwave Power Institute 40(3): 174-185
Royzman, E.; Atanasov, P.; Landy, J.F.; Parks, A.; Gepty, A. 2014: CAD or MAD? Anger (not disgust) as the predominant response to pathogen-free violations of the divinity code. Emotion 14(5): 892-907
Yu, Q.; Gong, X.; Shen, G. 2013: CAD presurgical nasoalveolar molding effects on the maxillary morphology in infants with UCLP. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 116(4): 418-426
Probst, F.A.; Mehl, A. 2008: CAD reconstruction using contralateral mirrored anterior teeth: a 3-dimensional metric and visual evaluation. International Journal of Prosthodontics 21(6): 521-523
Bazzocchi, M.; Mazzarella, F.; Del Frate, C.; Girometti, R.; Zuiani, C. 2007: CAD systems for mammography: a real opportunity? A review of the literature. La Radiologia Medica 112(3): 329-353